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ABSTRACT 
Moser, Sydney E., Ph.D., Purdue University, August 2016. Ability of Dietary 
Polyphenols to Modulate Carbohydrate Digestion and Glucose Transport. Major 
Professor: Mario Ferruzzi. 
 
Both epidemiological and clinical evidence support the notion that polyphenol 
rich foods and beverages may modify glycemic response, glucose homeostasis and 
subsequent risk of Type-2 diabetes.  In vitro evidence typically derived from experiments 
with pure phenolics and phenolic rich extracts have pointed to this benefit being 
associated with two potential mechanisms: (1) the ability of specific polyphenolics to 
inhibit carbohydrate digestion (amylase and glucosidase) and (2) polyphenolic inhibition 
of intestinal glucose transport. While the high potential of these activities is evident, little 
is actually known regarding the extent to which these benefits are extendable to the actual 
food matrix these phenolics are naturally present in.  Further, the extent to which co-
consumption of polyphenol rich foods may actually result in decreased glycemic 
response from a mixed meal remains mostly unknown. Considering these limitations, 
additional insights are required in order to advance knowledge on the benefits of 
polyphenolics on glucomodulatory mechanisms and translation of these insights into 
meaningful recommendations and products for consumers. With this in mind, the 
objectives of these studies were to determine the extent to which phenolic-rich foods 
(grapes and potatoes) exert glucomodulatory properties in model food systems using in 
xiv 
vitro and in vivo assessments. First, mechanisms associated with polyphenol rich extracts 
or model foods on carbohydrate intestinal digestion and glucose transport were 
investigated in vitro using a three-stage in vitro digestion model coupled to the Caco-2 
human intestinal cell model. Components of this model used individually or in 
combination allowed for assessment of the two main mechanistic steps in phenolic 
modulation of glycemic response (starch digestion and glucose transport) in the context 
of interactions with bioaccessible phenolics.  Additionally, the ability of the coupled in 
vitro digestion/Caco-2 model to predict in vivo outcomes was assessed. 
The first study compared the ability of 100% Niagara or Concord grape juice (GJ) 
phenolics to modify carbohydrase activity and intestinal glucose transport relative to a 
sugar sweetened beverage. While grape juices remain a major dietary source of phenolics, 
they are also well recognized to be naturally high in sugar content.  Insights into the 
ability of natural fruit phenolics to modify glycemic response of grape juice were 
investigated in vitro.   Also, in consideration that 100% GJ is consumed with meals, the 
extent to which modulation of carbohydrate digestion and intestinal absorption by GJ 
phenolics can be extended to a carbohydrate rich meal was evaluated. In the first 
experiment, inhibition of α-amylase and α-glucosidase by GJ extracts (300 and 500 μM 
total phenolics) and ability of GJ extracts (10 to 100 μM total phenolics) to modulate 
labelled glucose and fructose transport across Caco-2 intestinal cell monolayers 
compared to a phenolic-free control were determined. GJ extracts decreased α-
glucosidase, but not α-amylase activity at both concentrations tested. Further, glucose and 
fructose transport were significantly (p<0.05) decreased in a dose-dependent manner by 
Niagara and Concord GJ extracts.  In a second experiment, GJs and phenolic-free control 
xv 
beverages were co-digested in vitro with a starch-rich model meal. Resulting aqueous 
digesta (AQ) from both experiments were used to assess impact of bioaccessible GJ 
phenolics on carbohydrate digestion and glucose transport. Concord and Niagara GJs 
significantly decreased in vitro gastrointestinal digestion of carbohydrate from model 
meal compared with a sugar-matched control. Further, d7-glucose transport from AQ 
fraction of GJ and co-digested GJ and carbohydrate-rich meal across Caco-2 human 
intestinal cell monolayers was significantly decreased compared to phenolic-free sugar-
sweetened control. 
The second study evaluated potential for phenolics from starch rich white, purple, 
or red potatoes to modulate carbohydrate digestion or glucose transport in a Caco-2 
intestinal cell model. Potato phenolic extracts (300 μM) had no impact on α-amylase 
activity, and marginally decreased α-glucosidase activity. However, potato phenolic 
extracts (25-100μM) did decrease d7-glucose transport compared to phenolic-free control. 
Interestingly, whole potato phenolic extracts reduced glucose transport to a greater extent 
compared to those from potato peel. To determine if results from aforementioned in vitro 
assays are predictive of effects in vivo, a pilot clinical study (n=11) was completed to 
assess differences in acute blood glucose response and gastric emptying following 
consumption of phenolic-rich purple and red potato chips compared to white potato chips 
(50g available carbohydrate) containing lower level of total phenolics. Blood glucose 
levels were measured for up to two hours. Peak blood glucose levels were lower for 
pigmented chips, especially purple chips, compared to white chips without any 
significant changes in gastric emptying. These results suggest that potato phenolics may 
xvi 
play a role in modulation of intestinal glucose transport and that these effects are 
translatable to consumer products such as potato chips.   
 Taken together, these data support the notion that phenolics intrinsic to select foods have 
the ability to modify glycemic response through alteration of glucose transport and to a 
certain extent starch digestion.  Therefore, it is likely that observed benefits associated 
with consumption of phenolic-rich foods and 100% fruit juices, as a part of an overall 
healthy diet, may be associated with the ability of intrinsic and bioaccessible phenolics to 
modify glycemic response. Future research that focuses on hypoglycemic effects of 
phenolic-rich foods should be larger scale and should evaluate a greater variety of 
phenolic-rich foods in order to better understand the extent to which phenolic class and 
food matrix impact hypoglycemic effects. Regarding meal-effects, a pilot clinical study 
should be completed to validate in vitro results and to provide information as to what 
degree various types of meal patterns alter glycemic effects of phenolic-rich foods.  Such 
information can be leveraged in the development of phenolic-rich food products that have 
post-prandial glycemic effects and for making recommendations of dietary choices which 
may result in improved glucose homeostasis.
1 
CHAPTER 1. REVIEW OF THE RELEVANT LITERATURE 
 Introduction 1.1
Phenolic phytochemicals are abundant in fruits, vegetables, and select whole-
grains. Historically, the U.S. Dietary Guidelines have stressed these phenolic rich food 
groups as important components of a healthful diet, providing guidance to increase fruit 
and vegetable intake and to consume more than half of grains as whole-grains [1]. 
Additionally, several epidemiological studies and meta-analyses suggest that increased 
consumption of phenolic-rich foods is associated with positive health outcomes such as 
cardioprotection, reduced oxidative stress and diabetes prevention [2–5]. About 29.1 
million people (9.3% of the U.S. population) have diabetes, with type 2 diabetes 
constituting about 90% to 95% of all diagnosed cases of diabetes in adults [6]. Therefore, 
prevention of type 2 diabetes, or adult-onset diabetes, through improved diet and exercise 
regimen has become an important focus for Americans. 
A major risk factor associated with development of diabetes is hyperglycemia, or 
the state of excess glucose in the blood stream [6]. Foods with high simple sugar or 
rapidly digestible starch content are considered high glycemic index (GI) foods and are 
well known stimulate an increased glycemic response[7–9]. Interestingly, whole grains 
and many fruits are in fact high in digestible carbohydrate or simple sugars creating a 
conflicting message. That being said, these foods have lower glycemic index compared to 
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other commonly consumed carbohydrate-rich foods such as white and wheat bread, pasta 
and tortillas [10].  Beyond simply avoiding high GI foods, it is unclear what types of 
dietary strategies may be used to effectively decrease glycemic response following a meal. 
However there is evidence that avoiding spikes in blood glucose levels and maintaining 
sustained energy and enhanced satiety is correlated to improved modulation of glycemia 
and decreased risk for development of obesity and diabetes [11–15]. Therefore, interest in 
development of diet-based strategies aimed to modify high glycemic response has grown 
[11–13].  
The ability of phenolics to modulate glycemic parameters was first postulated by 
Thompson et al. [16] who reported in a systematic study on grains, pulses and other 
starch rich foods that the phenolic content was inversely correlated to glycemic index.  
Since this study, clinical evidence exist that show that dietary phenolics may result in 
reduced post-prandial glucose response or fasting blood glucose levels [17–30]. 
Specifically, results suggest co-consumption of phenolic-rich fruits, vegetables, whole 
grains, or select spices with a meal may lower post-prandial glycemic response and have 
sustained impact on markers of glycemia. Similarly to work with extracts and starchy 
foods, consumption of phenolic-rich berry fruits and select 100% fruit juices appear to 
result in a reduced glycemic effect despite their higher sugar content [22–26,28–30]. 
While these observations are promising, mechanisms behind these effects have not been 
clearly identified. Some evidence suggest that phenolics may impact glucose transport or 
modify glucose homeostasis through inhibition of starch digestion by α-amylase and α-
glucosidase [21,22,31–44]  However, there are still gaps in knowledge concerning 
mechanisms that may be related to the ability of a phenolic-rich foods to modulate 
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glucose homeostasis. Furthermore, despite the promising observations, the extent to 
which these effects can be translated to more complex products or to meals and dietary 
patterns is unknown. This review focuses on providing an overview of studies that have 
investigated hypoglycemic effects exerted by phenolics and the mechanisms involved as 
a background for the specific objectives investigated in this research. 
 
 
 Dietary Flavonoids 1.2
Flavonoids are one of four main classes of polyphenols, the remaining classes 
being phenolic acids, stilbenes, and lignans [45]. Flavonoids are complex polyphenols 
having a C6–C3–C6 backbone in which the two C6 units are of phenolic nature [46]. 
Major flavonoid classes include anthocyanins, flavan-3-ols, flavones, flavonols, and 
flavanones (Figure 1-1). Select flavonoid-rich foods are outlined in Table 1-1. 
Anthocyanidins are flavylium cations and are generally in nature as glycosides 
bound at either the 3 or 5 position of the C ring (Anthocyanins- in their conjugated forms). 
Key glycosylation sugars include glucose, galactose, rhamnose, and arabinose.  These 
flavonoids contribute to the hue of plants through a process known as copigmentation 
[47]. At low pH, anthocyanins are in their protonated, colored form, but at high pH they 
assume a deprotonated colorless form. Anthocyanins are abundant in colored fruits and 
vegetables including berries, purple grapes, and red or purple potato, cabbage, and onion. 
Flavan-3-ols are the most abundant flavonoid consumed in the western diet [48].  
They are present in common foods and beverages including tea, apple, cocoa, grape and 
4 
grape derived products [49,50]. Flavan-3-ols are structurally characterized by a lack in a 
double bond between C2 and C3, a C4 carbonyl, and by conjugation to glycosidic moiety 
at C3. The unique structure of flavan-3-ols allows for formation of two chiral centers and 
four diastereoisomers [46]. The primary flavan-3-ols include (+/-) catechin, epicatechin, 
epigallocatechin, epicatechin-gallate, and epigallocatechin-gallate. Further, flavan-3-ols 
can be polymerized to form complicated polymers referred to as proanthocyanidins 
(PACs) ranging in degree of polymerization from DP2 to about DP30 [51–53].  These 
polymers are commonly found in cocoa, cider, and red wine [54,55]. 
Flavones are characterized by a double bond between positions 2 and 3 and a 
ketone in position 4 of the C ring. Flavones are much less common in fruit and vegetables 
compared to other flavonoid classes. Luteolin and apigenin glycosides are the primary 
flavones present in foods. Parsley, celery, millet and citrus peels contain flavones [54,56].   
Compared to flavones, flavonols have a hydroxyl group in position 3 of the C ring, 
which may be glycosylated. Flavonols are the most ubiquitous flavonoids in foods, albeit 
they are generally present at relatively low concentrations. These compounds are found 
naturally in glycosylated form, primarily associated with glucose or rhamnose. The main 
representatives of flavonols are quercetin and kaempferol. The richest sources of 
flavonols include onions, kale, leeks, broccoli, dill weed, apples and blueberries [54,56].  
Flavanones also have similar structure to flavones, except they lack a double bond 
between positions 2 and 3 of the C ring and are generally glycosylated by a disaccharide. 
Citrus fruit, namely oranges and grapefruit are particularly rich in flavanones. In addition, 
tomatoes and aromatic plants such as mint contain flavanones [54,56]. 
5 
 
Figure 1-1: Major Flavonoid Subclasses
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Table 1-1: Flavonoid content in selected foods from top 100-ranked richest (mg per 100 g 





Rank Primary flavonoid classes  
Cocoa powder 3448 4 Flavan-3-ols, flavonols  
Mexican oregano, dried 2319 5 Flavanones, flavones, flavonols  
Black chokeberry 1756 7 Anthocyanidins, flavonols  
Dark chocolate 1664 8 Flavan-3-ols  
Highbush blueberry 295 23 Anthocyanidins, flavan-3-ols  
Blackberry 260 30 Anthocyanidins, flavan-3-ols, flavonols  
Strawberry 235 33 
Anthocyanidins, flavan-3-ols, flavanones, 
flavonols 
 
Coffee, filter 214 36 Flavan-3-ols, flavonols  
Almond 187 40 
Anthocyanidins, flavan-3-ols, flavanones, 
flavonols 
 
Black grape 169 41 Flavan-3-ols, flavonols  
Red onion 168 42 Anthocyanidins, flavones, flavonols  
Apple 136 48 
Anthoycyanidins, flavan-3-ols, flavones, 
flavonols 
 
Spinach 119 49 Flavones, flavonols  
Black tea 102 52 Flavan-3-ols, flavonols  
Red wine 101 53 
Anthocyanidins, flavan-3-ols, flavones, 
flavonols 
 
Green tea 89 54 Flavan-3-ols, flavones, flavonols  
Yellow onion 74 56 Flavones, flavonols  
Pure apple juice 68 59 Anthocyanidins, flavan-3-ols, flavonols  
Broccoli 45 70 Flavones, flavonols  
Asparagus 29 78 Flavonols  
Potato 28 80 Flavonols  
Green grape 15 95 Flavan-3-ols, flavonols  
White wine 10 99 Anthocyanidins, flavanones, flavonols  
7 
 Epidemiological associations between flavonoid consumption and health  1.3
Flavonoids are one of the main dietary polyphenols forms associated with health 
endpoints. Several epidemiological studies have reported the associations between 
flavonoid intake and select markers of disease risk. Importantly, studies have focused on 
common preventable chronic diseases such as cardiovascular disease and diabetes.  
 
 Cardiovascular disease risk 1.3.1
There is high consensus among prospective cohort studies that consuming diets 
rich in flavonoids is protective against cardiovascular disease (CVD). Studies have shown 
that consumption of foods rich in flavonoids are inversely associated with the incidence 
of coronary heart disease (CHD) and, more specifically, quercetin intake decreases risk 
for ischemic heart disease [57,58]. Similarly, results from a prospective study in 
postmenopausal women showed consumption of anthocyanins and anthocyanin-rich 
foods, specifically red wine and strawberries, was significantly inversely associated with 
risk of CHD and CVD [59]. In addition, flavanones, flavanone-rich grape fruit, and 
flavanol-rich apples and chocolate were associated with decreased risk of CHD or CVD.  
Conversely, an earlier study by Sesso et al. [60] suggested that flavonoids were not 
associated with CVD risk. Similarly, flavonols and flavones were not associated with risk 
for CHD and isoflavones were not associated with decreased CVD risk [61,62].  
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 Diabetes.   1.3.2
As diabetes has recently become a primary health concern for Americans, 
epidemiological studies and meta-analyses have been focusing on investigating the 
potential for flavonoids to decrease risk for or to mitigate symptoms of diabetes [58,63–
65]. In a meta-analysis completed by Mahoney & Loprinzi [65], the relationship between 
flavonoid-rich diet and diabetes-related markers was determined. Data was taken from 
381 participants with diabetes from NHANES 2003-2006. The study found that increased 
flavonoid consumption was associated with improved glycemic control as indicated by 
lower levels of blood glucose and glycosylated hemoglobin (HbA1c). Similarly, results 
from additional meta-analyses and prospective cohort studies suggest diets high in 
anthocyanins, quercetin and myricetin, as well as increased consumption of anthocyanin-
rich foods, apples and tea were associated with decreased risk of type 2 diabetes 
[58,63,64]. Conversely, a prospective cohort study by Nettleton et al. [66] observed that 
no glycemic effect was associated with consumption of flavonoid rich foods in 
postmenopausal women. Similar to epidemiological and cohort studies, results from 
clinical trials directly studying effects of flavonoids on diabetes risk have been mixed, 
suggesting more information is needed. In vivo and in vitro investigations that have 
elucidated some potential mechanisms of actions related to the effects will be discussed 
in the subsequent sections.  
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 Relationship between Flavonoid Intake and Glucose Homeostasis: Pre-clinical 1.4
Evidence  
 Animal studies 1.4.1
Animal models for disease are critical screening tools to determine efficacy of 
health-promoting compounds prior to clinical investigation.  A number of studies have 
used streptozotocin-induced (STZ) diabetic rats to determine if inclusion of phenolic 
extracts from flavonoid-rich fruits and vegetables or individual flavonoids into the 
experimental diets may impact blood glucose levels compared to STZ-free control (Table 
1-2). Overall, acute effects of flavonoid extracts from fruit and select spices on glycemia 
have been observed with a general trend to reduction of glucose response. In a study by 
Hogan et al. [67], red grape pomace extract (22.1mg/g total flavonoids) was administered 
to STZ rats by gavage (400mg/kg bw) followed by a potato starch challenge (2g/kg bw). 
Glycemic AUC response two hours following starch challenge was 35% lower for 
treatment group compared to STZ control group receiving water. Similarly, ingestion of 
flavonoid and tannin-rich cinnamon bark extract (300 and 600mg/kg bw) by STZ rats 
before consumption of maltose/sucrose (2g/kg bw) decreased two hour post-prandial 
glycemic response by 78-86% compared to STZ control group receiving maltose/sucrose 
solution without cinnamon bark extract [68]. Overall, results suggest that flavonoid-rich 
extracts decrease acute post-prandial hyperglycemic response for up to 2 hours following 
a carbohydrate challenge.  
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Table 1-2: Impact of flavonoid consumption on postprandial or resting blood glucose 
concentration in streptozotocin-induced (STZ) rats 
 1
Controls for each study are STZ rats receiving matching phenolic-free treatment or diet. 
2
NC = not calculated














Compared to STZ 
Control 
Reference 
Red grape pomace 
extract 
22.1mg/g total flavonoids; 
400mg/kg bw 
Potato starch  
(2g/kg bw) 
2hr ↓35% NA 
Hogan et al. 
2010 
Cinnamon bark extract 300 and 600 mg/kg bw 
Maltose/sucrose 
(2g/kg bw) 
2hr ↓78-86% NA 
Shihabudeen 




polyphenols; 0.2% in diet 
NA 4wks NA ↓17% 
Jurganski et 
al. 2008 
Red cabbage extract 1g/kg bw daily  NA 8.5wks NA ↓~35% 
Kataya et al. 
2007 
Bilberry extract  27g/kg bw daily NA 5wks NA ↓~25% 
Takikawa et 
al. 2010 
Kaempferetin 100mg/kg bw 
Glucose 
(4g/kg bw) 
3-4hrs ↓20% NA 
deSousa et al. 
2004 
Epicatechin 30mg/kg 2x/day NA 6 days NA ↓~70% 
Kim et al. 
2003 
Quercetin 100mg/kg bw 
Soluble starch 
(1g/kg bw) 
3-4hrs ↓50% NA 
Kim et al. 
2011 
Quercetin 0.08% in diet NA 7wks NA ↓14% 
Kim et al. 
2011 
Isoquercetin 5 and 15mg/kg bw NA 11d NA No effect 
Hunyadi et al. 
2012 
Rutin 5 and 15mg/kg bw NA 11d NA ↓32% 
Hunyadi et al. 
2012 
Fisetin 10mg/kg bw NA 30d NA ↓~60% 
Prasath et al. 
2011 
Quercetin 0.05mg/kg bw NA 8wks NA No effect 
Dias et al. 
2005 
Hesperedin or Naringin 50g/kg bw NA 4wks NA ↓54-58% 
Mahmoud et 
al. 2012 
Diosmin 100mg/kg bw NA 6.5wks NA ↓~70% 
Srinivasan et 
al. 2011 
Pelargonidin 3mg/kg bw NA 3wks NA ↓60% 
Roy et al. 
2008 
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In addition to acute effects, many studies have investigated chronic effects of 
flavonoid consumption on hyperglycemia with positive results. Fasting blood glucose 
levels of STZ rats treated with 0.2% PAC rich chokeberry extract (714 mg polyphenols/g 
extract) for 4 weeks was decreased by 17% compared to STZ rats consuming matched 
extract-free diets [69]. More moderate effects were observed for addition of anthocyanin 
rich red cabbage and bilberry extracts (1g/kg bw daily, 8.5 wks and 27g/kg bw, 5 wks, 
respectively) to diet of STZ rodents, with treatments resulting in 25% decrease of fasting 
blood glucose levels compared to STZ  rats receiving vehicle control [70,71].   
Hypoglycemic effect of individual flavonoids has also been investigated. 
Flavonols and flavan-3-ols, in particular, have been subject of many investigations as 
they are ubiquitous in many foods. Addition of specific flavonols to the diet of STZ rats 
has been shown to mitigate acute glycemia compared to control STZ rats consuming 
matching diets free of the specific flavonol. Specifically, kaempferetin (100mg/kg bw) 
and quercetin (100mg/kg bw) administered to STZ rats decreased postprandial glucose 
levels (3 to 4 hours post-consumption) by 20% and 50%, respectively, compared to STZ 
rats receiving vehicle control [72,73].  
Chronic hypoglycemic effects of flavonols have also been reported. Addition of 
the flavan-3-ol epicatechin (EC) (30mg/kg bw, 2x/day) to diets mitigated effects of STZ, 
resulting in significantly decreased fasting blood glucose levels compared to STZ control 
rats [74]. Further, blood glucose levels in EC-treated STZ rats were similar to normal 
control rats. Chronic exposure to quercetin (0.08% in diet, 7 weeks), and rutin and fisetin 
(15mg/kg bw, 11 days and 10mg/kg bw, 30 days, respectively) decreased fasting blood 
glucose by 14, 32, and 60%, respectively, in STZ rats compared to STZ rats consuming 
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matching diets containing vehicle control [73,75,76]. However, addition of quercetin 
(0.05g/kg, 8 wks) to diet had no apparent effect on fasting blood glucose levels in STZ 
rats compared to STZ control rats [77]. Regarding other flavonoid classes, flavonoid 
glycosides hesperidin and naringin (50mg/kg, 4 wks), the flavone diosmin (100mg/kg, 
6.5 wks), and the anthocyanin pelargonidin (3mg/kg, 3 wks) were all reported to decrease 
fasting blood glucose levels in STZ rats by 60 to 70% compared to STZ control rats [78–
80]. Although studies have shown that addition of flavonoid-rich extracts from foods or 
individual flavonoids to diet have the ability to decrease blood glucose levels in models 
for hyperglycemia, there is little information on hypoglycemic effect by flavonoid 
treatment in normoglycemic models. 
 
 Evidence from human studies 1.4.2
Results from population based studies, meta-analyses and preclinical models 
examining the association between flavonoid-rich diet with glycemic modulation or risk 
of diabetes do suggest that diets rich in phenolics or, more specifically, flavonoid-rich 
foods are associated with lower fasting blood glucose levels and can potentially influence 
the risk of type 2 diabetes [58,63–65]. Clinical intervention studies have in fact been 
completed to obtain direct evidence of these effects in human participants using more 
controlled conditions in order to support observations made using epidemiological studies 
(Table 1-3). More recently, an acute hypoglycemic effect following consumption of black 
tea with sugar compared to sugar sweetened control beverage (water) was reported in 
humans [17]. The phenolic profile of black tea is interesting because in addition to
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Table 1-3: Results from clinical interventions observing impact of flavonoid-rich food 





























Glucose (75g) 2hr ↓1.3mmol/L% NA 
Bryans et 
al. 2013 
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Vinson et 
al. 2012 






1hr ↓20% NA 
Ghanim a et 
al. 2010 
Berry Pureé  300mL 35g Sucrose 3-4hrs 









300mL 15g Sucrose 2hrs 









(50g CHO)  
2hrs No effect NA 




7mL/kg bw/d NA 8wks NA ↓3mg/dL 
Dohadwala 
et al. 2010 
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native flavan-3-ols such as those found in green tea (catechins), black tea is rich in 
oxidized flavonoid polymers, including theaflavins and thearubigins. Following ingestion 
of instant black tea beverages (1.0g, 350mg phenolics, 39mg flavan-3-ols/g; 75g glucose), 
postprandial plasma glucose concentrations was similar relative to consumption of 
control (75g glucose) for up to 60min, but was significantly reduced at 120 min by 
1.3mmol/L. Although results suggest that black tea may elicit a latent hypoglycemic 
response to carbohydrate from a sugar matched phenolic-free beverage, the extent to 
which this effect can be translated to a more complex meal is unknown. Considering that 
tea is typically consumed with food this remains a critical question to consider. 
In that regard, a few studies have observed effects from co-ingestion of flavonoid-
rich plant materials with starchy foods related to subsequent glycemic response. Herbs 
and spices are commonly used as seasonings to enhance the flavor of foods. As they are 
low in energy and contain high levels of phenolics, spices are an appropriate vehicle for 
flavonoids to determine effects of seasoning a carbohydrate-rich food on post-prandial 
glycemic response. Hlebowicz et al. [18,19] investigated glycemic effects due to addition 
of proanthocyanidin-rich cinnamon (1, 3, or 6g) to rice pudding (300g). Addition of a 
high load (6g) of cinnamon to the pudding resulted in reduction of incremental 
postprandial blood glucose concentration (mmol/L) at 15, 30, and 45 minutes compared 
to control. However, this effect was not observed for pudding containing lower levels of 
cinnamon. Therefore, it appears that cinnamon added at very high concentrations to a 
starchy food may have an acute effect on post-prandial glycemic response. 
Overweight individuals (body mass index (BMI) >25kg/m
2
) are more susceptible 




A study by Almoosawi et al. [20] completed a 4 wk study in which obese and non-obese 
participants consumed 20g polyphenol-rich dark chocolate (500mg polyphenols/day) to 
determine if chronic dark chocolate consumption may have a positive impact on glucose 
homeostasis. Consumption of dark chocolate significantly decreased fasting blood 
glucose levels by 0.59 mM compared to phenolic-free control in overweight subjects, but 
not in subjects with normal weight. At the beginning of the study, overweight individuals 
had higher fasting blood glucose levels compared to normal weight individuals. 
Therefore, the flavan-3-ols and other polyphenols from dark chocolate may have a 
beneficial effect only for those consumers who have impaired glycemic control.   The 
extent to which this effect is related to differences in glycemic control or in flavonoid 
bioavailability or metabolism is unknown. 
 
 Studies on Potatoes 1.4.3
Potatoes are common staple foods that provide a good source of both 
carbohydrate and phenolics in the form of phenolic acids and chlorogenic acids (Figure 
1-2). Per 100g, potatoes provide 93 kcals, 2.2g of fiber, 535mg potassium, and 9.6mg 
vitamin C [81].  Additionally potatoes are rich in phenolics. Notably, studies have found 
chlorogenic acid accounts for the majority of potato phenolic content, with levels 
reaching 1833 mg chlorogenic acid per 100g [82–85]. Pigmented potatoes contain 
anthocyanins, with purple and red potatoes characteristically containing high levels of 




Figure 1-2: Major phenolic acid subclasses, including those found in potatoes 
(chlorogenic acid and caffeic acid). 
  
and micronutrients (potassium, iron, vitamin B6, and vitamin C) and lower in 
carbohydrate and energy per 100g compared to other carbohydrate-rich staples such as 
macaroni and long grain brown rice [81], potatoes have been classified with medium to 
high GI and are often cited as a contributor to diabetes risk [87–89]. Therefore, interest in 
determining their true contribution to post prandial glycemia has grown.   
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 Clinical trials have been completed to determine if select consumption of 
anthocyanin and phenolic-rich potatoes with pigmented flesh and skin may result in 
decreased glycemic response compared to the commonly consumed white fleshed potato.  
Ramdath et al. [21] reported an inverse correlation between polyphenol content of 
microwaved potato cubes and GI. Specifically, purple and red pigmented potatoes, high 
in total phenolics (120-145mg gallic acid equivalents (GAE)/50g available carbohydrate 
(CHO)) and specifically rich in anthocyanins (15mg cyanidin-3-glucoside 
equivalents/50g CHO), tended to have reduced acute (15min) glucose responses and GI 
values compared to white or yellow varieties (50-70mg GAE/50g CHO), decreasing 
blood glucose concentration (mmol/L) by ~15%. However, consumption of 6-8 small 
anthocyanin rich purple potatoes (~138g total; 6.5mg/g dw anthocyanins; 10mg/g dw 
total phenolics)  2 times per day for 4 weeks did not impact fasting blood glucose 
compared to a comparable amount of refined starch as cooked biscuits [90]. These results 
suggest that although potatoes may exert hypoglycemic effects, the phenolic profile may 
be a factor in determining the extent to which they deliver glucose to the GI tract.  
Further these effects may be acute rather than more sustained effects. 
 
 Studies with Fruits and Juices   1.4.4
Fruits have historically been recommended as part of a balanced diet by the 
USDA Dietary Guidelines for Americans. However, fresh fruits and fruit juices are also 
known to high natural sugar content. That being said, fruits are rich sources of phenolics, 
including flavonoids [91]. Therefore, it can be postulated that fruits or their products 
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consumed as an alternative to other low or non-flavonoid sugar sweetened beverages or 
snacks may result in lowered glycemic response. However, the extent to which fruit may 
contribute GI active phenolics that can modulate carbohydrate digestion and absorption 
remains a question.  That being said, recent research does suggest that consumption of 
fruits and fruit juices in the context of a meal reduces acute postprandial glucose response.  
Orange juice (rich in flavanones and flavones) and apple juice (rich in flavan-3-




, respectively, for per capita consumption in 
the US [92]. According to results from previous studies, both orange and apple juice have 
been shown to reduce acute glycemic response relative to sugar matched controls. 
Specifically, consumption of orange juice (300kcal) in place of a beverage matched for 
calorie content along with a high-fat, high-carbohydrate meal reduced 1 hr postprandial 
blood glucose levels by ~20% [26]. Additionally, apple juices (400mL; cloudy or clear; 
containing 1567µM and 463µM total phenolics, respectively) significantly delayed 
glucose absorption over 30 minutes as indicated by incremental glucose area under the 
curve (AUC) [22]. Results suggest that consumption of orange juice or apple juice with a 
meal results in lower post-prandial glycemic response compared to a phenolic-free sweet 
beverage with comparable sugar content. 
In addition to juices, berry fruits including raspberries, blueberries, and 
crowberries, have been strongly associated with anti-obesity and diabetes benefits.  Berry 
fruits are well established as a rich source of flavonoids and are especially known for 
their high anthocyanin content, which ranges from 83 – 615 mg/100g for blueberries, 
blackberries and grapes [91][28]. Co-consumption of anthocyanin, flavonol, and flavan-
3-ol-rich berry purée or blackcurrant juice fortified with crowberry powder (300mL) with 
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a standard meal both resulted in significantly decreased postprandial blood glucose levels 
compared to control (sugar matched beverage). With regards to berry purée consumption, 
blood glucose levels were significantly decreased compared to control 15 minutes 
following consumption, but significantly increased after 90 minutes [29]. Between 15 and 
90 minutes, there were no significant differences between treatments. On the other hand, 
following consumption of blackcurrant juice fortified with crowberry powder, plasma 
glucose levels were initially not different compared to control, but increased compared to 
control 90 minutes post-consumption [30]. These results suggest that although berries 
processed into a purée or juice may decrease immediate glycemic response compared to 
sugar-sweetened beverages, a rise in blood glucose may eventually occur.  
Another acute study was completed in which blood glucose was tested following 
participants’ consumption of pancakes supplemented with either raspberries or 
blueberries (100g in meal) or control pancakes containing similar amounts of fructose 
and glucose [27]. Unlike aforementioned berry studies, results showed that addition of 
flavonoid-rich raspberries or blueberries to a starch rich meal did not result in lowered 
blood glucose response. Null effects may have been observed be due to the lower dose of 
flavonoid-rich berries compared to aforementioned studies (100g vs. 300g). Although 
flavonoid content was not measured in these studies, the amount of berry served from the 
first two studies mentioned was higher compared to the third study by at least 150%. 
Although there are many acute studies investigating effects of fruit and fruit 
beverages on glycemic response, there have been limited studies addressing long term 
benefits to fasting or postprandial blood glucose response. Although little data exists, 
there have been some interesting clinical results. For example in a double-blind crossover 
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study, Concord grape juice (7 mL/kg/d) rich in flavan-3-ols, flavonols, and procyanidins 
or matched placebo beverage was consumed for 8 wks and blood glucose levels were 
measured [23]. Interestingly, fasting blood glucose decreased 2 mg/dL following 
consumption of grape juice and increased 1 mg/dL following consumption of the placebo 
beverage suggesting that addition of 100% grape juice to the diet may result in improved 
glucose homeostasis in the long term.  
 
 Mechanisms involved in Flavonoid Modulation of Glucose-Homeostasis during 1.5
Gastrointestinal Digestion 
Increasing interest in the hypoglycemic effects of polyphenol rich foods has 
stimulated the investigation of mechanisms associated with such effects. Central 
hypotheses in regards to the hypoglycemic effects of flavonoids specifically revolve 
around the potential for flavonoids to modulate carbohydrate digestion and intestinal 
glucose transport.  Additionally,  modulation of insulin response through stimulation of 
insulin secretion by β-cells in the pancreas and activation of insulin receptors; stimulation 
of glucose uptake by insulin-sensitive tissues such as adipose and muscle cells; and 
suppression of hepatic glucose output have all been postulated (reviewed by Hanhineva et 
al. [93]). Ample studies have investigated mechanisms central to the gastrointestinal tract, 
associated with the ability of specific flavonoids and plant-derived flavonoid-rich extracts 
to modulate intestinal carbohydrate digestion and glucose transport (Figure 1-3). Both are 
somewhat predicated on the polyphenols’ ability to interact non-specifically with 
macromolecules including starch and protein (reviewed by Bordenave et al. [56] and 
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Ferruzzi et al. [94]).  The result of such interactions may in fact be the inhibition of 
carbohydrate digestion through modest inhibition of α-amylase and glucoamylase 
[21,31–40]. Additionally, flavonoids have been reported to interact directly with glucose 
transporters SGLT1 and GLUT2, potentially reducing the rate at which glucose is 
translocated from the lumen into the enterocyte [22,41–44].  Combined these effects may 
serve to decrease the rate of both glucogenesis and glucose transport from digested foods 
in the gut. 
 
 Flavonoid-Macronutrient Interactions.   1.5.1
Flavonoid-protein interactions have been extensively investigated with a primary 
focus on food quality and digestive impacts [95–102]. The dominant forces associated 
with these non-specific interactions are hydrophobic stacking generated by π-π 
interactions and London forces between dipoles within polyphenols and aromatic amino 
acid side chains within protein [103–105].  In addition to these primary forces, protein-
flavonoid binding can be further stabilized by hydrogen bonds between hydroxyl groups 
of polyphenols with those of protein chains.   
Research suggests that flavonoid structure can greatly influence the nature and 
strength of their interaction with proteins (Table 1-4). In most cases, large molecular 
weight flavonoids with greater extent of aromatic rings (such as polymeric flavan-3-ols) 
appear to have increased binding with proteins. For example, galloylation of flavonoids 
has been shown to increase binding interactions due to increased availability of aromatic 
rings and hydroxyl groups. However in some cases, low conformational mobility of large 
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flavonoids may serve to decrease binding affinity [99,106–109]. Binding is also 
improved with increased hydroxylation on A and B rings of a flavonoid or presence of 
ortho phenolic hydroxyl groups [106,108,109]. On the other hand, binding affinity tends 
to decrease by flavonoid methoxylation, glycosylation, and hydrogenation of C2=C3 
double bond  [108–110]. 
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Aromatic side chains 
on protein; 
hydrophobic areas  (ie. 
center of helices, β-






Increased degree of 
polypmerization 
↑ 
Aromatic Rings ↑ 
Galloylation ↑ 
Hydroxylation ↑ 




Increased Charge ↑ 
Charged carbohydrate 
(pectin and lignin) 
Ionic interaction 
Methoxylation ↓   
Glycosylation ↓ NA NA 
Hydrogenation of 
C2=C3 double bond 
↓   
1
NA = not applicable 
 
Impacts of flavonoid-protein interactions within food matrices on beverage 
stability and protein digestion have been extensively investigated. An example of this is 
that of beverage haze. Beverage haze is a phenomena characteristic of beverages that 
contain naturally occurring polyphenols and haze-active proteins, for example juice, wine, 
and beer. Haze active proteins contain proline groups that form complexes with 
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polyphenols through hydrophobic and electrostatic interactions, thereby causing the 
beverage to appear cloudy [111].  
Milk proteins are popular models for flavonoid interaction with dietary protein. A 
study by Xiao et al. investigated the extent of binding between various flavonoids with 
proteins from diluted bovine milk. Hydroxylation and galloylation of flavonoids 
enhanced flavonoid-protein interaction whereas glycosylation and hydrogenation of 
flavonoids weakened their affinity to protein [108].  Structural analysis has also been 
used to show that catechins bind β-LG and α- and β-caseins via both hydrophilic and 
hydrophobic interactions, with gallated catechins having lower binding constants [97,98]. 
Ultimately, such interactions between flavonoids with dietary proteins may alter protein 
digestion.  
Polyphenols have also been shown to interact with carbohydrate. One study 
showed incorporation of tea polyphenols to 10% w/w in a high amylose (0.1% w/w) 
maize starch solution increased hydrodynamic radius of amylose, suggesting the tea 
polyphenols interact with amylose units, bridging them together [112]. In a study by 
Takahama et al. [113], phenolics were extracted from buckwheat flour and were then 
individually re-incorporated into the flour to determine extent of phenolic interaction 
with starch. Individual phenolics (epicatechin-dimethylgallate and rutin) extracted from 
buckwheat flour bound with amylose and amylopectin. It was suggested that the 
hydrophobic helical structures present in amylose and amylopectin interacted with 
hydrophobic areas on the phenolics. Similarly, a study by Barros et al. [114] showed 
addition of sorghum extracts (monomeric phenolic-rich and proanthocyanidin-rich 
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varieties) at 5 to 10% w/w in corn starches (normal or high amylose content) resulted in 
3x increased formation of resistant starch compared to phenolic-free control. Results 
from subsequent analyses indicated polymeric proanthocyanidins interacted more 
strongly with amylose and linear fragments of amylopectin compared to branched 
amylopectin, suggesting hydrophobic interaction dominated. 
Research studying flavonoid interaction with fiber has elucidated further possible 
mechanisms behind flavonoid-polysaccharide interactions.  In general, flavonoid 
molecular size, conformational flexibility and extent of galloylation and hydroxylation 
favored flavonoid-β-glucan or β-cyclodextrin interaction [102,115,116]. However, 
flavonoid-β-glucan adsorption deteriorated with flavonoids bearing more than three 
hydroxyl groups [102]. In addition to galloylation, flavonoid degree of polymerization 
has been shown to increase binding between procyanidins and apple cell wall material. 
Interestingly, binding was also shown to increase with proportion of (+)-catechin as 
opposed to (-)-catechin, indicating a stereochemical specificity for flavan-3-ols [117]. In 
another study anthocyanins, due to their charged nature, were reported to preferentially 
interact with pectin and lignin, likely due to their negatively charged nature [114,118]. 
These results highlight the importance of both flavonoid and polysaccharide structure to 
their interaction with each other. With regards to characteristics of flavonoid structure 
that decrease binding, results from a recent study indicate that similar to protein 
interaction, phenolic methylation and methoxylation decreased their ability to interact 
with β-glucan [102]. 
Overall, it appears that flavonoid structure is important to flavonoid-protein and 
flavonoid-carbohydrate interactions. Specifically, increased extent of flavonoid molecular 
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size, galloylation, and hydroxylation typically increases interactions, whereas 
methylation and methoxylation tend to decrease interactions. The relationship between 
flavonoid structure and binding affinity for protein and carbohydrate are important to 
consider when investigating carbohydrate digestion.  However, it is important to note that 
little is known in regards to polyphenol-starch interactions and the impact that these 
interactions in foods may have on glucose release in the GI tract.  
 
 Inhibition of starch digestive enzymes by flavonoids 1.5.2
In vitro gastrointestinal digestion models have been used to determine 
digestibility of carbohydrate from specific foods (reviewed by Woolnough et al. [119]). 
The simplest of these models is the Englyst method, which focuses on classifying 
carbohydrates based on how quickly they are digested to glucose units that are ready to 
be absorbed by the intestine. In this method, HPLC is used to measure amount of glucose 
released from a test food during incubation with digestive enzymes [120]. More complex 
models that encompass broader digestive interactions occurring within model foods or 
meals rich in carbohydrate have been applied to investigate the impact of flavonoids on 
starch digestion and glucose release [33,121,122].  In combination with in vitro 
experiments focused on measuring specific enzyme inhibitory and structure-function 
effects related to binding with α-amylase or glucoamylase by specific flavonoids, 
extensive knowledge can be gained relative to the impact of co-digested flavonoids and 
starch using in vitro digestion models that more closely mimic in vivo digestion processes. 
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Using such methods, it has been reported that formulation of phenolic rich 
buckwheat flour into a wheat flour bread resulted in lower glycemic inedex (GI) 
compared to wheat flour bread without added buckwheat flour [123]. A study by 
Takahama & Hirota [123] aimed to determine which constituents of buckwheat flour may 
be responsible for the effect.  After fractionation of buckwheat flour into its fatty acid, 
rutin, proanthocyanins, and flavan-3-ols constituents, release of sugars from in vitro 
digestion of starch suspensions was determined using the individual fractions or native 
buckwheat flour. Release of reducing sugars was faster and reached higher levels by 
digestion of extracted buckwheat starch compared to non-extracted buckwheat starch. 
Flavonoids extracted from buckwheat flour, specifically rutin (a flavonol) and 
epicatechin-dimethylgallate (a flavan-3-ol), were found to bind both amylose and 
amylopectin. Therefore, lower GI from bread fortified with buckwheat may be attributed, 
in part, to inhibitory activity of flavonoids against starch digestion through their 
interaction with amylose and amylopectin. 
Similar results were observed in a study by Shen et al. [37] investigating the 
impact of citrus flavonoids on starch digestion. Citrus flavanones neohesperidin and 
naringin (0.8 and 1.0mM, respectively) significantly inhibited amylase-catalyzed 
digestion of soluble potato starch (0.6mg/mL). Interestingly, naringin and neohesperidin 
mainly inhibited amylose digestion, whereas hesperidin and nobiletin inhibited both 
amylose and amylopectin digestion. In agreement, results from binding studies suggest 
that naringin and neohesperidin bind to amylose, whereas hesperidin and nobiletin bind 
to both amylose and amylopectin. On the other hand, these flavonoids showed weak 
inhibitory activities against digestive enzymes [37]. These results suggest that citrus 
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flavonoids decrease digestion of amylose and amylopectin from starch by binding with 
starch rather than by decreasing activity of specific digestive enzymes such as amylase or 
glucoamylase. Further, it appears that each flavanone has preferential and differential 
binding capacities with specific starch structures providing evidence for structure 
function relationships that can be leveraged. 
Similarly, the flavonol kaempferol inhibited α-amylase-catalyzed starch digestion 
as a function of kaempferol concentration in the presence of 0.1 mg/mL starch [38]. 
Specifically amylose, soluble starch, and amylopectin digestion were inhibited by 40 to 
75%, 20 to 60%, and 10 to 40%, respectively by kaempferol (10 to 100µM). IC50 was 
observed at concentrations of about 12, 50, and 100 µM kaempferol for amylose, soluble 
starch, and amylopectin, respectively. Further, results from binding studies indicated that 
kaempferol binds directly to amylose and amylopectin indicating kaempferol activity is at 
least partly due to its ability to shield starch from digestion by carbohydrases.  
In addition to their ability to interact with macronutrients, flavonoids have been 
shown to directly inhibit activity of several digestive enzymes including lipase 
[31,124,125], protease [31,126,127] and starch digestive enzymes including amylase and 
glucoamylase [21,22,31–44]. With regards to starch digestive enzymes, theaflavin-rich 
black tea (2.8mL; 2.3 and 3.3 mg GAE/mL) was able to moderately retard pancreatin-
catalyzed digestion of rice noodle (120mg), ultimately reducing glucose liberation by up 
to 28% [35]. Supplementary data from enzyme inhibition studies revealed that black tea 
extract (0.1mg GAE/mg tea leaves primarily as complex oxidized flavan-3-ols) inhibited 
α-amylase and α-glucosidase with IC50 of 0.42 to 0.67 and 0.56 to 0.58mg tea extract/mL, 
respectively. Additionally, the black tea flavan-3-ol oxidized dimer, theaflavin, had IC50 
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of 2.9µM and 165µM against α-amylase and α-glucosidase, respectively. Outcomes from 
this study suggest that theaflavin specifically decreases digestion of starch at least in part 
by inhibition of α-amylase and α-glucosidase activity. However, it is not clear to what 
extent black tea flavonoids may be binding to rice noodle starch. 
Similar results were observed in a study by Goto et al. [34] who investigated the 
mechanisms behind reported anti-diabetic activity of tiliroside (kaempferol 
glucopyranoside), a flavonol present in medicinal herbs. Tiliroside (0.1 to 1mM) 
significantly inhibited pancreatic α-amylase activity compared to phenolic-free control in 
vitro in a dose dependent manner (30 to 96% inhibition), as indicated by decreased 
release of p-nitrophenol from 4-nitrophenyl-a-D-glucopyranoside. However it inhibited 
activity of maltase and sucrase minimally, decreasing activity by 25 and 33%, 
respectively, at 1mM dose. These results are contradictory to those from several other 
studies showing increased inhibition of glucoamylase compared to α-amylase by 
flavonoids. Specifically, recent studies show grape tannins and grape pomace and skin 
extracts rich in anthocyanins, flavonols and flavan-3-ols can inhibit glucoamylase activity 
by ~20 to 85%, but do not inhibit α-amylase activity [39,67,128].  This selective 
inhibition is one that has been previously reported for various plant-derived phenolic 
extracts by Garza et al. [129], Links et al. [130], and Lordan et al. [131]. Interestingly, it 
appears that phenolic compounds with differing structures (catechin, chlorogenic acid, 
and EGCG) selectively inhibit individual C- and N-terminal units of maltase-
glucoamylase and sucrose-isomaltase to various extents through noncompetitive type 
inhibition.  Chlorogenic acid and EGCG exhibited strong inhibitory activity to C-terminal 
subunits of both glucosidases [132]. 
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Contradictory enzyme inhibition results are likely due to structural differences 
between flavonoids of interest and/or models used to assess activity. Results from a study 
by McDougall et al. [133] suggest that tannin-rich fractions from fruits have high α-
amylase activity and low glucoamylase activity, whereas the opposite trend is found for 
anthocyanin-rich fractions, suggesting inhibitory activity of large polymers may be more 
specific to α-amylase whereas inhibitory activity of monomeric flavonoids may be more 
specific to glucoamylase. In agreement, a study by Yilmazer-Musa et al. [40] showed that 
procyanidin-rich grape seed extract strongly inhibited both α-amylase and α-glucosidase 
activity while tea extracts and individual catechins were less effective inhibitors of α-
amylase, but strong inhibitors of α-glucosidase. Further, nongallated catechins had no 
inhibitory activity toward digestive enzymes. Galloylation was also important to 
theaflavin derivatives’ ability to inhibit α-amylase [36]. Specifically, results suggested 
that inhibitory effects were greatest for theaflavin-3,3’-di-O-gallate followed by 
theaflavin-3’-O-gallate, theaflavin-3-O-gallate, and finally theaflavin. In addition to 
galloylation, inhibitory activity was dependent on presence of hydroxyl groups as they 
promote hydrogen bonding between theaflavin aromatic groups with the catalytic 
residues within the active site of α-amylase. 
Overall, results suggest that flavonoids influence starch digestion by non-
covalently binding to starch, shielding starch from digestion by α-amylase and 
glucoamylase, and through direct interaction with α-amylase and glucoamylase, thereby 
decreasing their activity. The combined effect of these activities is a general delay of 
starch digestion and release of starch digestive products including glucose in the GI 
lumen and at the brush boarder.  The extent to which a specific flavonoid is involved in 
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either mechanism is dependent on the structure of both the flavonoid and carbohydrate or 
enzyme involved in the reaction.  Further leveraging of this activity by delay of glucose 
uptake is discussed next. 
 
 Mechanisms involved in inhibition of glucose transport by flavonoids 1.5.3
Although in vitro digestion and enzyme inhibition assays provide some 
information about possible mechanisms behind hypoglycemic effects of flavonoid-rich 
foods, there are additional mechanisms likely responsible for these effects that require 
further analyses. Following gastrointestinal digestion of starch to glucose, small intestinal 
epithelial cells are responsible for absorbing glucose from the lumen and transporting it 
to the blood. The primary intestinal glucose transporters involved include sodium-
dependent glucose transporter 1 (SGLT1) and glucose transporter 2 (GLUT2). SGLT1 is 
located on the apical membrane of small intestinal cells. At low glucose concentrations, 
SGLT1 co-transports glucose with sodium against the glucose concentration gradient. At 
low glucose concentrations, GLUT2 is primarily located on the basolateral membrane of 
intestinal cells. At higher luminal concentrations, such as that characteristic of the post-
prandial state, GLUT2 is translocated to the apical membrane in order to transport 
glucose into the cell. Flavonoids have been shown in cell-based mechanistic studies to 
decrease glucose transport by competitive inhibition of SGLT1 and by inhibition of 
GLUT2 [134].  
Investigation of flavonoid impacts on glucose transport started using SGLT1-
containing brush-border-membrane vesicles (BBMV) from pig jejunum. In a study by 
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Cermak et al. [135], the flavonols quercetin-3-O-glucoside (Q3G) and -4-O-glucoside 
(Q4G) significantly decreased sodium-dependent uptake of radio-labelled D-glucose into 
BBMV for up to 1 minute. Specifically, Q3G (0.4 to 0.8mM) inhibited sodium-dependent 
uptake of radio-labelled D-glucose into BBMV after 5 sec in a dose-dependent manner, 
with IC50 achieved using 0.8mM dose. Also, the constant for half-maximal glucose 
uptake in presence of Q3G was increased, suggesting competitive inhibition of glucose 
uptake by Q3G. Q4G also inhibited sodium-dependent glucose uptake, whereas the 3-O-
galactoside, 3-O-glucorhamnoside, and aglycone forms of quercetin were ineffective. 
Further, naringenin-7-O-glucoside, genistein-7-O-glucoside and cyanidin-3,5-O-
diglucoside were also ineffective. Although results suggest specific quercetin derivatives 
may decrease glucose transport, the model utilized is not closely related to human 
intestinal cells. Further, incubation times were very short (5 seconds to 5 minutes) 
compared to what is physiologically relevant with regards to postprandial hyperglycemia 
in humans (15 mins to 2 hrs). Also, the activity of GLUT2 could not be investigated with 
this model.  
In a subsequent study, GLUT2 transport was modeled in Xenopus laevis oocytes 
and Caco-2E human intestinal cells [42]. Robust inhibition of glucose and fructose 
transport by GLUT2 was achieved by the flavonols myricetin (IC50 17.2 and 11.9µM), 
fisetin (IC50 47.2 and 42.2µM), and quercetin (IC50 12.7 and 15.9 µM). However, there 
was only moderate inhibition by flavones, and inhibition by flavanones, isoflavones, 
catechin, and anthocyanidins was low to undetectable above 300µM dose. Further, results 
from this study showed GLUT5 and SGLT1 were unaffected by flavonoids; fructose was 
transported only by GLUT2 and GLUT5; and quercetin selectively inhibited GLUT2. 
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Therefore, subsequent assays were completed utilizing Caco-2E human intestinal cells to 
study GLUT2 transport of fructose as affected by quercetin. Quercetin (200 µM) 
inhibited fructose transport at 5 min by ~30 to 60% compared to flavonoid-free control 
over a wide fructose concentration range (1 to 100 mM). Over 45 minutes, quercetin (200 
µM) inhibited transport of 50 mM fructose by up to ~75% compared with flavonoid-free 
control. This work filled in gaps from the previous GLUT2 study that was completed 
using BBMV by utilizing a more relevant human intestinal cell model to demonstrate 
GLUT2 and SGLT1 activity. However, glucose transport was not examined using the 
model. 
In response, intestinal transport of radiolabeled glucose across Caco-2 human 
intestinal cells treated with strawberry or apple extracts or individual flavonoids was 
studied [43]. Further, inhibitory activity of flavonoids in the context of sodium-
containing conditions in which both SGLT1 and GLUT2 are active and sodium-free 
conditions in which just GLUT2 is active was assessed. Both strawberry and apple 
extracts contained anthocyanins, flavonols, flavan-3-ols, and flavanones, however 
strawberry contained more species of each flavonoid class. Strawberry and apple extracts 
(100 to 400mg/mL)  decreased intracellular glucose concentration and glucose transport 
over 30 minutes compared to flavonoid-free control. Using sodium-containing and 
sodium-free conditions, IC50 for strawberry and apple extracts were 324 and 66mg/mL 
extract and 121 and 52 mg/mL extract, respectively, suggesting apple extract was a more 
potent inhibitor of glucose transport compared to strawberry extract and inhibition of 
GLUT2 was greater than that of SGLT1. The ability of derivatives of pelargonidin (an 
anthocyanidin), quercetin (a flavonol), and epicatechin (a flavan-3-ol) on glucose 
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transport was also studied. Results showed the quercetin derivative was a potent inhibitor 
of glucose transport (IC50=31µM) and the anthocyanidin derivative exerted moderate 
inhibitory activity (IC50=802µM), however the epicatechin derivative had no effect. In a 
similar study by Johnston et al. [136], the effect of flavonoid glycosidation and 
galloylation on inhibition of glucose uptake by Caco-2 cells was examined. Under 
sodium-dependent conditions, dietary glycosylated flavonoids, but not aglycones nor 
flavan-3-ols, inhibited glucose uptake. Conversely under sodium-free conditions, 
flavonoid aglycones and flavan-3-ols inhibited glucose uptake while flavonoid glycosides 
had no effect. Therefore, results showed that aglycones selectively inhibit facilitated 
glucose uptake and glycosides preferentially inhibit active glucose uptake whereas 
gallated and galloylated flavan-3-ols were inhibitors of both transporters. Results from 
both glucose transport studies indicate that similarly to enzyme inhibition by flavonoids, 
molecular structure is an important factor in the efficacy of flavonoids to impact glucose 
transport activity. 
In addition to deciphering glucose transport effects by flavonoids in sodium-
dependent and sodium-independent conditions, acute (15min) and chronic (16hr) effects 
of flavonoid-rich berry extract and berry anthocyanins on glucose transport were 
determined [41]. Treatment of Caco-2 cells with berry extract (0.125% w/v) decreased 
glucose transport by about 40% using both sodium-dependent and sodium-independent 
conditions. Similar to the study by Manzano & Williamson et al. [43], it was shown that 
berry extracts decreased acute glucose transport compared to flavonoid-free control under 
both conditions, with inhibition being greatest under sodium-free conditions. Results also 
showed that individual anthocyanins (100µM) decreased glucose transport, but the effect 
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was more subtle compared to that of the berry extract. However, chronic treatment of 
cells with berry extract (16hr) did not significantly decrease total glucose transport, 
although sodium independent glucose transport was significantly decreased. Interestingly, 
both GLUT2 and SGLT1 mRNA expression were significantly decreased compared to 
baseline by up to 85 and 70%, respectively, following treatment of cells with berry 
extract for over 12 hours. However, although GLUT2 protein was significantly reduced 
compared to control by treatment of blueberry extract for 16 hours, SGLT1 protein levels 
were not affected. Results show that both short-term and long-term glucose transport 
effects by berry flavonoids are governed by reduction of glucose transport by GLUT2 in 
part due to reduction of GLUT2 expression. Further, acute effects are likely due to 
physical interaction of flavonoids with glucose transporters, whereas chronic effects are 
likely a function of changes in genome that translate to altered transporter expression. 
There is a consensus between studies that certain flavonoids have the ability to 
mitigate glucose transport across Caco-2 intestinal epithelial cells. In addition, flavonoids 
have greater impact on GLUT2 compared to SGLT1 activity and expression. Similarly to 
carbohydrate binding and digestive enzyme inhibitory activity by flavonoids, glucose 
transport inhibitory activity by flavonoids is dependent on flavonoid structure. Further, 
results from limited studies on structure-function relationship between flavonoids and 
their ability to inhibit glucose transport indicate that increased hydrophobicity, gallation 
and galloylation increase flavonoid inhibitory activity toward both transporters. Further, 
glycosylation appears to promote flavonoid ability to mitigate sodium dependent glucose 
transport, but not sodium independent glucose transport whereas the opposite is true for 
flavonoid aglycones.  
37 
 Conclusions, Research Gaps & Objectives 1.6
Results from epidemiological studies indicate that increased consumption of 
flavonoid-rich foods promote health due to ability of flavonoids to exert cardioprotective 
effects, reduce oxidative stress and prevent diabetes [2–5]. As diabetes has become a 
principal health concern, development of diet-related strategies targeted at decreasing 
development of health-related risk factors associated with the disease has been 
increasingly important. Therefore, many clinical studies have been completed to 
determine efficacy of specific flavonoid-rich foods or flavonoids to decrease post-
prandial glycemic effect.  
Overall, results have consistently shown consumption of flavonoid-rich foods or 
meals results in reduced glycemic response or improved glucose homeostasis. Therefore, 
it appears that it may be beneficial to recommend those at risk of developing diabetes to 
regularly consume flavonoid-rich snacks or meals in replacement of those low in 
flavonoids as a diet-based approach to promote glucohomeostasis. In vitro studies suggest 
that the primary mechanisms behind hypoglycemic effect of flavonoids include 
decreasing carbohydrate digestion by interaction with carbohydrate or carbohydrate 
digestion enzymes, and decreasing intestinal glucose transport by physically inhibiting 
glucose transporters or by decreasing expression of glucose transporters on a genomic 
level. Importantly, each mechanism has generally been screened with extracts or 
individual phenolics and appear to be dependent on flavonoid structure. Therefore, it is 
important to consider flavonoid profile of a food when determining its efficacy in 
blunting postprandial hyperglycemic response.  
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Furthermore, most mechanistic insight has been gathered using in vitro assays 
relating to impacts of flavonoids on glucose transport across intestinal epithelial cells and 
have been completed using extracts from flavonoid-rich foods or individual flavonoids, 
but not the food itself. Therefore, there is a lack of information about how the food matrix 
and digestion environment may impact observed effects. Insight into the extent to which 
these effects may translate to whole food systems or whole meals is critical to 
development of appropriate guidance and products for consumers.   
 
 Proposed Objectives 1.7
To translate what is known about impact of flavonoids on glucose transport to 
possible in vivo glycemic effects following consumption of flavonoid-rich foods, 
additional insight into the ability of flavonoids from specific foods to survive 
gastrointestinal conditions and modulate glucose transport by intestinal epithelial cells 
needs to be obtained. Further, similar information for flavonoid-rich foods consumed 
with a carbohydrate and protein-rich meal should be acquired. The specific objectives of 
this group of studies were therefore to (1) examine the potential for flavonoids intrinsic to 
carbohydrate rich foods (juices and potatoes) to modulate carbohydrate digestion and 
glucose uptake/transport in a coupled in vitro digestion/Caco-2 human intestinal cell 
model and (2) assess the ability of a co-consumed flavonoid-rich foods such as juices 
with a model starch rich meal to modulate starch digestion, glucose transport, and SGLT1 
and GLUT2 gene expression using a coupled in vitro digestion/Caco-2 model. 
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CHAPTER 2. CONCORD AND NIAGARA GRAPE JUICE AND THEIR PHENOLICS 
MODIFY INTESTINAL GLUCOSE TRANSPORT IN A COUPLED IN VITRO 
DIGESTION/CACO-2 HUMAN INTESTINAL MODEL 
 Abstract 2.1
While the potential of dietary phenolics to mitigate glycemic response has been 
proposed, the translation of these effects to phenolic rich foods such as 100% grape juice 
(GJ) remains unclear. Initial in vitro screening of GJ phenolic extracts from American 
grape varieties (V. labrusca; Niagara and Concord) suggested limited inhibitory capacity 
for α-amylase and α-glucosidase (6.2-11.5% inhibition; p<0.05).  Separately, all GJ 
extracts (10 to 100 µM total phenolics) did reduce intestinal trans-epithelial transport of 
deuterated glucose (d7-glu) and fructose (d7-fru) by Caco-2 monolayers in a dose-
dependent fashion, with 60 min d7-glu/d7-fru transport reduced 10-38% by GJ extracts 
compared to control.  To expand on these findings by assessing the ability of 100% GJ to 
modify starch digestion and glucose transport from a model starch-rich meal, 100% 
Niagara and Concord GJ samples were combined with a starch rich model meal (1:1 and 
1:2 wt:wt) and glucose release and transport were assessed in a coupled in vitro 
digestion/Caco-2 cell model.  Digestive release of glucose from the starch model meal 
was decreased when digested in the presence of GJs (5.9 to 15% relative to sugar 
matched control).  Furthermore, transport of d7-glu was reduced 10-38% by digesta 
containing bioaccessible phenolics from Concord and Niagara GJ compared to control.  
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These data suggest that phenolics present in 100% GJ may alter absorption of 
monosaccharides naturally present in 100% GJ and may potentially alter glycemic 
response if consumed with a starch rich meal. 
 
 Introduction 2.2
On average, Americans consume 0.43 gallons per capita of grape juice (GJ) 
annually, making GJ the third most commonly consumed juice in the US [1]. Native 
American Concord and Niagara grape cultivars are sources for production of purple and 
white juice, respectively. Both grapes and their corresponding juices are well established 
sources of nutrients and bioactive phenolic compounds, including flavan-3-ols, flavonols, 
stilbenes, phenolic acids and, for Concord grapes, anthocyanins [2–5]. With total 
phenolic and anthocyanin levels reported as high as 2900 mg/L and 880 mg/L, 
respectively, for 100% Concord GJ and similarly high levels of phenolics in 100% 
Niagara GJ, these products can be significant contributors to health promoting 
phytochemicals [4].  
Phenolic rich 100% Concord GJ consumption has been reported to have health 
promoting activities including improved cardiovascular and cognitive function [6-8].  
Primary outcomes mediated by Concord GJ include increased flow mediated dilation, 
decreased platelet aggregation, modulation of LDL oxidation lag time, and improved 
memory function and brain signaling (reviewed by Blumberg et al. [6]; Krikorian et al. 
[7,8]).  While promising, these benefits have been observed with consumption of between 
~12 and 20 oz of 100% GJ, which contains ~36g sugar per 240mL serving [9].  While 
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fruit juices have been reported to have similar glycemic response to whole fruits when 
matched for sugar load [10], realization of these benefits remains challenged by 
consumer concern related to the higher sugar content and risk for obesity and diabetes.  
Therefore, while evidence for the benefits of GJ and GJ phenolics continues to expand, 
there remains a hesitation in recommending 100% GJ consumption to certain populations 
due to its natural high sugar content.     
Over the past decade, the potential of phenolics to modulate glucose homeostasis 
has emerged (reviewed by Hanhineva et al. [11] and Williamson et al. [12]). Specifically, 
phenolics derived from foods including berries, juices, tea and coffee have demonstrated 
the ability to modulate intestinal digestion of starch by inhibition of α-amylase and α-
glucosidase enzymes as well as intestinal glucose absorption through inhibition of 
glucose transporters such as GLUT2 [13–20]. While primarily based on experiments with 
purified phenolics and phenolic extracts, these data would suggest that sugar in the 
context of a phenolic rich food or beverage may be processed differently in the intestine 
resulting in a modified glycemic response. Interestingly, while similar glycemic 
responses have been observed between grape juice and fruit, juice resulted in lower 
insulin response [21]. Johnston et al. [22] previously reported that 3hr glycemic response 
from both clear and cloudy 100% apple juice was in fact lower in healthy volunteers 
compared to a phenolic-free, sugar-matched placebo beverage. While no mechanistic 
tests were performed, the authors postulated that phenolics in apple juices, including 
phloridzin or other polyphenols, may be responsible, in part, for the observed delay in 
intestinal absorption of glucose. In a related fashion, chronic consumption of 100% 
Concord GJ (8wks) decreased fasting blood glucose levels compared to placebo beverage 
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[23]. These results do in fact suggest that specific 100% juice components might modify 
glucose absorption and/or homeostasis in humans.  In a related fashion, chronic 
consumption of 100% Concord GJ (8wks) decreased fasting blood glucose levels 
compared to placebo beverage [23]. These results do in fact suggest that specific 100% 
juice components might modify glucose absorption and/or homeostasis in humans.   
While these data are promising, additional insight into the ability and mechanisms 
by which GJ phenolics may modulate glucose absorption is required.  Also, considering 
the potential mechanism of phenolic inhibition of starch digestive enzyme and glucose 
transport it is important to consider the potential impact of a complex meal on these 
effects.  Although clinical studies remain the gold standard for investigating health-
related outcomes, in vitro models provide an effective screening tool to investigate 
mechanistic steps and screen a broader set of food matrix factors that impact nutrient and 
phytonutrient bioavailability prior to refining designs for clinical evaluation [24–28]. 
Leveraging a similar approach, the specific objectives of this study were to (1) examine 
the potential for 100% GJ phenolics to modulate carbohydrate digestion and intestinal 
glucose transport in vitro, and (2) determine if bioaccessible phenolics from 100% GJ can 
alter carbohydrate digestion and intestinal glucose transport in the presence of a starch 
rich meal using a coupled in vitro digestion/Caco-2 model. 
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 Materials and Methods 2.3
 Chemicals, Solutions and Standards 2.3.1
Chromatography solvents, acids and salts including acetonitrile, methanol and water, 
formic acid and ammonium formate in addition to analytical standards (gallic acid, 
caffeic acid, epicatechin, quercetin-3-O-β-D-glucoside, quercetin-3-glucuronide, 
quercetin, resveratrol, and cyanidin-3-O-glucoside) were purchased from Sigma-Aldrich, 
(St. Louis, MO). Material for test meal including nonfat dry milk (NFDM; Maple Island, 
North St. Paul, MN) and corn starch (Tate and Lyle) were purchased at a local market. 
Materials for in vitro digestion including urea (U5378), uric acid (U2625), porcine mucin 
(M2378), α-amylase (A3176), pepsin (P7125), lipase (L3126), pancreatin (P1750) bile 
salt extract (B8631), KH2PO4 (VWR), K2SO4 (Riedel-de Haën), potassium citrate, 
sodium citrate, KCl, CaCO3, MgCO3 and Tris-HCl were also purchased from Sigma-
Aldrich. NaCl, HCl, and NaHCO3 were purchased from Mallinckrodt (Phillipsburg, NJ). 
Reagents for enzyme inhibition assays including dimethylsulfoxide (DMSO), acarbose, 
phosphoric acid, α-amylase (A3176), rat intestinal α-glucosidase, NaCl, glucose oxidase-
peroxidase, maltose, maltotriose, maltotetrose and maltopentose, were obtained from 
Sigma-Aldrich. Cell culture reagents including Dulbecco’s Modified Eagles Medium 
(DMEM), non-essential amino acids (NEAA), penicillin/streptomycin (pen/strep), and 
phosphate buffered saline (PBS) were purchased from Lonza (Walkersville, MD).   Cell 
culture reagents including 4-(2-hydroxylethyl)-1-piperazineethanes (HEPES), bovine 
serum albumin (free fatty acid free) (FFA) and glucose-free DMEM were purchased from 
Sigma-Aldrich.  NaHCO3, monosodium phosphate, and disodium phosphate were 
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obtained from J.T. Baker (Center Valley, PA). Fetal bovine serum (FBS) (Atlanta 
Biologicals), gentamycin (J.R. Scientific), trypsin (Thermo Scientific, Waltham MA), 
glucose and fructose (Research Products International Corps, Mt. Prospect IL), and D-
glucose-1,2,3,4,5,6,6-d7 (d7-glu) and D-Fructose-1,1,3,4,5,6,6-d7 (d7-fru) (Aldrich) were 
used in glucose transport experiments.   
 
 Grape Juice Samples 2.3.2
100% Niagara and Concord GJ were provided by Welch Foods Inc. (Concord MA) 
(Table 2-1). 100% juices were produced from two harvest years (2013 and 2014) and 
were pasteurized and maintained refrigerated at 4°C until used in experiments.  The 
Niagara GJs were processed with and without the addition of sulfur dioxide.  
 
Table 2-1: Description of 100% grape juice samples assessed.
1 
Grape juice description Form of juice Sugar content 








Concord, 2013 harvest Not from concentrate 16.5°Brix 




SO2 Niagara, 2014 harvest Not from concentrate 13.3°Brix 
Concord, 2014 harvest Not from concentrate 15.9°Brix 
1
All samples received from Welch’s Foods Inc (Concord, MA, USA) 
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 Phenolic Extraction 2.3.3
Phenolics were extracted from aliquots (5 mL) of GJ by solid phase extraction 
(Oasis® HLB 6cc (150mg) extraction cartridges) using the method of Song et al. [29]. 
Briefly, 5mL of juice were loaded onto the SPE cartridges (Milford, MA, USA) and 
rinsed with 2% formic acid in water.  Elution of phenolics was completed with 2% formic 
acid in methanol. Eluates were dried down under nitrogen and kept frozen (-20°C) until 
analysis. Total phenolic content of extracts was measured using a modified Folin-
Ciocalteau assay as described by Waterhouse et al. [30]. 
 
 Analysis of Polyphenol and Anthocyanin-Rich Fractions by LC-MS 2.3.4
Dried GJ extracts were resolubilized in 2.0% formic acid in water and 
characterized by LC-MS using methods outlined by Song et al. [29] with modification.  
Single ion responses (SIRs) were used to quantify individual GJ phenolics. Phenolic 
acids, flavonoids and stilbenoids were quantified using multi-level response curves 
constructed with authentic standards of each phenolic species identified by co-
chromatography with limited exception. Piceid concentration (a resveratrol glucoside) 
was estimated using a resveratrol calibration curve.  Concentration of all quercetin-O- β -
glucosides were estimated using quercetin-3-O-β-D-glucoside. Finally, concentrations of 




 Impact of GJ Phenolic Extracts on Starch Digestive Enzymes In Vitro 2.3.5
Impact of GJ phenolic extracts on starch digestion by α-amylase and α-
glucosidase was determined as described by Lee et al. [31].  Briefly, GJ phenolic extracts 
were dissolved in DMSO (5 mM). A waxy maize starch solution (1g/50 mL) was 
prepared in 20 mM sodium phosphate buffer and boiled to achieve gelatinization (20 
min). Starch solutions (50 µL) were then combined with GJ phenolic extract (15 µL, 
delivering 10-500 μM of total phenols), pancreatic α-amylase (37°C, 10 U/37.5 µL) and 
phosphate buffer (20 mM, pH 6.8). Samples were incubated for 10 minutes after which 
the reaction was terminated by boiling. Samples were diluted 10x in water prior to 
quantification of maltose and maltotriose by HPAEC-ECD. Percent inhibition of α-
amylase by GJ phenolics was calculated relative to vehicle control (DMSO with no GJ 
extract) and compared to positive control acarbose. 
Inhibition of α-glucosidase by GJ phenolics was assessed using a Megazyme 
glucose assay kit. Briefly, rat intestinal α-glucosidase solution (1 g/10 mL, 10 µL) was 
mixed with inhibitor (10 µL, 100-5000 µM total polyphenols). Sodium phosphate (0.1 M, 
pH 6.8, 70 µL) was added to the enzyme-inhibitor solution and the mixture was vortexed 
well. Maltose solution (10 µL, 100 mg/mL) was then added. The reaction mixture was 
incubated at 37°C for 90 minutes. Enzymes were inactivated by placing the samples in 
boiling water. Samples were then centrifuged. The supernatant was collected and diluted 
10x. Glucose content was determined by addition of glucose oxidase-peroxidase reagent 
and measuring absorbance at 510 nm. Percent inhibition of α-glucosidase by phenolic 
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extracts and acarbose was determined by comparing the difference in absorbance 
between control and extract relative to absorbance of the control. 
 
 Inhibition of Glucose/Fructose Transport through Caco-2 Human Intestinal Cell 2.3.6
Monolayers by GJ Phenolic Extracts 
Potential for inhibition of glucose and fructose intestinal transport by GJ phenolic 
extract was assessed using a three-compartment Caco-2 human intestinal cell culture 
model.  Caco-2 (TC7 clone) cells were maintained in DMEM supplemented with 10% 
v/v FBS, 1% v/v NEAA, 1% v/v HEPES, 1% v/v pen/strep and 0.1% v/v gentamicin. 
Cells were seeded (2.12x105  cells/cm
2
), grown and differentiated in 6 well insert plates 
(Corning® Transwell® polyester membrane, 24mm diameter, pore size 0.4μm) under a 
humidified atmosphere of air/CO2 (95:5) at 37°C. All experiments used differentiated 
monolayers (electrical resistance > 250 Ω) at passages 90-95, with transport studies 
conducted 21-24 days post-confluency.  Cells were incubated in glucose-free DMEM for 
2 hours preceding treatment. Test media for initial experiments was prepared by 
solubilizing glucose and fructose (9mM each), d7-glu and d7-fru (3mM each), and GJ 
phenolic extracts in PBS pH 5.5 (delivering 10-100 µM total phenolics, respectively). 
Cellular viability was assessed using the MTT assay (Biotium, Hayward, CA). Cells 
treated with phenolic extracts and digesta (at concentrations >100 µM) for 4 h were 
found to have >95% viability. Test media was applied to the apical surface of cell 
monolayers. After 60 min incubation, basolateral and apical media were collected and 
cells were washed twice with 0.1% fatty acid free PBS. Membranes were then washed 
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with ice cold PBS to terminate glucose transport, and cells were collected by scraping 
and frozen until analysis.  Treatments were replicated in quadruplicate. 
 
 Analysis of d7-Glucose and d7-Fructose Concentration in Basolateral Media by 2.3.7
LC-MS 
Basolateral media (100 µL) was extracted using acetone (0.5 mL), dried down 
under nitrogen, resolubilized in mobile phase (0.6 mL), and centrifuged (14,000 rpm, 5 
min) prior to analysis for the chlorine adduct of d7-glu and d7-fru by LC-TOF-MS [32]. 
10μL of sample was injected on a Waters ACQUITY UPLC H-Class system equipped 
with an ACQUITY QDa mass detector. Separation was achieved according to a method 
by Liu et al. [33] with minor modification. A Waters BEH-amide column (2.1 mm id x 
150 mm, 2.5 μM particle size) was heated to 30°C under isocratic conditions with flow 
rate of 0.65 mL/min for 6 min and mobile phase 87:13 acetonitrile:water with 8 mM 
ammonium formate, pH 9.8. Conditions were as follows: ionization mode: ESI (-); mass: 
222 m/z; capillary voltage: 0.8 kV; cone voltage: 20 V; probe temp: 350°C; desolvation 
temp: 600°C.  Glucose, fructose, d7-glu and d7-fru concentrations were calculated using 
calibration curves made from authentic standards. 
 
 Impact of 100% GJ on Glucose Release/Transport in a Coupled In Vitro 2.3.8
Digestion/Caco-2 Model 
To extend beyond GJ extracts, a coupled three-stage in vitro digestion/Caco-2 
model was used to determine if bioaccessible GJ phenolics could inhibit starch digestion 
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and/or glucose transport with or without a co-consumed starch rich meal.   Initially 100% 
GJ or sugar matched phenolic free control (~10 mL) was introduced to a three-stage in 
vitro digestion with oral, gastric and small intestinal phase as described by Moser et al. 
[34] and modified according to conditions described by Vermeirssen et al. [35]  to 
include rat intestinal powder (0.15g/reaction) as a source of α-glucosidase. Aliquots of 
undigested beverage starting material (SM), and centrifuged aqueous intestinal digesta 
(AQ) containing bioaccessible GJ phenolics were collected and acidified with aqueous 
acetic acid (1% total in sample) and stored frozen at -80°C until phenolic analysis by 
HPLC-MS (outlined above). A separate aliquot of AQ digesta was then diluted 2:7 with 
PBS (pH 5.5) (delivering ~21-56 µM total bioaccessible GJ phenolics, ~24 mM 
monosaccharides), spiked with d7-glu (6mM), and applied to the apical surface of Caco-2 
monolayers. A matching phenolic-free control was prepared by solubilizing glucose and 
fructose (24mM total) with d7-glu (6mM each) in blank AQ digesta diluted 2:7 with PBS. 
Treatments were replicated in quadruplicate. Transport of d7-glu was followed as 
described previously.  
In a second experiment, 100% GJ was co-digested with a test meal consisting of a 
starch/nonfat dry milk model meal. The model meal was prepared by mixing corn starch 
and non-fat dry milk (NFDM) in double-distilled water (10% v/v each).  The mixture was 
then heated (95°C, 30 min) and cooled slowly to 4°C. The resulting product was blended 
and an aliquot (5g) was combined with 2.5 or 5g of 100% GJ (Concord or SO2 Niagara, 
2013 harvest) or sugar-matched control beverage (50:50 Glucose:Fructose; 16° Brix) 
prior to introduction to the oral phase of digestion.  Starting materials (GJ plus model 
meal) and final AQ digesta were collected and stored (-80°C). Bioaccessibility of 
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phenolics was determined by comparing individual phenolic content of AQ digesta 
relative to starting material.  The extent of starch digestion was determined by 
comparison of initial glucose content in starting material to that in final AQ digesta. 
Percent inhibition of starch digestion by GJ was determined by comparing release of 
glucose from starch during digestion of model meal with grape juice relative to phenolic-
free control.  Following digestion, the ability of co-digested GJ to further inhibit glucose 
transport was determined by diluting AQ digesta 2:7 with PBS (pH 5.5) containing 6mM 
d7-glu (delivering ~5 to 16 µM total bioaccessible phenolics, determined using Folin-
Ciocalteu assay [30]) and applying to the apical surface of Caco-2 monolayers. Feeding 
material containing AQ from high and low level GJ samples contained ~12mM and 6mM 
glucose and fructose total, respectively. Matching phenolic-free controls were prepared. 
Treatments were replicated in quadruplicate.  Transport of d7-glu (6mM) was tracked and 
compared to control matched for sugar content. 
 
 Data Analysis 2.4
Data for polyphenol, anthocyanin, (d7)-glu and (d7)-fru content of GJ samples, AQ 
digesta and basolateral material are expressed as mean ± SEM. Relative (%) 
bioaccessibility is defined as the percent of polyphenol recovered in final digesta from 
that in starting material. Absolute bioaccessibility (μM) is the amount of phenolic 
available in AQ digesta relative to that present in starting material, calculated by 
multiplying % bioaccessibility by concentration (μM) of phenolic in starting material. 
Percent (%) glucose release from corn starch by α-amylase was calculated as the fraction 
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of glucose released compared to negative control. Glucose transport is expressed as 
concentration (μM) of d7-glu appearing in the basolateral compartment over time.  
Percent (%) glucose transport was then calculated on the basis of initial d7-glu content in 
the apical compartment at time 0. In order to facilitate comparison between treatments 
and control for variability between individual replicates, percent (%) glucose transport 
was normalized using the d7-glu transport from control. Differences in phenolic profile, 
bioaccessibility data, enzyme inhibitory activity and glucose transport for each GJ or GJ 
extract were performed using JMP (SAS Institute, Cary, NC), and evaluated using 
ANOVA followed by a Tukey’s test or t-test. All significant differences testing used α< 
0.05.   
 
 Results 2.5
 Phenolic and Anthocyanin Profiles of 100% Grape Juice 2.5.1
Phenolic content including anthocyanins and non anthocyaninin phenolics (Table 
2-2) in Niagara and Concord GJ were comparable to that reported previously [5,36]. 
Several phenolic species previously reported in these native American grape varieties 
were observed including phenolic acids, flavonoids, stilbenes and anthocyanins. Concord 
GJ had higher levels of total phenolics compared to Niagara GJ for both 2013 and 2014 
harvest juices. Further, GJ produced from 2014 harvest grapes had higher (p<0.05) levels 
of caftaric acid, epicatechin, quercetin, quercetin-3-O-glucoside and specific 
anthocyanins compared to that from 2013 harvest grapes. Overall, phenolic acids, 
quercetin, and resveratrol were the most prominent phenolics observed in all samples, 
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1Values represent mean ± standard error of mean from a triplicate analysis 3 
2NC = Non Detected 4 
3Presence of different letter between values indicates significant differences in concentration of phenolic class between grape juices (p<0.05)   5 






with levels up to 1134 µM. Use of SO2 during Niagara GJ processing did result in higher 
phenolics levels in finished juice compared to untreated juice (p<0.05). 
Anthocyanins were present in GJ at lower levels compared to other phenolics 
(Table 2-2). Consistent with a report by Wang et al. [37], cyanidin and delphinidin 
derivatives were primary contributors to total anthocyanin content in Concord GJs.  
Concord GJ contained 80.8 to 102.6 µM total anthocyanins compared to 3856.5 to 4629.6 
µM non-anthocyanin phenolics. Specifically, cyanidin-3,5-O-diglucoside and 
delphinidin-3-O-glucoside were the most abundant anthocyanins in Concord GJ, present 
at up to 24.7 and 29.0 µM, respectively. Further, cyanidin-3-O-p-coumaroyl-5-O-
diglucoside and delphinidin-3-O-p-coumaroylglucoside were the only anthocyanins 
detected and tentatively identified in Niagara GJ and only at low levels (0.9 to 1.9 and 3.7 
to 4.1 µM, respectively). 
 
 Modulation of α-Amylase and α-Glucosidase Activity by Grape Juice Phenolic 2.5.2
Extracts 
The ability of GJ phenolic extracts (50 to 500μM) to inhibit α-amylase and α-
glucosidase were determined in vitro. Only results from higher level phenolics 
experiments (300 and 500µM) are shown (Table 2-3) as no activity was observed at less 
than 300µM (data not shown).  For both assays, the positive control (acarbose) decreased 
α-amylase and α-glucosidase activity significantly (p<0.05) with complete inhibition of 
α-amylase activity observed at 300µM.  α-Glucosidase inhibition was observed by 
300µM and 500µM acarbose at 88.9 and 92.4%, respectively.  
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Inhibitor concentration (μM 
GAE)
5 Percent (%) inhibition 
 α-amylase α-glucosidase 
 Negative Control 0 0 0 
Acarbose (Positive 
Control) 
500 103.2 ± 5.1 92.4 ± 1.2 
300 102.0 ± 6.1 88.9 ± 0.9 
5 30.5 ± 2.9 6.2 ± 0.8 
3 17.6 ± 5.1 2.3 ± 0.5 
Niagara, 2013 
500 7.9 ± 4.5
a,b*
 10.0 ± 4.2
ab*
 
300 4.5 ± 2.2
b,c*
 6.6 ± 2.9
ab*
 
SO2 Niagara, 2013 
500 9.4 ± 3.3
a*
 11.5 ± 3.1
a*
 
300 -3.9 ± 2.0
f




500 8.7 ± 4.3
a*
 9.2 ± 0.8
ab*
 
300 -3.4 ± 2.0
f




500 0.7 ± 1.7
d,e
 6.2 ± 3.4
ab*
 
300 -1.9 ± 2.6
e,f
 3.8 ± 2.0
b
 
SO2 Niagara, 2014 
500 9.2 ± 3.9
a*
 7.1 ± 2.7
ab*
 
300 0.5 ± 1.0
d,e




500 3.4 ± 1.4
c,d*
 9.3 ± 3.2
ab*
 
300 -1.2 ± 2.1
e,f




Experiments represent average of n=3 replicates;  
2
Preliminary dose finding experiments conducted with range of 10-1000μM of phenolic extracts;  
3
Presence of different letter between values indicates significant differences in percent inhibition 
between GJ extracts (p<0.05);  
4
Presence of asterisk following values indicates significant differences in percent inhibition by 
inhibitor compared to negative control (p<0.05); 
  
5
Total phenolics in digesta determined using Folin-Ciocalteu Assay and expressed as gallic acid 




GJ phenolic extracts demonstrated only modest inhibitory capacity for α-amylase 
and α-glucosidase (Table 2-3). At 500 µM, GJ phenolic extracts only modestly decreased 
α-amylase activity compared to phenolic-free control, with 2013 extracts (7.9 to 9.4% 
inhibition) generally having greater (p<0.05) impact compared to 2014 extracts (0.7 to 
9.2% inhibition).   α-Amylase inhibition at lower GJ phenolic levels was not observed. 
Conversely, all GJ extracts exhibited modest α-glucosidase inhibitory capacity at both 
300 and 500 µM.  2013 harvest GJ extracts had similar inhibitory capacity for α-
glucosidase (5.4 to 11.5% inhibition) compared to 2014 extracts (3.8 to 9.3% inhibition). 
 
 Modulation of glucose transport across Caco-2 intestinal cells by grape juice 2.5.3
phenolic extracts  
Previous studies have shown that various plant-derived phenolic extracts have 
ability to decrease basolateral glucose transport [18–20].  To determine if GJ phenolics 
exhibit similar activity, their ability to modulate intestinal glucose and fructose transport 
was assessed using a three-compartment Caco-2 human intestinal cell model.  GJ extracts 
containing between 10 and 100 µM total phenolics were able to reduce transport of d7-
fru and d7-glu compared to control, with effect generally being increased with increased 
phenolic concentration (Figure 2-1; Table A-1). Inhibition was similar across all GJ 
extracts and was greater for d7-fru compared to d7-glu transport, ranging from 10.9 to 
41.3% and 4.7 to 35.7% inhibition for d7-fru and d7-glu transport, respectively. Overall, 




Figure 2-1: Impact of 2013 or 2014 harvest grape juice extracts on d7-fructose (A,B) or d7-glucose (C,D) transport across Caco-2 
human intestinal cell monolayer. Data is represented as concentration of deuterated sugar in basolateral compartment at 60 min. Data 
represent mean ± SEM for n=4 replicate wells at each time point. Presence of different letter between values indicates significant 






and d7-fru and generally exhibited a greater ability to inhibit transport relative to 
Concord GJ extracts. 
 
 Influence of bioaccessible phenolics from 100% grape juice phenolics on 2.5.4
carbohydrate digestion and glucose transport when co-digested with starch rich 
model test meal  
In order to better understand the extent to which inhibition of starch digestion and 
glucose transport from GJ extracts translates to 100% GJ and whole food systems, 
Niagara and Concord GJs were subjected to an in vitro gastrointestinal digestion model 
with and without a starch based model meal. Bioaccessibility of GJ phenolics from each 
juice was determined to evaluate differences in delivery of phenolics to the upper GI tract 
from AQ digesta based on grape variety (Concord, Niagara), harvest year (2013, 2014), 
and SO2 treatment (Table 2-4). Impact of bioaccessible phenolics on intestinal transport 
of glucose was then assessed (Figure 2-2). Additionally, the impact of co-digestion of GJ 
with a starch rich model meal on bioaccessibility of phenolics from GJ, starch digestion, 
and intestinal transport of glucose from AQ digesta was assessed (Tables 2-5 and 2-6; 
Figure 2-3 and Table A-2).   
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Table 2-4 Relative (%) and absolute (µM or nM) bioaccessibility of phenolics for 3 types of grape juices over 2 harvest years.
1,2,3,4,5
 
1Values represent mean ± standard error of mean from a triplicate analysis;  
2NC = Non Detected;  
3Presence of different letter between values indicates significant differences in concentration of phenolic class between grape juices (p<0.05); 
4Quercetin-3-O-glucoside bioaccessibility from Concord grape juices was between 7.2±2.7 to 8.1±3.5%. Delphinidin-3-O-p-coumaroyl glucoside bioaccessibility from 
Niagara juices and Concord juices was between 8.4±0.5 to 24.3±1.0% and 6.3±0.6 to 10.1±0.8%, respectively;  
5Phenolics in GJs and digesta determined using LC-MS.   
Non-anthocyanin Phenolic Relative Bioaccessibility (%) 
100% Juice: 
Grape, harvest year 
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Non-anthocyanin Phenolic Absolute Bioaccessibility (µM) 
100% Juice: 
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Figure 2-2: Impact of 2013 and 2014 100% grape juice aqueous digesta (AQ) on d7-
glucose transport across Caco-2 human intestinal cell monolayers over 60 min. Data 
represent mean ± SEM for n=4 replicate wells. Asterisk indicates significant difference in 
basolateral glucose concentration (mM) compared to control (p < 0.05). 
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Table 2-5: Glucose transport by Caco-2 small intestinal epithelial cells co-treated with 
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Treatments included aqueous digesta (AQ) diluted 2:7 prior to introduction to apical 
compartment of three-compartment Caco-2 cell model 
2
d7-Glucose (6mM) was used as a marker for glucose transport; Diluted Concord, Niagara, and 
blank digesta AQ contained 15, 12, and 12mM glucose, respectively and 12, 17, and 12mM 
fructose, respectively 
3
Data represent an average of n=4 wells per experiment 
4
Presence of different letter between values indicates significant differences in glucose transport 
between treatment and control, within experiment comparing AQ digesta from different juices or 
experiment comparing AQ digesta with and without model test meal (p<0.05) 
5
Total phenolics and sugars in digesta determined using LC-MS 
6
Percent of d7-glucose transported from apical media to basolateral compartment 
7
Amount of d7-glucose transported basolaterally over 60 minutes relative to daily control 




Table 2-6. Percent decrease in release of glucose from starch-rich model meal 




Concentration of phenolics 
in aqueous digesta (AQ) 




Percent decrease in 
glucose release from corn 





1:1 Concord:Model meal 73.7 15.0 
1:2 Concord: Model meal 35.4 5.9 
1:1 SO2 Niagara: Model meal 25.9 12.1
 





Figure 2-3 d7-Glucose transport across Caco-2 human intestinal cell monolayers from 
AQ digesta of co-digested GJ and starch rich test meal. Data is represented as a 
concentration of deuterated glucose in basolateral compartment at 60 min by treatment 
compared to control over 60 minutes. Data represent mean ± SEM for n=4 replicate wells 
at each time point. 
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Overall, relative bioaccessibility (Table 2-4) of non-anthocyanin phenolics was 
similar between Concord and Niagara GJ varieties and generally consistent with previous 
reports of phenolic bioaccessibility from fruit juices [38–40]. SO2 treatment generally did 
not significantly alter bioaccessibility of non-anthocyanin phenolics from Niagara GJ. 
Phenolic acids were the most bioaccessible form of phenolics in GJ ranging from 22.0 to 
56.0% relative bioaccessibility. Overall caftaric acid was the most bioaccessible non-
anthocyanin phenolic from GJ, with bioaccessibility ranging from 30.3 to 56.0%. 
Remaining phenolic acids as well as epicatechin and resveratrol were less bioaccessible 
(~11.8 to 44.7%). Quercetin, isorhamnetin, and piceid generally had higher (p<0.05) 
relative bioaccessibility from 2013 harvest Niagara GJ compared to 2014 harvest. 
Although there were few trends for differences in relative bioaccessibility of phenolic 
acids between GJs, absolute bioaccessibility (µM) of most non-anthocyanin phenolics 
were significantly (p<0.05) higher from SO2 Niagara compared to non SO2 treated 
Niagara GJ and phenolic acids and epicatechin were significantly higher (p<0.05) from 
Concord GJ compared to Niagara GJs (Table 2-4). 
Relative bioaccessibilities of individual anthocyanins from GJ were generally 
lower compared to other phenolics, ranging from 3.7 to 37.2% (Table 2-4). Notably, 
malvidin-3-O-glucoside had the highest bioaccessibility among anthocyanins (37.2±1.7%) 
from Concord 2013 harvest GJ. Similar to the trend for phenolics, relative 
bioaccessibility for anthocyanins were higher (p<0.05) from 2013 harvest compared to 
2014 harvest Concord GJs. For Niagara GJs, delphinidin-3-O-p-coumaroylglucoside 
bioaccessibility was significantly higher from 2013 compared to 2014 harvest GJ 
(24.3±1.0% compared 9.5±0.1%).  Unlike non-anthocyanin phenolics, anthocyanin 
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absolute bioaccessibility from each GJ were reflective of the trends observed in relative 
bioaccessibility. Notably, cyanidin-3,5-O-diglucoside had highest absolute 
bioaccessibility (13.4 to 16.2 nM). Absolute bioaccessibility was low for remaining 
anthocyanins ranging between 0.9 to 10.1 nM. 
Following assessment of bioaccessibility, AQ fractions from final digesta of 
juices and sugar-matched controls were diluted with PBS (pH 5.5, 6mM d7-glu) and 
applied to the apical side of Caco-2 monolayers to determine intestinal glucose transport 
from phenolic rich GJ. Apical to basolateral transport of d7-glu was assessed over 60 min. 
Compared phenolic-free sugar matched control beverages, all media containing GJ AQ 
digesta reduced d7-glu transport efficiency by  34.3 to 45.2% over 60 min (Table 2-5, 
Figure 2-2).  These results were similar to those observed from GJ extracts described 
earlier (Figure 2-1) and suggests that activities observed in extract screen are preserved 
through digestion.   
To better understand the potential influence of macronutrients from a complex 
meal on the ability of GJ to influence carbohydrate digestion and glucose transport, 
Concord and SO2 Niagara GJ (2013 harvest) were co-formulated with a model test meal 
(1:1 and 1:2 (wt:wt) in starting material) consisting of a corn starch and milk protein rich 
model meal and digested in vitro. Co-digestion of starch-rich model meal with Concord 
and SO2 Niagara GJ at both high (1:1 GJ:model meal) and low (1:2 GJ:model meal) juice 
levels resulted in decreased glucose release (5.9 to 15.0% reduction) from starch 
digestion relative to phenolic-free sugar matched control (Table 2-6), suggesting 
bioaccessible phenolics from 100% GJ have ability to modulate glucose availability by 
decreasing the digestive release of glucose from starch in the small intestine.  
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To confirm that bioaccessible GJ phenolics resulting from co-digestion of GJ with 
test meal maintain the ability to modulate d7-glu intestinal transport, AQ digesta fractions 
from co-digestion experiments were diluted with PBS containing a final concentration of 
6mM d7-glu. Despite lower phenolic concentration in test media, distinct inhibition of 
glucose transport was observed (Table 2-5; Figure 2-3). Specifically, d7-glu transport 
was decreased by 4.8 to 21.4%, with a significant (p<0.05) decline in glucose transport 
observed for treatment with 50% Concord GJ inclusion in the model meal.   
 
  Discussion 2.6
Clinical evidence exists to support the notion that certain phenolic-rich foods and 
beverages may modify glycemic parameters [22,23,41–46].  100% GJ is a particularly 
rich source of dietary phenolics, but is also naturally high in sugar (~36g sugar per 
240mL serving) [9]. While it has been reported that fruit juices have similar glycemic 
response to their corresponding whole fruits [10]), GJ has also been shown to have a 
lower insulinemic response than corresponding grapes [21].  This may be related to the 
differential profile of grape juice compared to grapes and thus a better understanding of 
the interaction between GJ phenolics and the intrinsic sugar in these products is required.  
This study was designed to develop insight into the ability and mechanisms by which GJ 
phenolics may modulate starch digestion and absorption of glucose in the context of a 
juice matrix with and without a starch rich meal. 
One mechanism that has been proposed for these effects is related to phenolic 
inhibition of starch digestion [47–50].  In the present study, GJ phenolic extracts (300 and 
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500µM) demonstrated only modest inhibitory capacity for α -amylase and α-glucosidase 
(Table 2-3).  Harvest year impacted α-amylase, but not α-glucosidase activity, with 2013 
extracts generally having greater impact compared to 2014 extracts. This may be related 
to subtle differences in qualitative phenolic profiles from 2013 to 2014 harvest GJs as 
total levels appeared similar between harvest years. Phenolic rich GJ extracts had greater 
inhibitory activity toward α-glucosidase compared to α-amylase. Similar results were 
previously reported for wine grape tannins, and pomace and skin extracts, showing 
inhibition of α-glucosidase (~20 to 85%), with little to no detectable impact on α-amylase 
activity [48,49].  Levels of phenolics required to achieve even modest inhibition were 
observed to be high (>300µM). However, it is important to note that concentrations of 
phenolics in the gut lumen from a serving of phenolic rich food or beverage may in fact 
be quite high and approach high µM to even mM levels as previously postulated [7,51]. 
Therefore, results here suggesting a modest ability of GJ phenolics to inhibit α-
glucosidase at a 300 µM dose do support the hypothesis that consumption of GJ with 
starch rich foods may have relevance to starch digestion and liberation of glucose in the 
gut lumen. 
A second mechanism by which phenolics may modulate glycemic response is 
through alteration of glucose intestinal transport [18–20].  In the present study, GJ 
extracts (10 to 100µM total phenolics) reduced intestinal glucose and fructose transport 
by Caco-2 human intestinal cell monolayers compared to control.  These findings are 
similar to those previously reported with plant-derived phenolic extracts [18–20] (Figure 
2-1; Table A-1). Overall, inhibition by GJ extracts was greater for d7-fru compared to d7-
glu transport, with extracts from Niagara GJ generally exhibiting greater inhibitory 
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activity relative to Concord GJ extracts. Since extracts were standardized for total 
phenolics, these results suggest that the qualitative phenolic profile of Niagara GJ, which 
is primarily composed of non-anthocyanin flavonoids and phenolic acids and minimal 
amounts of anthocyanins (Table 2-2), may be most critical to consider in selection of 
juices and therefore merits additional investigation as a targeted modifier of intestinal 
glucose transport. The mechanism behind this reduction of glucose transport may be 
related, in part, to the ability of GJ phenolics to inhibit expression of hexose transporters 
(GLUT2 and SGLT1) or through direct inhibition of these transporters. Alzaid et al. [20] 
demonstrated that GLUT2 and SGLT1 mRNA were significantly decreased compared to 
baseline by up to 85 and 70%, respectively, following treatment of cells with berry 
extract for over 12 hours. However although GLUT2 protein was significantly reduced 
compared to control by treatment of blueberry extract for 16 hours, SGLT1 protein levels 
were not affected. In a preliminary experiment, expression of GLUT2 and SGLT1 mRNA 
were measured in Caco-2 monolayers exposed to 100% GJ phenolic extracts (SO2 
Niagara and Concord 2013) for 4 and 24 hrs. Interestingly, GLUT2 mRNA was 
significantly (p<0.05) decreased 2-fold following treatment by Concord GJ phenolic 
extract, but no significant change in SGLT1 expression was observed (Figure A-1).  
While these preliminary results are consistent with previous observations [18–20] they 
cannot fully explain the observed effects in the present study.  Previous reports have also 
demonstrated that bioavailability of select polyphenols may be increased in the presence 
of carbohydrates [52-54] suggesting the potential for additional interrelated mechanism 
impacting the transport of both phenolics and carbohydrate. Transepithelial flux of grape 
juice phenolics was not simultaneously monitored in this study, and as such it is not 
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possible to speculate to these mechanisms.  Further investigations are therefore warranted 
to better delineate the extent to which phenolic inhibit of natural juice sugars may be 
related to changes in transporter expression or function or alternative mechanisms. 
Finally, in order to better understand the extent to which these effects would be 
extendable to 100% GJ, Niagara and Concord GJ or matching phenolic free control were 
formulated with and without a starch rich model meal and digested in vitro. Differences 
observed in phenolic relative bioaccessibility from juice alone are suggestive of 
variations in grape phenolic components between harvest years (Table 2-2 and 2-4). On 
the other hand, SO2 treatment did not impact relative bioaccessibility of phenolics from 
Niagara GJ. These results logically suggest that starting concentration of phenolics in 100% 
GJ have a direct impact on concentration of phenolics available for interactions in the gut 
and ultimate stability and accessibility of phenolics in the small intestine.  Following 
assessment of phenolic bioaccessibility, transport of glucose from AQ digesta of 100% 
GJ and sugar matched controls by Caco-2 intestinal cells was assessed. All GJ AQ 
digesta reduced d7-glu transport efficiency compared to phenolic-free sugar matched 
control by up to 45% over 60 min (Figure 2-2; Table 2-5).  These results were similar to 
those observed from extract screening and suggest that reduced efficiency of intestinal 
glucose transport may be a factor to consider in assessing glycemic response from GJ 
relative to a phenolic free sugar sweetened beverage. Interestingly, this observation is 
consistent with the glycemic response of phenolic rich apple juice that had previously 
been shown to be lower relative to sugar matched controls in healthy humans [22,41].   
To build on these findings with the awareness that GJ is commonly consumed 
with meals, it is important to consider the consequences of co-consumed food on ability 
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of GJ phenolics to modulate carbohydrate digestion and glucose transport. It is well 
known that phenolics interact non-covalently with protein and carbohydrate (reviewed by 
Bordenave et al. [55] and Jakobek et al. [56]). These interactions in the context of a co-
consumed meal may result in changes to the activity of phenolics relative to endpoints 
critical to glycemic response, namely carbohydrate digestion and glucose transport.  
Therefore, digestion of carbohydrate from a starch and protein-rich test meal co-
formulated with GJ compared to phenolic-free control was determined. Although the 
level of GJ phenolics in AQ digesta resulting from co-digestion of GJ with test meal was 
lower compared to level of phenolics from GJ extracts used in enzyme inhibition assays 
(Tables 2-3 and 2-5), results for inhibition of starch digestion were in fact similar.  
Therefore, it appears bioaccessible phenolics in the context of a complex meal still have 
the ability to impact digestion of carbohydrates derived from the meal.  The extent to 
which this may be due to the proximity of phenolics and macronutrients in the meal and 
specific interactions that may develop through preparation and/or digestion remains to be 
explored.    
Modifying glucose transport by GJ in the context of a digested meal was also 
determined. The effect of AQ digesta from GJ containing meals demonstrated only 
modest inhibitory effects (Figure 2-3) which reach significance only for 100% Concord 
GJ.  While in contrast with extract screening that found Niagara phenolics to be more 
effective, this observation was not totally unexpected as the phenolic concentrations 
resulting from digestion of mixed meals were lower than extract and juice experiments, 
especially for Niagara (Table 2-5).  Considering that in humans concentrations in the gut 
lumen may reach high µM to mM levels [12] from typical food doses and gut dilution, 
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responses within a meal such as those observed with berries by Törrönen et al. [57] may 
be expected. While requiring additional clinical insights as to the direction and extent of 
this effect in vivo are required, current results, while in vitro, do reflect the modest but 
important changes in glycemic response observed in recent clinical trials involving 
phenolic-rich foods and beverages [22,23,41–46]. This is relevant considering that 
moderate post-prandial hyperglycemia blood glucose levels (148 to 199mg/dL) have been 
shown to be indicative to development of negative health effects including 
atherosclerosis and endothelial damage [58]. This range represents a ~6% increase 
compared to recommended <140mg/dL post-prandial (2hr) blood glucose target [59], 
suggesting that even subtle improvements to post-prandial blood glucose level may 
prevent development of negative health outcomes. Therefore while subtle, the current 
observations that 100% GJ may impact both carbohydrate digestion and glucose transport 
both from juice and in the context of a model meal suggest that the benefits of 100% GJ 
may be extendable beyond the glucose derived from the juice to the response of a full 
meal and thus may have positive impacts to health.  
 
 Conclusions  2.7
Although high in natural sugar, 100% Concord or Niagara GJ remains a rich 
source of dietary phenolics that have been reported to modify glycemic parameters 
through alteration of carbohydrate digestion and glucose transport. Results of the current 
study are in general agreement with previous studies reporting the ability of phenolics to 
decrease α-glucosidase activity [48,49] and also indicate that 100% GJ phenolics have the 
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ability to decrease glucose transport even following simulated oral gastric and small 
intestinal digestions. Further, results suggest that 100% GJ when placed in the context of 
a meal maintains the ability to decrease intestinal starch digestion and subsequent glucose 
transport in a fashion consistent with promotion of healthy glucose homeostasis.  Further 
clinical assessments of 100% GJ in the context of glycemic response are warranted to 
clarify the impact of both intrinsic fruit sugar in juice and the potential impact fruit 
phenolics on glycemic response from a meal. 
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CHAPTER 3. PHENOLICS FROM PIGMENTED POTATOES AND THEIR CHIPS 
IMPACT INTESTINAL GLUCOSE TRANSPORT AND MODIFY GLYCEMIC 
RESPONSE IN HUMANS 
 Abstract: 3.1
Potatoes are an important dietary source of phenolic compounds. Beneficial effects 
of some phenolic compounds in modulation of carbohydrate digestion and glycemic 
response have been reported, however the effects of phenolics from potatoes and 
processed potato products on these endpoints are not well known. The objectives of this 
study were to characterize the phenolic profile of fresh potatoes (purple, red, or white 
fleshed; 2 varieties each) and potato chips and to examine the potential for potato 
phenolic extracts (PPE) to modulate in vitro starch digestion and intestinal glucose 
transport in a Caco-2 human intestinal cell model. Following in vitro assessment, a pilot 
clinical study (n=11) assessed differences in glycemic response and gastric emptying 
between chips from pigmented and white potatoes. PPEs were rich in anthocyanins (~98, 
11 and ND mg/100 g dw) and chlorogenic acids (~519, 425 and 157 mg/100 g dw) for 
purple, red and white varieties, respectively. While no significant effects were observed 
on starch digestion by -amylase and α-glucosidases, PPEs (from whole potato and peel) 
significantly (p<0.05) decreased the rate of glucose transport, measured following 
transport of 1,2,3,4,5,6,6-d7 -glucose (d7-glu) across Caco-2 human intestinal cell 
monolayers, by 4.5-83.9%. Further, consistent with in vitro results, consumption of 
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purple potato chips significantly (p<0.05) (albeit moderately) decreased blood glucose at 
60 minutes post consumption compared to white chips without any significant changes in 
gastric emptying. These results suggest that potato phenolics may play a role in 
modulation of glycemic response and these effects may be translatable to finished 
consumer products such as potato chips.   
 
 Introduction: 3.2
Potatoes can be converted to numerous food products that play a role in delivering 
nutrients to consumers around the world [1]. Globally, potatoes are the third highest 
consumed food crop [2] and are considered a staple in the US diet. As a vegetable, 
potatoes are low in fat but high in carbohydrate (as starch) and modestly high in fiber, 
depending on method of preparation.  Additionally, potatoes have appreciable levels of 
select micronutrients including vitamin C, potassium and magnesium [3,4]. In addition to 
traditional nutrients, potatoes are also a rich dietary source of dietary phytochemicals 
including phenolics (phenolic acids, anthocyanins, and flavan-3-ols), tocochromanols 
(tocopherols and tocotrienols), and carotenoids (lutein, zeaxanthin and -carotene) [5-7]. 
While carotenoids and anthocyanins predominate in yellow/orange and red/purple potato 
cultivars, respectively, phenolic acids and chlorogenic acid derivatives are widely 
distributed in most commonly consumed potato cultivars. Concentrations can vary widely 
across cultivars, but high values (473 to 1833 mg chlorogenic acid per 100g) are 
commonly reported in raw tubers [5-7,8]. An average serving of potatoes can provide up 
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to 20 mg of phenolics [9], making them one of the most important dietary sources of 
phenolics in the US diet [10].   
Despite these positive attributes, the high inherent starch content, and added fat 
and sodium commonly present in potato dishes and snacks, have been implicated in 
obesity and diabetes risk [11,12].  However, data on glycemic response from potato 
products is mixed (reviewed by Ek et al. [13]).  As commonly prepared (boiled, baked, 
fried etc.) potatoes are considered to be a medium to high glycemic index (GI) food 
[3,14].  Still, consumer perception often reverts to the notion that potatoes are exclusively 
a high glycemic food.  In this context, interest in understanding factors that can be 
leveraged to modify the glycemic response of potato products has grown.  
 Many efforts have focused on modifying the type and extent of processing to 
impact the glycemic response to potato products [14-16]. Process modification can be 
leveraged to alter the structure of potato starch and by extension digestibility.  This 
includes conversion of rapidly digestible starch in cooked potatoes to slowly digestible or 
resistant starch by processing techniques including microwave heating and frying [17,18]. 
In addition to processing efforts, polyphenols from multiple dietary sources of phenolics 
including fruits, vegetables and cereals have been shown to modulate carbohydrate 
digestion leading to reduced glycemic response (reviewed by Williamson et al. [31] and 
Hanhineva et al. [19]).  Phenolic acids, flavonoids and chlorogenic acids, commonly 
found in potatoes, have all demonstrated in vitro and in vivo activities consistent with 
modulation of glycemic response.  This includes altering glucose release in the gut 
through interactions with starch and digestive enzymes [20,21]. A recent report from 
Ramdath et al. [22] found an inverse correlation between polyphenol content of potatoes 
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and glycemic index (GI) in microwaved potato cubes. Specifically, highly pigmented 
potatoes, rich in anthocyanins as well as chlorogenic acids, tended to elicit reduced blood 
glucose responses and GI values compared to white or yellow varieties. This effect, while 
not reaching statistical significance, was attributed, in part, to polyphenol inhibition of 
intestinal α-glucosidase enzymes in the gut and, by extension, glucose generation in the 
GI tract. The significance of these results remains unclear.  Further, considering the 
documented ability of certain phenolics to modify glucose intestinal transport [23,24] it 
remains to be determined if enzyme inhibition is the only mechanism responsible for this 
modest effect.  Additionally, it is critical to understand if this effect holds for commonly 
consumed snack foods, such as chips, that undergo more extensive processing that may 
impact phenolic profiles.  Leveraging these findings to broader consumer potato products, 
including snacks, requires additional insights into the recovery of bioactive polyphenols 
through processing and the ability of these phenolics to contribute to mechanisms related 
to glycemic response including both digestive enzyme inhibition and glucose transport. 
The specific objectives of this study were therefore to (1) characterize the phenolic 
composition from fresh and processed potato chips made from distinct varieties of 
colored potatoes; (2) examine the potential for potato phenolics to modulate carbohydrate 
digestion in vitro and glucose transport in a Caco-2 human intestinal cell model; and (3) 
to assess if these factors translate to acute changes in the glycemic response to potato 




 Chemicals, solutions and standards 3.3.1
Sigma Aldrich (St. Louis, MO) was the supplier of solvents including hexane, 
acetonitrile, methanol, water, formic acid and ammonium formate; Folin-Ciocalteau 
reagent, gallic acid, and sodium acetate for the Folin-Ciocalteau assay; reagents for 
enzyme inhibition assays including dimethylsulfoxide (DMSO), acarbose, phosphoric 
acid, α-amylase (A3176), rat intestinal α-glucosidase, NaCl, glucose oxidase-peroxidase, 
maltose, maltotriose, maltotetrose, maltopentose, and epigallocatechin gallate (EGCG); 
cell culture reagents including 4-(2-hydroxylethyl)-1-piperazineethanes (HEPES), bovine 
serum albumin (free fatty acid free) (FFA), and glucose-free DMEM; as well as  and D-
glucose-1,2,3,4,5,6,6-d7 (d7-glucose). Waxy corn starch for enzyme assays was 
purchased from Tate and Lyle (London, UK). The glucosidase assay was completed 
using a Megazyme glucose assay kit. Caco-2 cells and Dulbecco’s Modified Eagles 
Medium (DMEM), non-essential amino acids (NEAA), penicillin/streptomycin 
(pen/strep), and phosphate buffered saline (PBS) used for cell culture maintenance were 
purchased from Lonza (Walkersville, MD).   NaHCO3, monosodium phosphate, and 
disodium phosphate were obtained from J.T. Baker (Center Valley, PA). Fetal bovine 
serum (FBS) (Atlanta Biologicals), gentamycin (J.R. Scientific), and trypsin (Thermo 
Scientific, Waltham MA) were also used for maintenance of cell culture. Glucose and 




Potato raw materials and industrial products used in this study were provided by 
PepsiCo  Inc. and included six cultivars/samples of fresh potatoes and six finished 
chipped products made from the same lot of potatoes in a commercial chipping and 
frying operation. Cultivars included: 2 purple, 2 red, a white and a yellow. Fresh potatoes 
were manually separated into flesh and peel fractions, sliced, freeze dried and ground to a 
fine powder prior to freezing at -80°C until extraction.  Potato chips were prepared 
following common commercial frying conditions.  Finished chips were stored frozen 
until use. 
 
 Polyphenol Phenolic Extraction  3.3.3
Powdered whole potato (~400mg), flesh (~400mg), peel (~200mg) and ground 
potato chips (~700mg) were defatted with hexane prior to phenolic extraction.  Samples 
were then extracted two times with methanol:water:formic acid (85:15:0.5).  The first 
extraction was performed at room temperature followed by a second extraction achieved 
by addition of formic acid (2%) in water and heat treatment (60°C, 15 min) to facilitate 
gelatinization of the starch and enhanced phenolics extraction. Extracts were combined, 
dried under nitrogen, and standardized to 5 mL in 2% formic acid in water. Resolubilized 
extracts (PPEs) were then frozen at -80°C until analysis. Total phenolic content of an 
aliquot of each sample was measured using a modified Folin Ciocalteau assay as 
described by Waterhouse [25] and corrected for vitamin C and sugar following 
methodology by Georgé [26]. Remaining PPE was used for phenolic analysis by LC-MS.  
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Extraction recovery, determined by a spike addition of ethyl-gallate (120 µmol per 
sample) as an internal standard to potato powder prior to extraction, ranged between 80 
and 115%. 
 
 Analysis of polyphenol and anthocyanin-rich fractions by LC-MS  3.3.4
Phenolic compounds from potatoes and potato products were characterized by 
LC-MS using methods adapted from Song et al.
 
[27]. Phenolic acids were detected in 
negative mode electrospray ionization (ESI).  Single ion responses (SIRs) were set to m/z 
353 and 179 for chlorogenic and caffeic acids, respectively.  Identification and 
quantitation of chlorogenic acids were acheived using standards 5-O-caffeoylquinic (5-
CQA) and 4-O-caffeoylquinic (4-CQA) acids and by comparison with previous literature 
[28,29,30]. Positive mode ESI was used to detect anthocyanins as anthocyanidin ions 
with SIRs set to m/z 272, 287, 301, 303, 317, and 331 for pelargonidin, cyanidin, 
peonidin, delphinidin, petunidin, and malvidin aglycone fragments respectively.  All 
anthocyanins were quantified using cyanidin-3-glucoside as an external standard.  Peak 
areas for each individual anthocyanidin SIR were summed to obtain a total content 
expressed for each anthocyanidin subclass. 
 
 Potato phenolic effect on carbohydrate digestion and intestinal transport  3.3.5
3.3.5.1 Inhibition of pancreatic α-amylase and α-glucosidase 
Release of sugars from starch by pancreatic α-amylase was completed using high 
performance anion exchange chromatography coupled with an electrochemical detector 
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(HPAEC-ECD).  Briefly, PPEs were dissolved in DMSO (~3mM). Then, a waxy 
cornstarch solution (1g/50 mL) was prepared in 20mM sodium phosphate buffer and 
boiled to achieve gelatinization (20 min). Corn starch solutions were combined with 
potato phenolics (delivering 10-300μM of total polyphenols) and pancreatic α-amylase (1 
mL, 37°C, 10 U/mL in phosphate buffer 20 mM, pH 6.9, containing 6.7 mM NaCl). 
Phenolic concentrations were chosen to emulate levels that may be possible in the gut 
lumen following consumption of phenolic rich foods [31]. Samples were incubated for 
10min after which the reaction was terminated by boiling. Samples were diluted 10x in 
water prior to quantification of maltose and maltotriose by HPAEC-ECD as described by 
Lee et al. [32]. Percent inhibition of α-amylase by potato polyphenols was calculated 
relative to a negative control (no PPE) and compared to a positive control acarbose and a 
phenolic control epigallocatechin gallate (EGCG) which has been previously reported to 
inhibit starch digestion [33].                      
Inhibition of glucosidases by potato phenolics was assessed using a Megazyme 
glucose assay kit. Rat intestinal α-glucosidase solution (2 g/20 mL, 10 µL) was mixed 
with inhibitor (10 µL, 10-300 µM). Sodium phosphate (0.1 M, pH 6.8, 70 µL) was added 
to the enzyme-inhibitor solution and the mixture was vortexed (30 min). Maltose solution 
(10 µL, 100 mg/mL) was then added. The reaction mixture was incubated at 37°C for 90 
min. Enzyme inactivation was completed by placing the samples in a boiling water bath. 
Samples were then centrifuged and supernatants were collected and diluted 10x. The 
glucose content was determined by combining sample (13 μL) with glucose oxidase-
peroxidase reagent (300 μL) and obtaining absorbance at 510 nm using a Molecular 
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Devices Spectra Max 190 96-well plate reader to calculate percent inhibition of α-
glucosidase.  
 
3.3.5.2 Glucose transport in Caco-2 human intestinal cell monolayers 
The ability of potato phenolics to inhibit transport of glucose across the intestinal 
epithelium was assessed using a three-compartment Caco-2 human intestinal cell culture 
model.  Caco-2 (TC7) cells were maintained using protocols described previously [34].  
Cells were grown, and differentiated in 6 well Transwell® inserts (Corning® Transwell® 
polyester membrane, 24 mm diameter, pore size 0.4 μm). All experiments used 
differentiated monolayers (transepithelial electrical resistance (TEER) > 250 Ω) at 
passages 85-95, with uptake/accumulation studies conducted 21-24 days post-confluency.  
Cells were incubated in glucose-free DMEM for 2 hours preceding treatment. Test media 
was prepared by solubilizing glucose (6 mM), d7-glu (2 mM), and PPEs (25-100 μM 
total phenolics) in PBS pH 5.5 prior to introduction to the apical surface of cell 
monolayers.  At predetermined time intervals (0, 15, 30, 60 min), basolateral media (150 
μL) was collected and replaced with fresh PBS. After 60 min, apical media was collected 
and cells were washed twice with 0.1% FFA bovine serum albumin in PBS followed by 
ice cold PBS prior to collection by scraping and then frozen until analysis.  Treatments 
were replicated in quadruplicate. 
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3.3.5.3 Analysis of d7-glu concentration in basolateral media by LC-MS 
Basolateral media was filtered through a 0.45 μm PTFE filter prior to analysis for 
d7-glucose by LC-TOF-MS. An aliquot (10 µL) was then injected onto an Agilent 1100 
Series HPLC system equipped with a Waters Micromass LCT Premier. Separation was 
achieved using a Varian Polaris C18-amide column (2.0 mm id x 150 mm, 3.0 μm 
particle size) heated to 30°C under isocratic conditions with flow rate of 0.3 mL/min and 
solvent mixture of 8 mM ammonium formate in 87:30 acetonitrile:water (pH 9.8). MS 
conditions adapted from Ikegami et al. [35] were as follows: ionization mode: ESI (-); 
capillary and cone voltage: 3200 and 20 V, respectively; source temp: 100°C; desolvation 
temp: 350°C; nitrogen gas flow rates for desolvation and cone gas: 350 and 50 L/hr, 
respectively.  d7-Glu was quantified using the extracted ion response at m/z 222 for the 
d7-glucose chlorine adduct. 
 
 Clinical assessment of glycemic response and gastric emptying from phenolic rich 3.3.6
potato chips  
3.3.6.1 Participants 
All study procedures were approved by the Purdue University Committee on the 
Use of Human Research Subjects and informed consent was obtained from all 
participants.  Participants had BMI between 18.5 to 25 kg/m
2
, were 18 to 50 years old, 
and had stable weight (+/- 2.5kg) for 3 months. Subjects were excluded if they had 
history of gastrointestinal disease, hypertension, diabetes, bariatric surgery, acute or 
chronic disease, smoked, consumed >30 units of alcohol/week, were peri- or post-
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menopausal women, were following a weight reduction program within the last 3 months, 
or had baseline blood glucose greater than 126 mg/dL.  
A total of 12 healthy adult subjects (6 male and 6 female) were recruited from the 
greater Lafayette, IN area using posted flyers. One female participant did not complete 
the study and therefore was excluded from analysis.  Average age and BMI of the 
participants were 25 (range 19-33) and 23 kg/m
2
 (range 20.1-29.1), respectively.   
 
3.3.6.2 Test foods  
Commercial potato chips produced from commercial White 1, Purple 1 and Red 1 
potatoes were obtained from PepsiCo as described above. Salted wheat crackers were 
obtained from a local market (West Lafayette, Indiana).  Product composition is provided 
in Table 3-3. Fat content of samples was determined gravimetrically. Fat was extracted 
from chips and crackers (2g) using hexane. Supernatants resulting from 2 rounds of 
extractions were combined and dried under nitrogen. Weight of remaining fat residue was 
recorded. Total carbohydrate was determined using a Megazyme kit (Total starch assay, 
amyloglucosidase/α-amylase method) according to manufacturer’s instructions. Total 
protein analysis was performed commercially using Leco combustion analysis (A & L 
Great Lakes Laboratories, Inc., Fort Wayne, IN, USA).  
On test days, the potato chips were portioned to deliver 50 g of available 
carbohydrate and served with a sugar-free fruit punch flavored beverage (240 mL) 
containing [13C]octanoic acid (0.1g). Participants consumed both food and beverage 
within 10 min. 
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3.3.6.3 Study Design.   
A randomized crossover study design was used where subjects were randomly 
assigned to one of four groups for intervention, each lasting one day with a one week 
free-living period between interventions.  Subjects were asked to consume one potato 
chip product made from either White 1, Purple 1 or Red 1 potatoes.  A plain salted wheat 
cracker was a control treatment. Treatments could not be blinded due to the different 
colors of the chips.  Participants reported to the laboratory after a 10 hour overnight fast. 
An initial capillary blood sample was collected by finger stick and fasting blood glucose 
was measured immediately using a commercial blood glucose meter (One Touch Ultra 
blood glucose meter). Following this, participants ingested either potato chips or cracker 
control (50 g available carbohydrate load) with an energy-free beverage containing 100 
mg [
13
C] labeled-octanoic acid as a marker to measure the rate of gastric emptying.  No 
other food or drink was allowed during the remainder of the test session.  Following 
ingestion, capillary blood samples were collected at 10, 20, 30, 60 and 120 min for 
immediate glucose assessment.  Breath samples were collected every 15 min for 4 h. The 
rate at which the test materials were emptied from the stomach was determined using a 
13
CO2 Urea Breath Analyzer POCone (Otsuka Electronics Co, Ltd, Osaka, Japan).  
 
 Data Analysis 3.3.7
Data for the polyphenol and anthocyanin content of potato samples and for in 
vitro digestive glucose release and transport assays are all expressed as mean ± SEM 
from a minimum of triplicate experiments. Percent (%) glucose release from cornstarch 
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by α-amylase was calculated as the fraction of glucose released compared to the negative 
control. Glucose transport is expressed as amount (μmol) of d7-glucose transported 
across the Caco-2 monolayers to the basolateral compartment.  Percent (%) glucose 
transport was then calculated on the basis of initial d7-glucose content in the apical 
compartment at time 0.  Rate (μmol/min) of d7-glucose transport was calculated by linear 
regression. To facilitate comparison between treatments and control for variability 
between individual replicates, percent (%) glucose transport was normalized with total 
transport of control d7-glucose samples at 60 min.   
Blood glucose concentrations (mM) were baseline corrected. Incremental area 
under the cuve (AUC) for blood glucose response following chip consumption was 
calculated for each potato tested by each participant using the trapezoidal method. 
Percent dose 
13
C recovered per hour (PDR) and cumulative PDR (CPDR) was calculated 
(Braden et al. [36]). Parameters related to gastric emptying rate (lag phase, ½ emptying 
time, and gastric emptying coefficient) were determined using methods by Maes et al. 
[37].  Analysis by one-way ANOVA was performed using SAS 9.3 (SAS Institute, Cary, 
NC) for phenolic profile data for each potato, with differences evaluated by Bonferroni’s 
post hoc test. Differences in enzyme inhibitory activity, glucose release and intestinal 
transport, blood glucose response, and gastric emptying parameters were performed using 
JMP (SAS Institute, Cary, NC), and evaluated using ANOVA followed by a Tukey’s test 




 Phenolic and anthocyanin profiles of six potato varieties 3.4.1
Two main phenolic classes were observed in the six tested potato varieties 
including phenolic acids and anthocyanins.  Caffeic acid was one of the main phenolic 
acid species in potatoes, but only in modest concentrations ranging from 1.8±0.3 to 
14.7±1.6 mg/100g dry weight (d.w.) whole potato (Table 3-1). Chlorogenic acid 
derivatives were the most abundant phenolic compounds in potato samples ranging in 
content from 43.0±19.1 to 503.8±15.0 mg/100g d.w.  Main chlorogenic acid species 
included 3-O-, 4-O-, and 5-O-caffeoylquinic acids. 5-O-caffeoylquinic acid was highest 
in whole potatoes (ranging from 21.4±5.0 to 312.1±14.4 mg/100 g d.w.) followed by 3-O 
and 4-O-caffeoylquinic acid (10.6±6.3 to 107.9±8.9 and 7.4±5.1 to 80.5±2.3 mg/100 g 
d.w., respectively). Red 2 was highest in total chlorogenic acid content, whereas Yellow 
1 and White 1 both had lower total concentrations (36.8±19.0 to 104.2±14.5 mg/100g 
d.w.). In pigmented cultivars total monomeric anthocyanin content ranged from 91.6±5.5 
to 147.6±0.3 mg/100g d.w. Red 2 had the highest anthocyanin content (147.6mg/100g 
d.w.) and remaining red and purple cultivars contained between ~90-100mg of 
anthocyanins per 100g d.w. Petunidin derivatives predominated in purple potatoes 
(79.4±13.8 to 83.3±21.2 mg/100g d.w. whole potato) whereas pelargonidin derivatives 
predominated in red potatoes (87.9±5.3 to 140.6±0.6 mg/100g d.w. whole potato). 
Petunidin, malvidin, and delphinidin derivatives were not detected in red potato and 
pelargonidin derivatives were not detected in purple potato.  
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Overall, potato peels had significantly (p<0.05) higher concentrations of 
phenolics relative to flesh and whole potato across varieties with up to 310.1±62.3 and 
1167.8±146.1 mg/100 g d.w of total monomeric anthocyanins and chlorogenic acids, 
respectively in peel; 132.9±4.2 and 420.6±25.2 mg/100 g d.w. of total monomeric 
anthocyanins and chlorogenic acids, respectively in flesh; and up to 99.3±20.59 and 
508.7±77.0 mg/100 g d.w. of total monomeric anthocyanins and chlorogenic acids, 
respectively, in whole potato (Table 3-1). 
To understand the impact of processing of potatoes into chips on phenolic content, 
raw potato flesh content was compared to that after chipping and frying (Figure 3-1). 
Phenolic levels in finished chips ranged from 13.4±0.8 to 362.1±9.2 mg/100g d.w. and 
31.7±6.09 to 78.4±31.23 mg/100g d.w. for total chlorogenic acids and total monomeric 
anthocyanins, respectively. While the general trend suggested that levels of phenolics in 
finished chips were lower relative to fresh potato flesh, this effect was not significant 
with the exception of Red 1 (p<0.05) for both total chlorogenic acids and monomeric 
anthocyanins and Red 2 (P<0.05) for total monomeric anthocyanins.  
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Table 3-1: Content of individual phenolic species (mg/100g d.w.), total phenolics (mg GAE/g d.w.) and total monomeric anthocyanins 
(mg Cyn3Glu/g d.w.) in flesh, peel, whole potato, and chipped potato for 6 varieties of potatoes.
1,2,3
 




 4-O- CQA 5-O- CQA 






Flesh ND 79.5±7.5 73.6±3.6 267.5±27.6 420.6±25.2 
Peel 60.7±6.6 256.9±31.4 253.9±9.6 657.0±114.1 1167.8±146.1 
Whole 3.3±0.4 107.9±8.9 80.5±2.3 312.1±14.4 500.5±15.0 
Purple 1 
Flesh ND 49.2±9.2 44.9±3.0 215.8±7.8 309.9±6.0 
Peel 264.7±5.8 179.5±10.2 195.7±18.7 669.1±33.0 1044.2±60.5 
Whole 14.7±1.6 69.5±4.0 63.9±1.8 263.6±25.8 396.9±27.8 
Red 1 
Flesh ND 60.1±21.3 47.1±3.2 233.1±21.5 340.4±39.3 
Peel 114.3±10.9 97.8±25.4 109.5±23.1 442.1±37.9 649.5±62.9 
Whole 4.6±2.5 51.4±23.0 64.2±6.3 232.0±42.6 347.6±70.7 
Red 2 
Flesh ND 43.2±15.3 54.0±6.3 257.7±42.6 354.9±63.7 
Peel 147.3±6.7 120.8±40.3 127.6±17.7 603.6±49.3 851.9±103.8 
Whole 5.1±1.6 90.7±26.4 85.5±11.5 327.4±39.3 503.6±77.0 
Yellow 1 
Flesh ND 7.2±7.2 13.9±12.9 33.9±17.4 55.0±36.9 
Peel 193.0±5.7 77.5±4.0 142.8±11.8 231.4±8.8 451.8±18.6 
Whole 6.2±1.8 11.9±7.9 7.4±5.1 21.4±5.0 36.8±19.0 
White 1 
Flesh ND 3.7±3.7 9.6±2.1 52.7±3.7 66.0±8.4 
Peel 84.3±7.8 56.8±12.8 81.9±12.7 189.3±16.7 328.0±28.4 







































1Values represent mean ± standard error of mean from a triplicate analysis 
2ND = Non Detected 
3Presence of different letter between values indicates significant differences in concentration of phenolic class between potato component within variety (p<0.05) 
4CQA= Caffeoylquinic Acid 
5Total chlorogenic acid isomers and total anthocyanins by HPLC-MS 




















Flesh 3.3±0.8 7.8±1.2 1.3±1.1 48.87±17.0 1.6±0.5 ND 62.8±16.1 
Peel 8.9±1.2 48.8±11.1 5.3±0.3 240.05±48.6 7.1±1.3 ND 310.1±62.3 
Whole 3.4±0.4 9.3±1.2 1.0±0.1 83.32±21.2 2.2±0.6 ND 99.3±20.6 
Purple 1 
Flesh 4.6±0.5 4.3±0.9 1.3±0.3 53.83±11.4 1.8±0.2 ND 65.0±12.8 
Peel 15.9±4.0 25.5±6.9 10.5±1.2 191.45±44.4 7.8±1.3 ND 250.6±57.5 
Whole 5.5±0.5 7.7±1.3 1.6±0.1 79.41±13.8 2.6±0.3 ND 96.5±15.8 
Red 1 
Flesh ND ND 2.2±1.1 ND 0.9±0.5 82.2±6.5 85.0±5.8 
Peel ND ND 23.8±1.3 ND 8.1±0.8 249.7±10.5 285.5±12.9 
Whole ND ND 2.5±0.1 ND 1.7±0.1 87.9±5.3 91.6±5.5 
Red 2 
Flesh ND ND 5.8±0.0 ND 0.2±0.0 126.8±4.1 132.9±4.2 
Peel ND ND 7.1±0.5 ND 4.8±0.5 332.6±29.4 344.4±30.4 
Whole ND ND 6.9±0.3 ND 0.1±0.0 140.6±0.6 147.6±0.3 
Yellow 1 
Flesh ND ND ND ND ND ND ND 
Peel ND ND ND ND ND ND ND 
Whole ND ND ND ND ND ND ND 
White 1 
Flesh ND ND ND ND ND ND ND 
Peel ND ND ND ND ND ND ND 







 Modulation of α-amylase and glucosidase activity by PPE 3.4.2
The ability of potato phenolics to inhibit starch digestive enzymes was assessed in vitro.  
Release of sugars (maltose, maltotriose, maltotetrose, and maltopentose) from corn starch 
by α-amylase with and without the presence of PPE (10-300 M) was quantified using 
HPAEC-ECD. Inhibition of glucosidase was determined using the glucose oxidase- 
peroxidase assay. Activity of PPEs was compared to positive control phenolic EGCG 
(300 μM) and acarbose (3 and 300 μM).  For all assays, the positive control decreased α-
amylase and glucosidase activity compared to negative control (Table 3-2). However, 
PPEs at the highest concentration (300 M) did not significantly inhibit α-amylase 
activity in vitro.  PPEs did exert a modest inhibitory effect on glucosidase activity, 
decreasing activity by 3.6-7.7% at the highest concentration assessed (300 M), with 
Purple 2, Purple 1 and White 1 extracts significantly (p<0.05) decreasing activity 
compared to negative control. 
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Figure 3-1: Phenolic profiles of potato flesh and chips.  (A) Total chlorogenic isomer 
content (mg/100g dry weight) in flesh and chips and (B) total monomeric anthocyanin 
content (mg/100g dry weight) in flesh and chips for each variety.  Data represent mean ± 
SEM for 4 replicate extractions and analysis by LC-MS with values representing the sum 
of individual chlorogenic acid isomers and individual anthocyanin species.  Presence of 
different letter between values indicates significant differences between potato 
component/product within variety (p<0.05)
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 Modulation of glucose transport across Caco-2 intestinal epithelial cells by PPEs  3.4.3
Phenolic extracts from both whole potato and peel significantly (p<0.05) reduced 
the rate of glucose transport through highly differentiated Caco-2 human intestinal cell 
monolayers (Table B-1; Figures 3-2 & 3-3). Specifically, exposure to extracts from whole 
Red 1 followed by White 1 potatoes resulted in greatest reduction in rate of d7-glu 
transport compared to d7-glu control from 3.0 to 0.5 and 1.1 µmol d7-glu per min, 
respectively. Remaining varieties decreased transport by 0.2 to 1.5 μmol d7-glu per min. 
On the other hand, peel PPEs had only a modest impact with the rate of glucose transport 
decreasing from 1.0 mol d7-glu per min to between 0.5 and 0.7 mol d7-glu per min for 
potato peel extracts. This almost 50% reduction in transport rate was less than that 
observed for whole potatoes.  However, it is important to note that these assays were run 
on separate days and variation in control response (1.0 versus 3.0 mol/min) may have 
also played a role in this observation.  Total % d7-glucose transport over 60 min 
normalized to control accounted for these day to day differences. These normalized data 
support the notion that while peel PPEs decreased total glucose transport it was much 
more modest than that observed for whole potato extracts, with peel and whole PPE 
achieving between ~16-53% and 49-98% inhibition, respectively.  
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Experiments represent average of n=3 replicates.   
2
Preliminary dose finding experiments conducted with range of 100-1000µM of phenolic extracts 
3
Unless otherwise noted, treatment concentration is 300µM 
4
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Figure 3-2: Impact of whole potato extracts from (A) Purple 2, and (B) Purple 1, C) Red 
1, D) Red 2, E) Yellow 1, and  F) White 1 on glucose transport in Caco-2 human 
intestinal cell monolayers. Each data point is represented as a ratio of total glucose 
transport by control over 60 minutes. Data represent mean ± SEM for n=4 replicate wells 
at each time point.
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Figure 3-3: Impact of potato peel extracts from (A) Purple 2, and (B) Purple 1, C) Red 1, 
D) Red 2, E) Yellow 1, and  F) White 1 on glucose transport in Caco-2 human intestinal 
cell monolayers. Each data point is represented as a ratio of total glucose transport by 
control over 60 minutes. Data represent mean ± SEM for n=4 replicate wells at each time 
point.
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 Modulation of glycemic response by phenolic rich potato chips 3.4.4
The ability of phenolics to modify the post-prandial blood glucose concentration 
from potato chips was assessed in healthy humans. Commercially available wheat based 
salted crackers were used as a positive control and compared to blood glucose AUC and 
blood glucose concentrations at stipulated time points for white, purple and red potato 
chips with differing phenolic profiles. Macronutrient profiles were similar between chips 
but differed significantly in fat content compared to the salted cracker control (Table 3-3). 
Total fat, carbohydrate, and protein content ranged between 8.5 to 10, 13.8 to 15.8, and 
1.7 to 2.0 g/28g serving of chips, respectively. White chips had significantly (p<0.05) 
higher carbohydrate content and significantly (p<0.05) lower fat and phenolic 
concentrations per serving compared to pigmented chips (Tables 3-3, B-2). In regards to 
phenolics, Red chips contained significantly (p<0.05) higher anthocyanin concentrations 
compared to Purple chips (1886.7±46.7 compared to 621.0±10.3 nmol/28g serving).  
However, Purple chips had higher total phenolic concentrations (including anthocyanins) 
compared to Red chips (82.3±1.4 compared to 65.3±4.2 μmol/28g serving) (Table 3-3).  
Participants (6 males, 5 females) involved in the clinical study included Caucasian 
(n=7), Hispanic (n=4) and Asian/Pacific (n=1) backgrounds with ages ranging from 19 to 
33 years with a mean BMI of 23.2±0.7 kg m
-2
 and normal fasting blood glucose 
concentrations (4.4±0.1 mM). The mean blood glucose AUC was significantly lower 
following consumption of white, red, and purple chips (99.8±14.1, 93.5±14.4, 
76.0±14.1mM) compared to crackers (181.0mM±28.9mM). Similarly, postprandial blood 
glucose concentrations were lower than control (salted wheat cracker) at each time point 
111 




Values represent mean ± standard error of mean from a triplicate analysis 
2
ND = Non Detected 
3
Presence of different letter between values indicates significant differences in macronutrient content or 




with blood glucose concentrations from 20 to 60 minutes being significantly (p<0.05) 
lower for chips compared to crackers (0.3 to 1.2 and 1.8 to 2.3mM, respectively). Gastric 
half-emptying time (hrs) and lag phase (hrs) were significantly longer (p<0.05) for each 
chip compared to cracker control (Table 3-4).  
There were no significant differences of total blood glucose AUC or incremental 
blood glucose AUC (iAUC) between 0 to 30 mins or 30 to 120 minutes among the chips 
(Table 3-4). However, there was a trend for lower blood glucose total AUC and iAUC 
(30 to 60 mins) for purple potato chips compared to white and red potato chips.  Blood 
glucose curves for each potato chip had distinct patterns, indicating potential for subtle 
differences in rates of carbohydrate digestion or glucose absorption (Figure 3-4). Peak 
blood glucose concentrations were similar for all chips (1.0 to 1.2 mM) but differed in 
time with Red and Purple chips displaying delayed responses.  Specifically, blood 
glucose concentrations peaked (Cmax= 1.2 mM) at ~20 minutes for white potato chips, 
compared to ~30 minutes for pigmented potato chips (Cmax= 1.2 and 1.0 mM for red and 






























































Values represent mean ± standard error of mean from n=11 participants
 
2
Presence of different letter between values indicates significant differences gastric emptying parameters 
between potato chips and crackers (p<0.05) 
3
Half emptying time and lag phase were calculated using regression estimated constants in mathematical 
formula from which a cumulative percentage dosage of 
13





 Gastric half-emptying time (G1/2) determined excluding outliers (confirmed using Q-test). Without 
correction, G1/2 was 6.1±4.0, 3.4±0.8, and 9.1±5.6 hrs for White 1, Purple 1, and Red 1 potato chips, 
respectively.  
5
Incremental AUC for blood glucose response following chip consumption was baseline corrected and 
calculated for each potato tested by each participant using the trapezoidal method. Blood glucose data for 

































































Figure 3-4: Baseline normalized blood glucose concentration (mM) following 
consumption of either pigmented (red-Mountain Rose, purple-Purple Majesty) potato 
chips, white potato chips and, in top figure, crackers. Data represent as blood glucose 
concentration (mM) mean ± SEM for n=11 participants at each time point. Presence of 
single asterisk and double asterisk indicate significant (p<0.05) difference in blood 
glucose concentration following consumption of crackers compared to potatoes or 
pigmented potato compared to white potato, respectively, within each timepoint. 
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purple chips declined at a faster rate compared to red and white potato chips, and 
maintained a significantly (p<0.05) lower blood glucose concentration at 60 min 
compared to white chips. There were no significant differences in markers of gastric 
emptying time including percentage dose of 
13
C recovered (PDR), cumulative percentage 
dose of 
13
C recovered (CPDR), half-emptying time, lag phase, or gastric emptying 
coefficient between the three chips (Tables B-3 and B-4, and Table 3-4).   
 
 Discussion 3.5
There is significant interest in understanding the potential for phenolics to modify 
glycemic characteristics of consumer products including potatoes.  Previous 
investigations have reported the ability of plant phenolics, as extracts or individual 
compounds, to modify both starch digestion and glucose intestinal transport in model 
systems [19-24,33,38]. Results from in vivo studies suggest that these mechanisms may 
translate to modified glycemic responses following consumption of phenolic-rich foods. 
For example, plasma glucose concentrations 3 hrs post-consumption were lower for 
volunteers that consumed both clear and cloudy apple juice (400 mL) rich in phenolics 
compared to that of those that consumed phenolic-free drinks matched for sugar content 
[39]. In another study, consumption of polyphenol-rich dark chocolate (20g daily, 500 
mg total polyphenols) for 4 weeks significantly decreased fasting blood glucose levels 
compared to low-phenolic placebo dark chocolate [40]. Additionally, interest in the 
association between phenolic content of potatoes and GI has grown. Recent research 
reported a significant inverse association between polyphenol content and GI of 
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microwaved red and purple potatoes, and associated this effect with the inhibition of 
starch digestion, specifically through inhibition of α-glucosidase [22]. In another study, 
consumption of anthocyanin rich purple potatoes for 4 weeks did not impact fasting 
blood glucose [41]. To better understand the impacts of consumer relevant pigmented 
potato products on the acute glycemic response, we assessed the recovery of phenolics 
through processing of potato chips from six phenolic-rich cultivars and determined the 
ability of potato phenolics to mitigate starch digestion and rate of glucose transport across 
Caco-2 human intestinal cells. We then completed a pilot study assessing the impact of 
potato phytochemicals on the post-prandial glycemic response.  
 Consistent with previous reports, chlorogenic acids were the most abundant phenolic 
species in all potato varieties [5-8]. Also in agreement with recent studies, pigmented 
varieties contained higher chlorogenic acid concentrations compared to non-pigmented 
white/yellow potatoes [22,42]. Here, levels of total anthocyanin pigments and individual 
anthocyanin classes in red and purple potatoes were similar to those reported by Giusti et 
al. [42], with petunidin and pelargonidin derivatives being dominant anthocyanins in 
purple and red potatoes, respectively (Table 3-1). Bioactive compounds including 
phenolic acids are commonly reported to be more concentrated in potato peel compared 
to flesh [6,43,44]. It was therefore expected that peels would have a greater phenolic 
content compared to potato flesh and whole potato for all six varieties. Total chlorogenic 
acid and anthocyanin content were both generally 2-5x more concentrated in peel 
compared to flesh on a dry weight basis (Table 3-1).  This trend was most pronounced for 
Yellow 1, which contained about 8x more total chlorogenic acids in the peel compared to 
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flesh. These results are consistent with previous reports that potato peeling may 
significantly reduce phenolic content especially for white and yellow varieties [6,43,44].
  
Potato chips are a snack food produced by high temperature frying. It is 
commonly reported that phenolics in fruits and vegetables degrade with increased 
temperature following first order kinetics, typical of Arrhenius behavior [27,44]. 
Therefore, it was anticipated that frying would be detrimental to phenolic profiles of 
finished potato chips. Interestingly, no significant difference in chlorogenic acid or 
anthocyanin content (mg/100g dry weight) was observed between raw potato flesh and 
final chipped and fried potato (Figure 3-1), with the exception of red varietals including 
Red 1 and Red 2. While commonly assumed to be extremely heat labile, phenolic 
stability observed during the chipping process is generally in agreement with previous 
studies reporting general stability for phenolics [45-47]. A possible reason for 
preservation of phenolics following chipping and frying despite phenolic susceptibility to 
degradation by high temperatures is that chipped potatoes are held at high temperatures 
for a relatively short amount of time during the frying process, between 3 and 20 min 
(Pedreschi et al. [48]).  Further, the frying process is a dehydration process that results in 
a low to intermediate moisture product
 
that may be more favorable to stability against 
oxidative reactions [49].  The apparent stability of anthocyanins and phenolics to chip 
frying suggests that finished chip products would generally preserve phenolics from fresh 
potatoes and therefore make them available to impact potential consumer health 
outcomes. 
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Considerable evidence exists that phenolics interact non-covalently with proteins, 
including digestive enzymes [50-54]. However, in the present study only minor inhibition 
of starch digestive enzymes, specifically α-glucosidases, was observed.  One possibility 
for this discrepancy with previous studies may stem from the nature of the assay for 
amylase inhibition. Colorimetric methods such as the Red Starch method and the 
dinitrosalicylic acid (DNS) method are commonly used for measurement of α-amylase 
activity [51,52,55]. These indirect methods may be affected by background colors of 
extracts and may result in over or under representation of inhibitory activity. In the 
present study, HPAEC-ECD was utilized to quantify products of amylase digestion 
directly and overall potato phenolics were not found to impact starch digestion by α-
amylase. On the other hand, α-glucosidase activity was significantly, but modestly, 
decreased compared to control. However, the inhibitory effect observed in the present 
study was only ~4 to 9% compared to ~30 to 40% inhibition by potato phenolics reported 
by Ramdath et al. [22]. These results suggest that while variation may exist in potatoes, 
observed correlations between phenolic profiles and glycemic response may not be 
exclusively due to alteration of starch digestion in the GI, but also by another mechanism 
including modulation of intestinal transport of glucose generated through digestion.  
To address this, we investigated whether potato phenolics, when present at 
physiologically relevant concentrations in the gut lumen (25-100 M), can modulate 
glucose transport in a Caco-2 human intestinal cell model.  Phenolic extracts obtained 
from various plant extracts have previously demonstrated the ability to decrease glucose 
transport across highly differentiated Caco-2 cell monolayers [23,24,38]. Results from 
Caco-2 experiments suggest that PPEs from whole potatoes of all varieties decreased the 
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rate of glucose transport and total glucose transport from apical to basolateral 
compartments after 60 minutes compared to control media. Similar effects were observed 
for peel PPEs, but this effect was modest compared to that observed for whole potato 
extracts. Together, standardization of PPEs to deliver between 25 and 100 M and the 
qualitative similarity between peel and whole potato (peel plus flesh) phenolic profile 
would suggest a similar level of inhibition between extracts. The greater effect of whole 
potato PPEs suggests that other factors from flesh beyond the phenolics assayed in this 
study may be may be responsible, in part, for the observed inhibitory effects in glucose 
transport by Caco-2 cells.   
To determine if results from in vitro enzyme and Caco-2 models are predictive of 
clinical responses, a clinical assessment of post-prandial blood glucose concentrations 
and gastric emptying following consumption of potato chips produced from Purple, Red, 
and White potato varieties was completed. Blood glucose concentrations at each time 
point, and therefore mean blood glucose AUC, were significantly lower following 
consumption of White, Red, and Purple chips compared to crackers. Further, gastric half-
emptying time (hrs) and lag phase (hrs) were significantly longer for each chip compared 
to cracker control. Increased fat content has been shown to decrease gastric emptying and 
the blood glucose response [55]. Therefore, these results were expected as chips have 
higher fat content compared to crackers.  
We hypothesized blood glucose concentrations following consumption of 
pigmented potato chips would be lower compared to white potato chips. Consistent with 
pre-clinical enzymatic and Caco-2 cell culture assays completed here, effects of potato 
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variety on glucose transport were modest. Still, among chips, results demonstrated that 
blood glucose concentrations at 60 minutes post-consumption were significantly lower 
for Purple chips compared to White chips.  Further, glucose concentrations were slightly 
increased from 60 to 120 minutes for Purple chips. This delay in response may be a result 
of delayed carbohydrate digestion or glucose uptake. Alternatively, Red chips did not 
differ compared to White chips. Considering that gastric emptying parameters were not 
significantly different between varieties, these results support the notion that observed 
effects are most likely associated with the inhibition of starch digestion and/or glucose 
transport by potato phenolics rather than to rate of gastric emptying (Table 3-4).  
Observations for phenolic-rich potato snack products produced using Purple Majesty, 
Mountain Rose, and white potatoes are similar for those observed for baked potatoes of 
the same varieties [22]. Similar to our results, the AUC blood glucose response and mean 
glycemic index were not significantly different between potatoes. However, polyphenol 
content did correlate inversely with the GI of potatoes. Taken together, it appears that 
increased phenolic content in pigmented potatoes may slow intestinal glucose transport 
compared to non-pigmented varieties. Ultimately, these results indicate pre-clinical in 
vitro assays may also be valuable as tools for prediction of in vivo outcomes. 
 
 Conclusions 3.6
Potatoes contain appreciable concentrations of phenolics including chlorogenic 
acids and anthocyanins, especially in pigmented varieties, which are well recovered 
through chip processing. When present at physiologically relevant concentrations, potato 
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phenolics modulated starch digestion to a limited extent and intestinal absorption of 
glucose to a greater extent.  Overall these results are in agreement with the observations 
of changes in glycemic response from similar potatoes observed by Ramdath et al. [22].  
These effects may be attributed to a combination of modest phenolic inhibition of the α-
glucosidases and perhaps more significant modulation of intestinal glucose transport.  
The long term impact of such subtle changes in blood glucose by phenolic rich products 
merits further evaluation.  
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CHAPTER 4. CONCLUSIONS & FUTURE DIRECTIONS 
 Conclusions 4.1
Interest in the mechanisms through which phenolic-rich foods may positively 
impact glycemic end-points has been driven by existing research connecting consumption 
of phenolic-rich fruits and vegetables with a decrease in those endpoints. Several studies 
have reported that phenolics may modulate glucose homeostasis through two key actions: 
(1) inhibition of carbohydrate digestion and (2) modification of intestinal glucose 
transport. Although several studies have observed inhibition of α-glucosidase enzymes 
and, to a lesser extent, α-amylase activity, only few studies have evaluated the impact of 
phenolic-rich extracts on glucose transport across the intestinal epithelium. Most of these 
studies to date have relied on purified extracts or phenolics rather than complex foods and 
beverages that have been associated with the actual benefits. Therefore, it remains 
unclear if these mechanisms are translatable to the broader food matrices these phenolics 
are included in.   
The impact of phenolics from within the food matrix on starch digestibility and 
intestinal glucose transport has not been clearly assessed. Considering that the food 
matrix is very impactful to the digestive stability and bioaccessibility of phenolics, it 
would not be surprising to see similar impacts to activities in the gut. Further, since 
phenolic-rich foods are consumed as a snack or a meal mechanistic information 
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supporting the bioactivity of bioaccessible phenolics from a fresh food must be placed in 
the broader context of a meal. In the present series of studies, in vitro models and test 
foods were leveraged to address these factors in a fashion that closely mimics in vivo 
patterns. These experiments were then translated, in part, to a clinical paradigm.  
 The objective of the first study was to determine the ability of intrinsic phenolics from 
100% Niagara or Concord grape juice (GJ) formulated with and without presence of a 
starch-rich model meal to mitigate starch digestion and intestinal glucose transport 
relative to a phenolic-free, sugar sweetened beverage. In this study, three juices were 
sourced from Welch’s including Concord, Niagara and SO2 treated Niagara.  All GJs 
maintained similar levels of natural sugar (~16°Brix as glucose and fructose) and samples 
were taken from 2 different harvest years (2013, 2014).  Phenolic content, 
bioaccessibility and glycemic modifying activities were assessed. Juices were rich in 
phenolic acids and flavonoids, especially caftaric acid, caffeic acid, and quercetin. In 
addition, Concord GJ was high in anthocyanins, primarily as cyanidin derivatives. While 
phenolic levels were similar between juices, Concord GJ did contain the highest level of 
phenolics. SO2 Niagara GJ contained higher levels of non-anthocyanin phenolics 
compared to Niagara GJ, confirming that the addition of SO2 stabilized phenolic through 
processing and storage.  
Extracts of GJs were initially screened for their ability to inhibit α-amylase and α-
glucosidase activity and intestinal glucose transport across Caco-2 intestinal cell 
monolayers. There is an abundance of information regarding the ability of plant-derived 
phenolics to inhibit α-amylase and α-glucosidase activity in vitro [1–8]. Studies 
completing α-glucosidase and α-amylase inhibition assays in parallel commonly observe 
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significant inhibition of α-glucosidase and low or no phenolic inhibitory activity toward 
α-amylase [3,5,4] . Similarly, results here showed GJ extracts (300 and 500 μM total 
phenolics) significantly decrease α-glucosidase activity, but have little to no impact on α-
amylase activity. Although extent of enzyme inhibition was similar between varieties, 
2013 harvest extracts generally decreased enzyme activity to a greater extent compared to 
2014 harvest. Therefore, it can be hypothesized that variation in environmental 
conditions between harvest years may have impact on phenolic profile and therefore alter 
ability of plant-derived phenolics to inhibit α-amylase and α-glucosidase activity. 
 Although there is limited information for impacts of phenolics on in vitro 
intestinal glucose transport, results from the current studies are in agreement with 
existing evidence [9–11]. Specifically, each GJ extract (10 to 100 μM total phenolics) 
decreased glucose transport compared to phenolic free control in an apparent dose-
dependent manner. Neither variety nor SO2 addition significantly impacted activity.  
Collectively, results suggest that GJ phenolics in extract form have the ability to 
decrease carbohydrate digestion and glucose transport in our model systems. To extend 
these findings to whole juice matrices and to better understand the extent to which these 
activities could be extended to more complex meals, further experiments were conducted.  
100% Concord and Niagara GJs were formulated with and without starch-rich model 
meals at different ratios and compared to phenolic free sugar matched control beverages. 
Samples were digested using a three stage in vitro digestion model and the extent of 
carbohydrate digestion and ultimate impact of aqueous digesta (AQ) containing 
bioaccessible phenolics on glucose transport were assessed. Each GJ AQ decreased in 
vitro digestion of starch leading to a similar release of glucose.  These effects were 
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consistent with the inhibitory activities observed through screening of GJ extracts.  
Further, AQ digesta from GJ and GJ co-digested with a starch-rich model meal decreased 
glucose transport compared to phenolic-free controls. As expected, phenolic impacts on 
carbohydrate digestion and glucose transport were modest ranging from 3.8 to 11.5 and 
4.8 to 21.4% inhibition, respectively. These results are nonetheless relevant considering 
that only a ~6% increase in blood glucose level compared to normoglycemic post-
prandial blood glucose target may result in negative health effects, suggesting that even 
subtle improvements to post-prandial blood glucose level may prevent development of 
negative health outcomes (Hanefeld et al. 1999). Taken together, results from the first 
study suggest that bioaccessible GJ phenolics may modulate glucose homeostasis by 
reducing extent of carbohydrate digestion and intestinal glucose transport in the context 
of foods containing high levels of intrinsic sugars and starch-rich foods. Further, 
consumption of 100% GJ may result in decreased post-prandial glycemic response 
compared with a sugar-sweetened beverage. 
 Although results from the first study are promising, in vivo data was not collected to 
complement the in vitro data obtained. Clinical studies are critical components of 
advancing the science of phenolics and providing a path to translate basic science to 
consumer guidance and products that have physiological relevance. With this in mind, a 
second series of studies were undertaken to parallel the juice work with phenolic rich 
starch foods (potatoes) that included both preclinical and clinical components. 
Potatoes are high-yielding and disease resistant vegetables, and are therefore an 
important staple crop in the US. Importantly, potatoes are low in fat and high in fiber and 
micronutrients including vitamin C, potassium and magnesium [12]. Additionally, 
129 
potatoes contain high levels of dietary phenolics, primarily phenolic acids, anthocyanins 
and flavan-3-ols, providing up to 20 mg of phenolics per serving [13–17]. Although 
potatoes are important sources of nutritive and non-nutritive dietary compounds, 
consumers are less aware of nutritional benefits of potatoes compared to their medium- to 
high- glycemic status [18,19]. Therefore, more information on processing and breeding 
conditions that may result in potato products with modified glycemic response is needed. 
Six varieties of potatoes were received from PepsiCo including red, purple, and 
white potatoes (2 varieties each). In the first set of experiments, a screening approach 
similar to that conducted with juice samples was performed to assess the potential for 
phenolics within potato matrices to modify starch digestive enzymes and glucose 
intestinal transport in vitro. Phenolic profiles of potatoes and their processed products 
(chips) were analyzed to determine if it may be possible that these activities can be 
extended to phenolics in products that undergo chipping and frying process.  
Consistent with literature, all potato varieties were rich in chlorogenic acids and 
red and purple potatoes contained anthocyanins, with red potatoes containing high levels 
of pelargonidins and purple potatoes containing high levels of petunidins [14–16,20,21]. 
As expected, phenolics were more concentrated in potato skin compared to flesh 
[14,22,23]. However surprisingly, processing potatoes into potato chips did not 
significantly alter phenolic content in finished product, with the exception of chlorogenic 
acids from red potatoes. Previous work has shown that phenolics degrade at high 
temperatures following first order kinetics, typical of Arrhenius behavior [23,24]. 
However, high recovery of potato phenolics through frying has been previously observed 
[25] and suggest that a well-controlled process may allow for high recovery and delivery 
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of phenolics in convenient and well accepted consumer snack form. This observed 
stability may be due, in part, to the lower moisture content of chips compared to fresh 
potatoes, resulting in improved phenolic stability to frying [26]. Results from enzyme 
inhibition assays suggested whole potato extracts from each variety moderately decreased 
α-glucosidase activity, however no effects were observed for α-amylase inhibition. This 
is consistent with observations with grape phenolics.  However, the inhibitory effect 
achieved by potato phenolics in the present study was lower compared to that recorded 
previously, reaching only ~4-9% inhibition compared to ~30-40% [27].  
On the other hand, potato phenolics (25 to 100 µM) effectively inhibited glucose 
transport by 16 to 98% compared to control. Interestingly, whole potato extracts had 
increased ability to modulate glucose transport compared to potato peel extracts, 
indicating there may be additional compounds present in whole potato that possess 
glucose transport inhibitory activity that were not assayed in the current model. On the 
other hand, there was no clear trend indicating the phenolic profile of a specific potato 
variety has an enhanced influence on glucose transport compared to another. 
Following completion of in vitro assays, a clinical assessment of three distinct 
potato chip products containing different qualitative and quantitative phenolic profiles 
was undertaken.  Participants (n=11; randomized cross-over design) were recruited to 
compare postprandial blood glucose levels at 10, 20, 30, 60, and 120 mins following 
acute consumption of pigmented potato chips compared to white potato chips (50g 
available carbohydrate each). Gastric emptying data was also obtained simultaneously. At 
60 minutes, blood glucose levels were significantly lower for purple potato chips 
compared to white potato chips. In addition, there was a trend for decreased postprandial 
131 
blood glucose AUC (0 to 120 mins and 30 to 120 mins) following consumption of purple 
compared to white potato chips. Gastric emptying rate was not different between 
treatments suggesting differences in blood glucose levels are likely attributed to altered 
carbohydrate digestion or intestinal glucose transport rather than to differences in gastric 
emptying.  
Each blood glucose curve had a unique shape, suggesting that each potato chip 
influences carbohydrate digestion or glucose uptake at diverse rate or extent. Peak blood 
glucose levels for Purple and Red potato chips were delayed compared to White potato 
chips, peaking at 30 minutes. Further, Red potato chip peak blood glucose concentration 
was higher compared to Purple potato chips. Interestingly, Purple potato chip blood 
glucose level declined from 30 to 60 minutes, and then slowly increased over the next 
hour. Results indicate delayed postprandial carbohydrate digestion or absorption 
following consumption of pigmented potato chips compared to white potato chips. 
Observations for phenolic-rich potato snack products produced using Purple Majesty, 
Mountain Rose, and white potatoes are similar for those observed for baked potatoes of 
the same varieties [27]. Similar to our results, while AUC for blood glucose response was 
not significantly different between baked Purple Majesty, Mountain Rose, and white 
potatoes, polyphenol content did correlate inversely with potato GI. 
Overall, results from these studies suggest that consumption of phenolic-rich 
foods and drinks may modestly impact blood glucose levels through their ability to 
modify starch digestion and glucose transport. Moreover, favorable effects appear to be 
maintained in the presence of a complex, starch-rich meal.  The main effects also appear 
to be through inhibition of α-glucosidase activity, but not α-amylase activity, and through 
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modification of intestinal glucose transport. Importantly, results indicating phenolic 
modulation of carbohydrate digestion and glucose absorption obtained using the coupled 
in vitro digestion/Caco-2 model were somewhat predictive of clinical outcomes in a study 
using a finished consumer good as the phenolic-rich source.   Therefore, while modest, it 
appears that phenolic rich foods may in fact be responsible for improved control of blood 
glucose from a food and these effects may be translatable to a broader meal.  These data 
suggest that strategies can be implemented to leverage these activities and generate 
improved glycemic profiles for starch/sugar rich foods. 
 
 Future Directions 4.2
While results from the present study and previous studies show phenolic-rich 
apple, baked pigmented potatoes, and pigmented potato chips moderately alter post-
prandial glycemic response compared to low phenolic matched controls, they may be 
underpowered (n=9 to 11).  Similar studies investigating hypoglycemic effects of 
phenolic-rich foods should use these pilot studies to determine statistical power for larger 
scale clinical trials. In addition to impacts on post-prandial glycemic response, 
information must be obtained concerning the influence chronic consumption of phenolic-
rich foods may have on resting blood glucose levels. Thus far, lowered resting blood 
glucose levels following consumption of Concord GJ was observed as a secondary 
outcome from a study completed by Dohadwala et al. [28].  
In addition to specific study designs and outcomes that require implementation, a 
larger variety of phenolic-rich foods need to be evaluated to better understand the extent 
to which various phenolic classes and food matrix components impact hypoglycemic 
133 
effects. For example specific fruits, vegetables, and herbs generally differ with regards to 
the dominant phenolic class. Colored fruits and vegetables contain high anthocyanin 
levels; tea, apples and cocoa are rich in flavan-3-ols; parsley, celery, and millet contain 
flavones; onions and kale are the richest sources of flavonols; and oranges and grapefruit 
are rich in flavanones [17,29–31]. It will be important to determine which phenolic 
classes, and therefore which specific foods, may have greatest influence on blood glucose 
levels. 
Although it is important to obtain information about influences of specific 
phenolic-rich foods on glycemic response, these individual foods are commonly 
consumed as part of a meal. Evidence exist suggesting phenolics interact with food 
matrix carbohydrates and protein (reviewed by Bordenave et al. [31]). Importantly, these 
interactions alter the availability and bioactivity of phenolics in the gut. Therefore, pilot 
clinical studies should be completed to validate in vitro results and to provide information 
as to what degree various types of meal patterns alter glycemic effects of phenolic-rich 
foods. Larger clinical studies must then be planned accordingly to achieve results with 
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Appendix A Supplementary Material for Chapter 2 
Table A-1: Glucose transport by Caco-2 small intestinal epithelial cells co-treated with sugar solution (Glu and Fru (9mM each), d7-
Glu and d7-Fru (3mM each) and phenolic extract from grape juice or phenolic-free control.
1,2,3
 
1d7-Glucose and d7-fructose (3mM) were used as markers for glucose transport. 
2Data represent an average of n=4 wells per experiment.  
3Presence of different letter between values indicates significant differences in glucose transport within treatment and compared to control (p<0.05).  





Percent (%) d7-Fru Transport Percent (%) d7-Glu Transport 
Percent (%) d7-Fru 
Transported over 60 min 
Relative to Control 
Percent (%) d7-Glu 
Transported over 60 min 
Relative to Control 
Control (24mM Glucose/Fructose) 0 2.8±0.2a 3.4±0.3a 100a 100a 
      
Niagara, 2013 extract 
10 2.5±0.2a,b 2.8±0.2a,b 89.5±5.8a,b 82.3±5.9a,b 
50 2.0±0.1c 2.4±0.04b 72.0±2.0c 71.5±1.0b,c 
100 2.1±0.1b,c 2.3±0.1b 73.9±4.0b,c 66.5±4.0c 
      
SO2 Niagara, 2013 extract 
10 2.5±0.1a,b 3.0±0.2a,b 88.3 ±4.6a 88.3 ±3.0a 
50 1.9±0.1b 2.8±0.1b,c 68.3 ±3.0b 83.0 ±2.7a,b 
100 2.0±0.1ab 2.4±0.1c 70.5 ±4.8b 70.3 ±3.9b 
      
Concord 2013 extract 
10 2.1±0.2b 2.9±0.2a 74.8±6.1b 84.6±4.7a 
50 2.2±0.1b 3.1±0.2a 77.9 ±3.9b 89.2 ±5.8a 
100 2.0±0.2b 2.8±0.2a 69.1±6.4b 82.3±6.0a 
      
Niagara, 2014 extract 
10 2.3±0.1a,b 3.0±0.1a 85.55±5.4a,b 95.3±2.6a 
50 2.1±0.2a,b 3.0±0.2a 78.9±6.3a,b 95.2±6.8a 
100 1.6±0.3b 2.4±0.4a 58.7 ±12.4b 77.8 ±12.4a 
      
SO2 Niagara, 2014 extract 
10 2.3±0.1a,b 2.8±0.1a 87.1±2.7a,b 89.7±1.6a,b 
50 2.0±0.2b,c 2.7±0.2a 76.7±7.3b,c 86.0±6.0a,b 
100 1.6±0.1c 2.0±0.3b 59.6±3.6c 64.3±9.1b 
      
Concord, 2014 extract 
10 2.4±0.1a 2.9±0.2a 89.1 ±5.4a 94.2±5.9a 
50 2.2±0.1a 2.8±0.1a 81.7±5.6a 89.0±2.4a 











Phenolic Bioaccessibility (%) 








Quercetin Isorhamnetin Piceid Resveratrol 
1:2 Concord:Model 
meal 
41.8±2.3a 63.1±6.3a 40.3±3.1a 8.8±1.3b 4.6±0.9a 2.2±0.1b 4.0±0.1b 5.7±0.4a 0.8±0.1c 1.5±0.2c 
1:2 Concord: Model 
meal 
19.5±1.4c 31.1±2.9c 14.7±1.7b 4.1±0.2c 1.3±0.1b 0.4±0.1d 2.0±0.2d 5.1±1.4a 0.5±0.05d 0.8±0.1d 
1:2 Concord:Water 33.8±1.2b 47.1±1.4b 15.5±0.5b 17.1±0.3a 5.1±0.2a 5.0±0.02a 6.7±0.1a 2.5±0.1b 1.9±0.04a 3.5±0.1a 
1:2 Concord:Water 16.0±0.6c 21.7±0.9c 5.6±0.4c 7.5±0.2b 1.3±0.02b 1.5±0.1c 4.3±0.2c 1.0±0.02b 1.2±0.04b 1.9±0.2b 













1:2 Concord: Model 
meal 
17.9±1.4b 21.2±1.7b 20.3±1.2b 19.1±4.2a 19.7±4.6b 31.3±2.4b 
1:3 Concord: Model 
meal 
11.4±1.1c 10.7±1.1c 4.9±0.3d 11.4±1.7a,b 12.8±1.3b 16.4±1.2c 
1:2 Concord:Water 30.1±1.8a 39.6±0.5a 27.7±1.6a 15.4±0.9a,b 39.5±1.4a 46.1±3.1a 
1:2 Concord:Water 14.9±0.4b,c 22.6±0.1b 12.4±0.8c 6.7±0.3b 18.5±0.6b 23.8±0.2b,c 
1Values represent mean ± standard error of mean from a triplicate analysis 
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Modulation of Caco-2 glucose/fructose transporter gene expression by GJ phenolic 
extracts 
Cells and experimental conditions for gene expression experiment were maintained 
and executed according to glucose transport experiments, with minor modifications. Test 
media was prepared by solubilizing glucose and fructose (12mM each) and GJ phenolic 
extracts in PBS pH 5.5 (delivering 50 µM total phenolics). Test media was applied to the 
apical surface of cell monolayers and cells were incubated for 4 or 24 hours. Cells were 
collected with RNAlater (Sigma-Aldrich) and frozen until analysis.  Treatments were 
replicated in quadruplicate. 
Characterization of mRNA expression and anthocyanin-rich fractions by LC-MS 
Total RNA was isolated from the cultured cells using TRIzol® (Invitrogen™ Life 
Technologies, Paisley, UK) according to the manufacturer's instructions. RNA 
concentration was measured using wavelength of 260 and 280 using a NanoDrop 2000 
UV-Vis Spectrophotometer (Thermo Scientific.) Following first strand cDNA synthesis, 
expression levels of glucose transporter mRNA and GAPDH mRNA (used as a 
housekeeping gene) were analysed by real-time quantitative PCR using an ABI Prism 
7700HT Sequence Detection System and a Power SYBR® Green PCR master mix kit 
(Applied Biosystems™ Cheshire, UK). The primer sequences used for each gene are 
given in Supplemental Table 3. cDNA was then synthesized from 150 ng RNA using M-
MuLV reverse transcriptase (BioLabs, Ipswich, MA). Real-time q-RT-PCR was 
performed using a CFX Connect Real-Time PCR Detection System (BioRad). The 
expressions of SGLT1 and GLUT2 were evaluated and the expression of housekeeping 
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gene β-actin was assessed. The primer sequences used for each gene are given in 
Appendix Table A3. 
 













F indicates forward primer, R indicates reverse primer. 













Figure A-1: Impact grape juice phenolic extract (50μM) treatment (4 or 24 hours) has on 
Caco-2 expression of SGLT1 or GLUT2 compared to phenolic-free control. Data is 
represented as protein expression compared to control β-actin. Data represent mean ± 
SEM for n=4 replicate wells. Presence of different letter between values indicates 









Appendix B Supplemental Material for Chapter 3 
Table B-1: Glucose transport by Caco-2 small intestinal epithelial cells treated with 6mM glucose (control) or co-treated with 6mM 
glucose and phenolic extract from whole potato and potato peel.
1,2 
















Percent (%) d7-Glu 
transported over 60 









Percent (%) d7-Glu 
transported over 60 






2.98 6.1±0.2a 100a 
 
0.97 2.9±0.09a 100a 
          
Purple 2 
25  1.94 4.5±0.1c 62.8±0.02b  0.74 2.3±0.07c 74.7±0.03d 
50  1.95 4.4±0.2c 64.3±0.04b  0.60 1.8±0.06b,c 59.3±0.03c 




   
 
   
Purple 1 
25  2.21 4.9±0.09c 117.8 ±0.05c  0.63 1.7±0.16b 70.2 ±0.07b 
50  1.00 2.1±0.08b 55.6 ±0.10b  0.68 2.0±0.07c 79.3 ±0.04b 
100  0.81 1.9±0.07b 46.6 ±0.08b  0.64 1.8±0.05b,c 74.5 ±0.03b 
 
         
Red 1 
25  1.46 4.3±0.7c 50.0±0.10c  0.81 2.3±0.41a 93.2±0.17a,b 
50  0.47 1.3±0.04b 15.9 ±0.01b  0.70 2.3±0.13a,b 81.0 ±0.05b 




   
 
   
Red 2 
25  1.63 3.3±0.5a 78.3±0.14c  1.08 3.1±0.58a 97.9±0.18a 
50  1.04 2.1±0.1b 51.8±0.04b  1.12 3.1±0.05a 95.10.04a 




   
 
   
Yellow 1 
25  0.66 7.7±0.5c 54.0±0.03c  0.96 2.9±0.07a 96.5±0.03a 
50  0.54 6.1±0.2b 44.2±0.02b  0.82 2.3±0.04c 78.9±0.02b 




   
 
   
White 1 
25  1.43 4.4±0.2b 45.7 ±0.03c  0.78 2.1±0.01a,b 75.7 ±0.03b,c 
50  1.10 3.4±0.2c 35.6±0.02b  0.80 2.4±0.08c 80.1±0.04c 
100  1.09 3.6±0.1b,c 36.2±0.02b,c  0.70 2.0±0.03b 67.6±0.03b 
1d7-Glucose (2mM) was used as a marker for glucose transport. 
2Data represent an average of n=4 wells per experiment.  
3Percent of d7-glucose transported from apical media to basolateral compartment. 




























1Values represent mean ± standard error of mean from a triplicate analysis 
2ND = Non Detected 
3Presence of different letter between values indicates significant differences in concentration of phenolic class between potato chips (p<0.05) 
Phenolic Content (µmol/28g serving) 
Potato Variety 3-O-CQA 4-O-CQA 5-O-CQA Caffeic Acid Total Phenolics 
White 1 4.1±0.03
c 3.9±0.01c 5.8±0.2b 3.0±0.1c 16.8±0.3c 
Purple 1 13.8±0.2
a 11.1±0.2a 37.4±0.7a 19.9±0.5a 82.3±1.4a 
Red 1 9.9±0.5
b 8.2±0.6b 32.6±2.4a 14.7±0.8b 65.3±4.2b 













 16.6±0.04b 164.0±4.0a 265.1±12.0a 125.9±4.1a 49.4±1.0b 621.0±10.3b 
Red 1 470.9±6.4
















































1Values represent mean ± standard error of mean from n=11 participants 
2Presence of different letter between values indicates significant differences in concentration of phenolic class between potato chips and crackers (p<0.05) 
Percent Dose Retained (%) (sampling interval (min)) 
Sample 15min 30min 45min 60min 75min 90min 105min 120min 
Cracker 24.2±4.4 a 29.9±2.6 a 26.4±2.2 a 24.1±1.8 a 21.2±1.5 a 18.9±1.4 a 16.6±1.3 a 14.3±1.2 a 
White 1 19.7±3.6 a,b 22.6±2.9 a,b 21.0±2..7 a,b 20.3±2.4 a,b 18.0±2.2 a,b 16.6±2.1 a,b 15.5±2.0 a 14.3±1.9 a 
Purple 1 15.6±3.5 a,b 20.4±2.9 b 19.0±2.5 b 17.0±2.2 b 15.8±1.9 b 14.5±1.7 a,b 13.4±1.5 a 12.9±1.4 a 
Red 1 13.0±3.6 b 18.5±2.5 b 16.8±2.2 b 15.1±2.0 b 14.0±1.8 b 13.3±1.6 b 12.1±1.5 a 11.0±1.3 a 
         
Percent Dose Retained (%) (sampling interval (min)) 
Sample 135min 150min 165min 180min 195min 210min 225min 240min 
Cracker 12.5±1.0 a 11.4±1.1 a 9.9±0.9 a 8.8±0.9 a 7.5±0.9 a 6.5±0.7 b 5.8±0.7 b 4.7±0.6 b 
White 1 13.5±1.7 a 12.9±1.7 a 12.1±1.6 a 11.4±1.5 a 10.4±1.5 a 10.0±1.4 a 8.9±1.3 a 8.3±1.3 a 
Purple 1 12.3±1.3 a 11.4±1.3 a 11.5±1.2 a 10.8±1.0 a 10.5±1.0 a 10.3±0.9 a 9.1±0.9 a 8.7±0.8 a 












































1Values represent mean ± standard error of mean from n=11 participants 
2Presence of different letter between values indicates significant differences in concentration of phenolic class between potato chips and crackers (p<0.05)  
 
Cumulative Dose Retained (%) (sampling interval (min) 
Sample 15min 30min 45min 60min 75min 90min 105min 120min 
Cracker 3.0±0.6a 9.8±1.4 a 16.8±1.9 a 23.1±2.4 a 28.8±2.7 a 33.8±3.0 a 38.2±3.3 a 42.1±3.6 a 
White 1 2.5±0.4a,b 7.8±1.2 a,b 13.2±1.8 a,b 18.4±2.4 a,b 23.2±2.9 a,b 27.5±3.4 a,b 31.5±3.9 a,b 35.2±4.3 a,b 
Purple 1 1.9±0.4 a,b 6.4±1.2a, b 11.4±1.8 b 15.9±2.3 b 20.0±2.8 b 23.8±3.1 b 27.2±3.5 b 30.5±3.8 b 
Red 1 1.6±0.5 b 5.6±1.1 b 10.0±1.5 b 14.0±2.0 b 17.6±2.4 b 21.0±2.8 b 24.2±3.1 b 27.1±3.4 b 
         
Cumulative Dose Retained (%) (sampling interval (min) 
Sample 135min 150min 165min 180min 195min 210min 225min 240min 
Cracker 45.5±3.8 a 48.5±4.0 a 51.1±4.1 a 53.5±4.3 a 55.5±4.5 a 57.2±4.6 a 58.8±4.8 a 60.1±4.9 a 
White 1 38.7±4.7 a,b 42.0±5.1 a,b 45.1±5.5 a,b 48.1±5.8 a,b 50.8±6.1 a,b 53.3±6.4 a,b 55.7±6.6 a,b 57.9±6.9 a 
Purple 1 33.7±4.0 b 36.7±4.2 a,b 39.5±4.4 a,b 42.3±4.6 a,b 45.0±4.8 a,b 47.6±4.9 a,b 50.0±5.1 a,b 52.2±5.3 a 
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Purdue University 
Institutional Review Board 
 
1. Project Title:   Post-prandial glucose response from phytochemical rich potato 
products 
    
2. Full Review        Expedited Review        
 
3. Anticipated Funding Source:  Internal and/or Pepsico Global 
4. Principal Investigator [ See Policy on Eligibility to serve as a Principal Investigator 
for Research Involving Human Subjects]:   
 Name and TitleDepartment, Building, Phone, FAX, E-mail address 
  Mario G. Ferruzzi (Prof) Department of Food Science, NLSN 765 494 0625, 
mferruzz@purdue.edu 
 
5. Co-investigators and key personnel [See Education Policy for Conducting Human 
Subjects Research]: 
 Name and TitleDepartment, Building, Phone, FAX, E-mail address 
         Richard D. Mattes (Prof) Department of Nutrition Science Stone Hall 4-0662, 
mattes@purdue.edu   
  Bruce R. Hamaker (Prof) Department of Food Science, NLSN, 4-5668, 
hamakerb@purdue.edu   
  Judy George, Clinical Study Coordinator, Dept of Nutrition Science, Stone Hall, 4-6192  
georgej@purdue.edu  
  Robin Rhine, Clinical Staff, Dept of Nutrition Science, Stone Hall, 765-494-
6192  rrhine@purdue.edu 
 
6. Consultants [See Education Policy for Conducting Human Subjects Research]: 
 Name and Title Department, Building, Phone, FAX, E-mail address 
  
7. The principal investigator agrees to carry out the proposed project as stated in the 
application and to promptly report to the Institutional Review Board any proposed 
changes and/or unanticipated problems involving risks to subjects or others participating 
in the approved project in accordance with the HRPP Guideline 207 Researcher 
Responsibilities, Purdue Research Foundation-Purdue University Statement of 
Principles and the Confidentiality Statement.  The principal investigator has received a 
copy of the Federal-Wide Assurance (FWA) and has access to copies of 45 CFR 46 and 
the Belmont Report.  The principal investigator agrees to inform the Institutional 





Review Board and complete all necessary reports should the principal investigator 
terminate University association. 
 
 ___________________________________      2/17/2015                                                                   
Principal Investigator Signature         Date 
 
8. The Department Head (or authorized agent) has read and approved the application.  S/he 
affirms that the use of human subjects in this project is relevant to answer the research 
question being asked and has scientific or scholarly merit.  Additionally s/he agrees to 
maintain research records in accordance with the IRB’s research records retention 
requirement should the principal investigator terminate association with the University. 
 
 Brian Farkas               Food Science 
 
Department Head (printed)                 Department Name 
     
             2/17/2015                                                                    
Department Head Signature                                     Date 
 
  





APPLICATION TO USE HUMAN RESEARCH SUBJECTS 
 
9. This project will be conducted at the following location(s): (please indicate city & 
state) 
  Purdue West Lafayette Campus 
=  Purdue Regional Campus (Specify):        
  Other (Specify):       
 
10. If this project will involve potentially vulnerable subject populations, please 
check all that apply. 
  Minors under age 18  
  Pregnant Women   
  Fetus/fetal tissue  
  Prisoners Or Incarcerated Individuals  
  University Students (PSYC Dept. subject pool ___)  
  Elderly Persons  
  Economically/Educationally Disadvantaged Persons 
  Mentally/Emotionally/Developmentally Disabled Persons  
  Minority Groups and/or Non-English Speakers 
  Intervention(s) that include medical or psychological treatment 
 
11. Indicate the anticipated maximum number of subjects to be enrolled in this protocol as 
justified by the hypothesis and study procedures:   12 
 
12. This project involves the use of an Investigational New Drug (IND) or an Approved 
Drug For An Unapproved Use. 
   YES          NO 
 Drug name, IND number and company:         
13. This project involves the use of an Investigational Medical Device or an Approved 
Medical Device For An Unapproved Use. 
   YES          NO 
 Device name, IDE number and company:         
14. The project involves the use of Radiation or Radioisotopes: 
   YES          NO 
 
15. Does this project call for: (check-mark all that apply to this study) 
   
  Subject Compensation?  Please indicate the maximum payment amount to 
subjects. $250 
 Purdue’s Human Subjects Payment Policy  Participant Payment Disclosure 
Form  
  VO2 Max Exercise?     
  More Than Minimal Risk?   
  Waiver of Informed Consent?  





        Extra Costs To Subjects?  
        The Use of Blood? Total Amount of Blood <5mL 
    Over Time Period (days) 35 days 
        The Use of rDNA or Biohazardous materials? 
        The Use of Human Tissue or Cell Lines? 
  The Use of Other Fluids that Could Mask the Presence of Blood (Including Urine 
and Feces)? 
  The Use of Protected Health Information (Obtained from Healthcare Practitioners 
or Institutions)? 
  The Use of academic records? 
16. Does investigator or key personnel have a potential financial or other conflict of interest 
in this study?  





A. PROPOSED RESEARCH RATIONALE 
  
Potatoes are a rich source of phenolic compounds that have been hypothesized to 
have the ability to modulate carbohydrate digestion and metabolism leading to 
reduced glycemic response.  An inverse correlation between polyphenol content of 
potatoes and glycemic index (GI) has been observed with select boiled purple and 
red potatoes rich in phenolic antioxidant pigments (anthocyanins).    In alignment 
with these finding, we have shown through a series of preliminary studies that 
potato phenolics may have a more pronounced effect on glucose intestinal transport 
as compared to starch digestion.  This effect was more pronounced for extracts 
generated from anthocyanin rich purple and red potatoes relative to white potatoes. 
These preliminary results suggest that a reduced post-prandial glycemic response 
might be expected from certain types of potato products and that phenolic 
antioxidants may play a critical role in predicting the physiological response from 
potato products.   
 
To better understand how potato product characteristics, specifically phenolic 
antioxidant content and profile, may alter post-prandial glycemic response, the 
proposed study will focus on assessment of glycemic response from consumer 
relevant products (chips) produced from commercially available antioxidant rich 
potato cultivars (Purple Majesty and Mountain Rose).   We will test the hypothesis 
that chipped potato products with a higher content of phenolics and specifically 
anthocyanins (red and purple pigments) will have a reduced glycemic response.  
Specifically, we will assess modified glycemic response from a serving of chipped 
potato products through capillary glucose monitoring.  Glycemic profiles will be 
related to gastric emptying rate through a 
13
C breath test and phenolic content.    
  
 





B. SPECIFIC PROCEDURES TO BE FOLLOWED 
   
 General Protocol:  
 Potential participants will respond to public advertisements (attached) and will also 
be asked to complete a questionnaire on the Laboratory for Sensory and Ingestive 
Studies website (IRB approval#504002017).  Those meeting initial screening 
criteria will be required to sign the consent form (attached).   
 
The entire study will consist of four five-hour sessions with a one week washout 
period between each treatment, where subjects will consume one of three 
commercial potato chip products or a white bread control.  Participants will report 
to the laboratory after a ten hour overnight fast.  Initially a capillary blood sample 
will be collected from a blood drop (~1-10uL) collected by finger tip stick.  
Samples will be collected by clinical staff Judy George or Robin Rhine who are 
trained in collection and processing of such samples.  Following this, the participant 
will ingest either 100g of potato chips or a white bread control along with a calorie 
free beverage containing 100 mg [
13
C] labeled-octanoic acid as a marker that will 
be detected through breath samples to measure the rate of gastric emptying. 
Octanoic acid is a generally recognized as safe (GRAS) food substance (21 CFR 
184.1025), and is a food additive permitted for direct addition to food for human 
consumption. Further, in 21 CFR 172.860, it is stated that “Octanoic acid is a food 
additive permitted for direct addition to food for human consumption, as long as 1) 
the quantity of the substance added to food does not exceed the amount reasonably 
required to accomplish its intended physical, nutritive, or other technical effect in 
food, and 2) any substance intended for use in or on food is of appropriate food 
grade and is prepared and handled as a food ingredient”. [
13
C]-labeled octanoic acid 
is a commercially available standard tracer used (100 mg) in human breath tests to 
measure gastric emptying rates. [1, 2] Breath samples will be collected in 300 ml 
bags every 15 min for four h from the time they finish consuming the potato chip.  
Subjects will be instructed to consume all of the potato given to them.  No other 
food or drink will be allowed during the remainder of the test session.  
Additional capillary blood samples will be collected at 10, 20, 30, 60 and 120 
minutes for glucose assessment. The total amount of blood collected will not exceed 
5mL during the course of the study.  
 
The rate at which the test materials are emptied from the stomach will be 
determined using a 
13
CO2 Urea Breath Analyzer POCone (Otsuka Electronics Co, 
Ltd, Osaka, Japan).  We have previous experience with both breath test methods 
(IRB Protocols # 1102010450, 04/09/2011 and # 1104010761, 05/24/2011). The 
Hamaker group has previous experience using the [
13
C] octanoic acid breath test 
method for gastric emptying assessment (IRB Protocols # 1102010450, 04/09/2011 
and # 1104010761, 05/24/2011). 
 
Study Samples:  
Test foods will consist of commercial potato made from different potato cultivars or 
white bread control.  Chips will have a defined composition of potatoes and oil and 









In addition to descriptive information (gender, height, weight, age, BMI), blood 
glucose response, [
13
C] breath recovery, gastric emptying time, and breath hydrogen 
recoveries will be determined 
 
 
C. SUBJECTS TO BE INCLUDED 
 Twelve healthy adult subjects (6 M and 6F) will be recruited to participate in this 
study. Other inclusion and exclusion criteria include: 
 
Inclusion Criteria: 









Peri- or post-menopausal women  
Following a weight reduction program or having followed one during the last 3 
months 
Acute or chronic disease 
Alcohol consumption > 30 units/week 
Hypertension 
Diabetes  
Previous bariatric surgery 
 
D.  RECRUITMENT OF SUBJECTS AND OBTAINING INFORMED 
CONSENT 
 Subjects will be recruited using flyers posted around campus. Interested individuals 
will be prescreened in person for verification of qualifying physical criteria. These 
individuals will be given an overview of the study and the test procedures for breath 
collection and blood sampling. Informed consent forms will be signed by qualified 
subjects who choose to participate in the study. Individuals that are found not to 
meet the requirements of the study during the prescreening process will not be 
allowed to participate and will not receive compensation.  
          
E.  PROCEDURES FOR PAYMENT OF SUBJECTS 
Subjects will receive compensation for their time and compliance with test 
procedures. Subjects will be paid at a rate of approximately $10/hr for their time 
and commitment to the study. We plan on paying each subject $250 in full after 
completion of the study. All subjects will fill out and sign a payment log with the 





Department of Food Science business office. Subjects who do not complete all five 
treatment sessions will receive a prorated payment. Non-resident subjects will be 
required to complete additional payment procedures via the Purdue Glacier system.  
  
F.   CONFIDENTIALITY 
 The records of subjects’ self-reported prescreening information and their progress 
in the study will be kept in a confidential file in a locked filing cabinet in a secure 
location on the Purdue Campus. A copy of the subject consent form, prescreening 
information, and their progress will be retained for at least three years after 
termination of the study and will be accessible to the principal investigator and 
researcher. At that time, they will be destroyed. The confidentiality of any computer 
record will also be carefully guarded by never including subjects’ names on any 
data file. The information will be stored electronically on a password-protected 
computer file.  No information by which subject can be identified, such as names, 
will be published. Names of subjects on all records will be de-identified by 
replacing names with numerical codes.  
 
 In the case that subjects’ information can be beneficial in further research purposes, 
subjects will be notified and their permission to use the current study’s information 
will be requested.  
         
              
G.   POTENTIAL RISKS TO SUBJECTS 
 There is a minor risk associated with all research.  The standard for minimal risk is 
that found in everyday life.  In addition there is minor risk of a breach of 
confidentiality pertaining to the information gathered from the subjects. However, 
all information and records of subjects will be locked in a secure location on the 
Purdue campus, and safeguards are in place for data security as described in Section 
F. Any record saved electronically will not contain names of subjects and the 
computer will require secure passwords to log in and gain access to the files. 
Additionally, there is slight risk of infection at the sites of blood collection and 
transient discomfort with the finger stick required to obtain a blood sample.    
 
                    
H.   BENEFITS TO BE GAINED BY THE INDIVIDUAL AND/OR SOCIETY 
There are no direct benefits to the subjects from their participation in this study. 
The results of this study will help us to understand the effects of slow release of 
glucose in the body and the role food derived phenolic compounds may play in 
modulating this response.  This may help to decrease the risk of chronic diseases 
like diabetes.  
 
 
I.   INVESTIGATOR’S EVALUATION OF THE RISK-BENEFIT RATIO 
The risk associated with participation are comparable to those associated with a 
routine blood test.  While there are no direct benefits to participants, the findings 





should provide insight into how dietary phenolics may help to modulate blood 
glucose response and risk for diabetes and obesity.  
 
J.   WRITTEN INFORMED CONSENT FORM  
         The approved copy of the Consent Form will be stamped with the IRB’s approval 
and returned to us for use. This approved consent form will be given to the subjects 
to read and understand the purpose of the study before signing it. Only the subjects 
that want to participate will sign and date the form.  
 
K. SUPPORTING DOCUMENTS  
  
 ● Recruitment flyer 
● Medical History Questionnaire 




1. "Octanoic Acid | C8H16O2 - PubChem." Octanoic Acid | C8H16O2 - PubChem. 
N.p., n.d. Web. 05 Mar. 2015. 
2. Perri, F., M. R. Pastore, and V. Annese. "13C-octanoic acid breath test for 
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Name: _____________________     Participant Number: 
_________ 
Gender: _________ 
DOB: __________                Age: ________ 
Email: _____________________________ 















RESEARCH PARTICIPANT  CONSENT 
FORM 
Glucose response from antioxidant rich 
potato chips Principal Investigator: Mario 
G. Ferruzzi, PhD.  R.D. Department of 






e, IN 47907 
(765) 494-0625 
 
What is the purpose of this study? 
There is considerable interest in how antioxidants in fruits and 
vegetables may help control blood glucose and provide health benefits 
(e.g., reduced risk of diabetes, obesity and cardiovascular disease).  
Potatoes are a rich source of both carbohydrate (as starch) and 
antioxidant compounds.  While assumed to be high in glycemic 
response, the antioxidants in potatoes may modify the ability of the 
body to digest the starch and ultimately slow the absorption of the 
glucose.  Considering there are several varieties of potatoes with higher 
levels of antioxidants, there are questions about whether use of these 
high antioxidant potatoes in production of common  snack foods, such 
as chips, can improve the glycemic response of potato snacks.  It is also 
possible that the higher antioxidants may slow rate at which foods are 
digested. The influence of each of these factors will be explored. 
What will I do if I choose to be in this study? 
To confirm your eligibility for this study, you must first read this 
consent form and ask any questions you may have about 
participation.You will report to the Laboratory for the Study of 
Sensory and Ingestive Studies in Stone Hall after a 10 hour fast on five 





separate occasions.  A blood sample (one drop) will be collected by 
finger prick (a small lancet will be inserted into a finger) and you will 
ingest a sample consisting of potato chips or white bread along with a 
calorie free beverage. Another blood sample will then be collected by 
finger prick.  Additional blood samples will be collected at 10, 20, 30, 
60, and 120 minutes.  You will also be 
asked to rate the palatability of the sample and your mood over the day. 
Testing will be conducted one week apart. 
 
How long will I be in the study? 
This study will require five visits, about 5 hours per visit, over a five week period. 
What.are the possible risks or discomforts? 
. All research has risk. This research has minimal risk, defined as the risk found 
in everyday life.  The food samples you will be asked to consume are made of 
commercially available ingredients and pose no foreseeable risk. The calorie 
free beverage wil1 contain labeled octanoic acid, This ingredient is an approved 
food additive   that  carries no risk at the levels used in this test.  All blood will 
be collected by an experienced technician, but the procedure may result in 
soreness at the site of collection (finger tips) and/or, infection.  The total 
amount of blood collected over all of the test sessions will be less than the 
amount normally taken during a routine blood test. To minimize any potential 
complications associated 
with the blood collection, you must not have donated blood in the past 3 months 
nor plan to donate during the upcoming 3 months. 
 
There is a minor risk associated with a breach of confidentiality pertaining to 
the information gathered from the subjects. However all information and 
records of subjects will be locked in a secure location on the Purdue campus 
and safeguards are in place to ensure safety of record. Any record saved 
electronically will also not contain names of subjects and the computer will 
require password security to log in and gain access to that information. 
 
Are there any potential benefits? 
You will receive no foreseeable direct benefits from my participation.  The 
knowledge gained may provide insights for improving dietary 
recommendations intended to reduce the frequency and complications of heart 
disease and cancers. 
Will I  receive payment or other incentive?  
You will receive a payment of $250.00 as compensation for any inconvenience my 





participation may have caused. Participants need to complete a payment log with 
the Department of Food Science Business Office in order to receive payment, and 
some personal information will be required including, name, address and social 
security number. Non-resident subjects will be required to complete additional 
payment procedures via the Purdue Glacier system. If you withdraw or are 
withdrawn from the study, you will receive a pro-rated payment. 
 
Are there costs to me for participation? 
There are no cost to participate in this study 
 
What happens if  I become in jured or ill because I took part in this study? 
 
If you feel you have been injured due to participation in this study, please 
contact Clinical Study Coordinator Judy George (765-494-6192; george 
j@purdue.edu) or Study PI Mario Perruzzi (765-494-0625; 
mferruzz@purdue.edu). Purdue University 
will not provide medical treatment or financial compensation if you are injured or 
become ill as a result of participating in this research project.  This does not waive 
any of your legal rights nor release any claim you might have based on negligence. 
 
Conflict of Interest Disclosure 
The following disclosure( s) is(are) made to give you an opportunity to decide if 
this(these) relationship(s) will affect your willingness to participate in the research 
study. 
 
• This study is supported, in part, by an unrestricted grant from PepsiCo, Inc. 
 
Will information  about me and my participation  be kept confidential? 
The project's research records may be reviewed by the study sponsor/funding 
agency (PepsiCo Inc.), Food and Drug Administration (if FDA regulated), Office 
for Human Research Protections (if federally funded) and by departments at 
Purdue University responsible for regulatory and research oversight. You 
understand that the record of your progress in the study will be kept in a 
confidential file in a locked filing cabinet in a secure location on the Purdue 





Campus.  A copy of this consent form and the record of my progress will be 
retained for three years after termination of the study. At that time, they will be 
destroyed. The confidentiality of any computer record will also be carefully 
guarded by never including my name on any data file. The information will be 
stored electronically on a password-protected computer file. No information by 
which you can be identified will be published.  However, you understand that it 
will be necessary to provide your name, social security number and address to the 
University business office to process any compensation payments.  In addition, 
research records may be inspected by the Purdue University Institutional Review 
Board or its designees, and (as allowable by law) state or federal agencies 
including the National Institutes of Health. 
 
In the case that subjects' information can be beneficial for further research 
purposes, subjects will be notified and their permission to use the current 
study's information will be requested. 
 
Please check one of the following boxes: 
 
DYes, you have my permission to use the current study's information for 
future research purposes. 
DNo, you do not my permission to use the current study's information for 
future research purposes. 
 
What are my rights if I take part in this study? 
Your participation in this study is voluntary.  You may choose not to participate or, 
if you agree to participate, you can withdraw your participation at any time without 
penalty or loss of benefits to which you are otherwise entitled. 




Who can I contact if l have questions about the study? 
 
If you have questions, comments or concerns about this research project, you can 
talk to one of the researchers.  Please contact Mario Ferruzzi (765-494-0625). 
 
If you have questions about your rights while taking part in the study or have 
concerns about the treatment of research participants, please call the Human 
Research Protection Program at (765) 494-5942, email (irb@purdue.edu)or write to: 
Human Research Protection Program - Purdue 
University Ernest C. Young Hall, Room 1032 
155 S. Grant St. 
West Lafayette, IN 47907-2114 
 
Documentation of Informed Consent 
 
You have had the opportunity to read this consent form and have the research study 
explained.  You have had the opportunity to ask questions about the research study, 
and your questions have been answered. You are prepared to participate in the 
research study described above.  You will be offered a copy of this consent form after 
you sign it. 
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The overall objective of this study was to determine if orange pomace could be 
leveraged as a source of bioaccessible phenolics capable of modulating intestinal glucose 
uptake. The specific objectives of this portion of the study were three-fold. The first was 
to characterize the phenolic composition of orange pomace generated from orange juice 
processing and of orange juice products formulated with pomace. The second objective 
was to determine the bioaccessibility of phenolics from orange samples provided by 
Pepsico R&D and the final objective was to examine the potential for bioaccessible 
orange pomace phenolics and fibers to modulate kinetics of intestinal glucose 




Orange fruit and industrial products used in this study were provided by Pepsico 




juice products (Valencia or Navel orange juice OJ)) formulated with citrus fiber or 
pomace (Table 1). Each sample was extracted and polyphenol profiles were obtained 
(Objective 1). The ability of phenolic extracts to inhibit glucose uptake was then 
evaluated (Objective 2).  
 
Table 1: Orange fruit and orange juice (OJ) sample description and codes received from 
Pepsi R&D Global.1 
Sample Sample Description 
Valencia fruit Orange Fruit Valencia 
Navel fruit Orange Fruit  Navel 
Navel OJ A7 OJ  
Navel OJ P1% A7 OJ w/ pomace (1% fiber) 
Navel OJ CF1% A7 OJ w/ Citri-Fi (1% fiber) 
Navel OJ CF2.8% A7 OJ w/ Citri-Fi (2.8% fiber) 
Valencia OJ Valencia OJ 
Valencia OJ P1% Valencia OJ w/ pomace (1% fiber) 
Valencia OJ P2.8% Valencia OJ w/ pomace (2.8% fiber) 
Valencia OJ CF1% Valencia OJ w/ Citri-Fi (1% fiber) 
Valencia OJ CF2.8% Valencia OJ w/ Citri-Fi (2.8% fiber) 
1
Fiber in final product 
 
Polyphenol extraction and analysis by LC-MS (Objective 1): 
Extraction of starting material and digesta using microwave-assisted extraction 
Orange phenolics were extracted using a microwave assisted extraction adapted 
from Proestos et al. [1].  Briefly, extraction solvent (60% acetone in water, 8 mL) was 
added to starting material or digestion fractions (2 mL) in a 15 mL conical.  Samples 




magnetic stirring using a Mars Xpress microwave. The parameters for irradiation were as 
follows: power- 750W; 45 seconds power on, 30 sec power off, 15 sec power on. The 
extract was then centrifuged (4500 rpm, 20 min, 4⁰C). The supernatant was recovered 
and diluted 1:1 with 0.4% formic acid in water and filtered (0.2µm) for injection on 
HPLC. 
Analysis of polyphenols by LC-MS 
Phenolic compounds from orange juice products were characterized by HPLC 
using methods adapted from those described by Song et al. [2].  Aliquots of starting 
material and digesta extractions were centrifuged (14krpm, 5min) and diluted 1:1 with 
mobile phase in preparation LC-MS and aliquots of aqueous digesta were direct injected. 
All samples were analyzed using a Waters 2695 Alliance system using a Waters X-
Bridge C18 column (2.5 µm, 100 x 2.0 mm i.d.) and a binary mobile phase consisting of 
2.0% formic acid (v/v) in ddH2O (Reservoir A) and 0.1% formic acid (v/v) in acetonitrile 
(Reservoir B).Initial conditions of 95:5 A/B was followed by a linear gradient to 65:35 
A/B (0-15 min), 30:70 A/B (15-17 min), 95:5 A/B (17-19 min), and 95:5 A/B (19-23 
min). Following separation the column effluent was introduced by negative mode 
electrospray ionization (ESI) into a Waters Micromass ZQ MSD.  MS conditions were as 
follows: ionization mode: ESI-; capillary voltage: 3.00kV; cone voltage: 40V; extractor 
voltage: 5V; RF lens: 0V; source temp: 150°C; desolvation temp: 250°C; desolvation gas 
flow: 400L/hr; and cone gas flow: 60L/hr. Following initial screening, key mass spectra 
single ion responses (609, 463, 593, 579, 301, 271, 287, and 317) were collected for 




Table 2: Single ion responses for identification and quantification of phenolic 
compounds. 











Polyphenol stability/bioaccessibility from model orange juice beverages (Objective 2) 
Phenolic bioaccessibility from orange products was determined using a three 
stage in vitro digestion as described by Thakkar et al. [3] and modified by Kean et al. [4].  
This method simulates oral, gastric and small intestinal digestion in sequence is order to 
assess the release and stability of bioactive compounds, including phenolics, from foods 
and beverages.  Oral phase digestive solution was prepared by addition of KCl, Na3PO4, 
Na2SO4, NaCl, and NaHCO3 for final concentrations of 242.78, 10.83, 8.03, 10.20, and 
40.33 mmol/L, respectively. Aliquots of formulated orange juice beverages (~20 g) were 
mixed with oral phase solution in a 50 mL centrifuge tube. The reaction tube was 
vortexed, blanketed with nitrogen, and incubated in a covered shaking water bath (37°C, 
85 opm, 10 min). Samples were then brought to 30 mL with saline solution (0.9% NaCl). 
The gastric phase was then initiated by addition of 2 mL porcine pepsin solution (20 
mg/mL in 0.1 M HCl) and adjustment of the reaction pH to 3.0 ± 0.1 with 1.0 M HCl. 




with nitrogen and incubated in a covered shaking water bath (37°C, 85 opm, 1 hr). 
Following incubation, the small intestinal phase was initiated by addition of 1.0 M 
NaHCO3 to adjust the pH of gastric digesta to 6.5 ± 0.1.  A cocktail of small intestinal 
enzymes (2 mL, 30 mg/mL pancreatin, 15 mg/mL lipase in 0.1 M NaHCO3) and porcine 
bile salts (3 mL, 120 mg/mL bile extract in 0.1 M NaHCO3) were added to the solution. 
Samples were then brought to a final volume of 50 mL with 0.9% saline solution, 
blanketed with nitrogen and incubated in a covered shaking water bath (37°C, 85 opm, 2 
hrs). After completion of the small intestinal phase, samples were centrifuged (10,400 x 
g, 4°C, 1 hr) and filtered using a 0.2μm filter.  Aliquots of undigested beverage starting 
material (SM), and centrifuged aqueous small intestinal digesta (AQ) were collected and 
applied to glucose transport studies (below) or acidified with aqueous acetic acid (1% 
total in sample) and stored frozen at -80°C until analysis by HPLC (outlined above). 
Glucose Transport by Caco-2 Small Intestinal Epithelial Cells (Objective 3) 
Caco-2 glucose transport model 
The potential for bioaccessible orange phenolics to inhibit intestinal glucose 
transport was investigated using the Caco-2 human intestinal cell culture model using the 
method of Manzano and Williamson [5] with modification applying d7-glucose as the 
labeled tracer for transport studies.  Caco-2 (HTB-37) cells were maintained in DMEM 
supplemented with 10% v/v fetal bovine serum, 1% v/v nonessential amino acids, 1% v/v 
HEPES, 1% v/v penicillin/streptomycin and 0.1% v/v gentamicin. Cells were incubated 









grown and differentiated in 6 well insert plates (Corning® Transwell® polyester 
membrane, 24mm diameter, pore size 0.4μm) under a humidified atmosphere of air/CO2 
(95:5) at 37
°C
. All experiments used differentiated monolayers (electrical resistance > 500 
Ω cm
2
) at passages 85-95, with uptake/accumulation studies conducted 20-22 days post-
confluency.  Cells were incubated in glucose-free DMEM for 2 hours preceding 
treatment. Test media was prepared by diluting aqueous digesta 1:2 with d7-glucose 
solubilized in PBS pH 5.5 for final glucose and d7-glucose concentrations of 11-13 mM 
and 2mM, respectively, prior to introduction to the apical surface of cell monolayers. 
Matching controls were prepared by diluting blank digesta 1:2 with glucose, fructose, and 
d7-glucose solubilized in PBS pH 5.5 for final glucose, fructose, and d7-glucose 
concentrations of 6 mM, 6 mM and 2 mM, respectively. At predetermined time intervals 
(0, 15, 30, 60 min), basolateral media (150μL) was collected. After 60 min, apical media 
was collected and cells were washed twice with 0.1% fatty acid free PBS. Membranes 
were then washed with ice cold PBS to stop glucose transport, and cells were collected 
and frozen until analysis.   
Analysis of glucose concentration in basolateral media by LC-MS 
Basolateral media was filtered through a 0.45 μm PTFE filter prior to analysis. 
10μL of sample was injected on a Waters 1100 Series HPLC system equipped with a 
Waters MicromassLCT PremierMS. Separation was achieved using a Varian Polaris 
C18-amide column (2.0 mm id x 150 mm, 3.0μM particle size) heated to 30°C under 




MS conditions adapted from Ikegami et al. [6] were as follows: ionization mode: ESI (-); 
mass: 222m/z; capillary voltage: 3.2 kV; cone voltage: 20 V; source temp: 100°C; 
desolvation temp: 350°C; desolvation gas flow: 350 L/hr; and cone gas flow: 50 L/hr. 
Data Analysis 
Data for polyphenol content of orange samples and for glucose samples are 
expressed as mean ± SEM from a minimum of n=3-4 replicates. Glucose transport is 
expressed as concentration (μM) of glucose in basolateral compartment, percent (%) 
glucose transport, rate (μmol/min) of glucose transport, and percent (%) glucose transport 
relative to control. Relative bioaccessibility (%) is defined as the percent of polyphenol 
recovered in final digesta from that in starting material. Absolute bioaccessibility 
(μmol/reaction) is the amount of phenolic available in digesta per gram starting material, 

















Figure 1: Levels of polyphenols in (a) starting material, (b) digesta, and (c) aqueous 
digesta of Valencia orange juice beverages formulated with varying types and amounts of 






Figure 2: Levels of polyphenols in (a) starting material, (b) digesta, and (c) aqueous 
digesta of Navel orange juice beverages formulated with varying types and amounts of 






Table 3. Concentration (μmol/100g) of polyphenols from raw material of Valencia orange juice beverages formulated with varying 
types and amounts of fiber, and from orange fruit and orange puree. 
 
 
Table 4. Concentration (μmol/100g) of polyphenols from raw material of Navel orange juice beverages formulated with varying types 




Didymin Didymin Narirutin Hesperetin Naringenin Eriodictyol Myricetin Total 
Valencia 
Fruit 
32.9 ± 1.3a 0.9 ± 0.03a 2.9±0.1a 2.0±0.1a 4.5±0.1a 11.7±0.1a,b 34.7±0.4a 2.0±0.04a 1.6±0.1a 93.2±2.0a 
Valencia 
OJ 
27.8±0.2b 0.2±0.01c 1.5±0.02c 0.8±0.02c,d 1.3±0.01c,d 11.2±0.1b 13.2±0.1c,d 1.2±0.01c 1.0±0.01c,d 58.1±0.4c 
Valencia 
OJ P1% 
25.5±0.3c 0.2±0.01c 1.6±0.04c 0.8±0.04d 1.4±0.04c,d 9.3±0.4d 12.6±0.6d 1.1±0.1c 1.0±0.1c 53.4±1.5d 
Valencia 
OJ P2.8% 
23.3±0.2d 0.2±0.01c 1.3±0.04d 0.6±0.01e 1.3±0.03d 9.3±0.1d 11.1±0.3e 0.9±0.02d 0.8±0.02d 48.8±0.7e 
Valencia 
OJ CF1% 








Didymin Didymin Narirutin Hesperetin Naringenin Eriodictyoll Myricetin Total 
Navel 
Fruit 
35.3±5.8a,b 0.3±0.02c 3.1±0.1a 2.6±0.5a 5.6±0.4a 11.5±1.1a,b 36.4±1.6a 1.5±0.1a 1.0±0.1b 97.4±9.5a 
Navel OJ 30.5±0.3
a,b 0.2±0.01c 1.6±0.01d 1.0±0.02b 1.8±0.02c 10.8±0.3b,c 16.2±0.2c,d 1.2±0.02b,c 0.8±0.01d 64.2±0.6c 
Navel OJ 
P1% 
27.1±0.3b 0.3±0.01b,c 1.7±0.1c,d 0.9±0.04b 1.7±0.04c 9.7±0.3c 15.7±0.3d 1.2±0.01c 0.9±0.02c 59.2±1.1c 
Navel OJ 
CF1% 
32.2±0.4a,b 0.3±0.01b 1.8±0.01c 1.1±0.02b 2.0±0.02b,c 11.5±0.1a,b 18.2±0.1c 1.3±0.03b 0.9±0.02c 69.4±0.6b,c 
Navel OJ 
CF2.8% 









Table 5. Relative (%) bioaccessibility of polyphenols from Valencia orange juice beverages formulated with varying types and 











Table 6. Relative (%) bioaccessibility of polyphenols from Naval orange juice beverages formulated with varying types and amounts 













Didymin Didymin Narirutin Hesperetin Naringenin Eriodictyol Myricetin 
Valencia Fruit 24.1±0.6a,b 48.9±3.4b 51.5±1.0b,c 39.9±2.8a 40.1±0.9d 19.1±0.7b 30.6±0.8b 40.5±0.6b 48.3±2.1b 
Valencia OJ 20.6±1.8b,c 22.8±2.9c 57.0±5.1b 30.7±2.1b,c 65.8±5.4a 5.8±0.5c 6.8±0.6c 12.4±0.9c 22.4±2.5c 
Valencia OJ 
P1% 
22.1±1.6b 21.0±2.2c 43.3±1.9d,e 38.9±4.9a,b 52.5±2.7b,c 6.5±0.5c 6.5±0.4c 12.4±0.9c 19.7±1.8c,d 
Valencia OJ 
P2.8% 
27.8±1.8a 64.5±3.6a 78.4±2.3a 37.8±2.7a,b,c 58.0±2.1a,b 25.1±1.4a 47.4±1.5a 45.8±0.7a 60.3±3.2a 
Valencia OJ 
CF1% 
17.2±1.0c,d 21.5±0.2c 45.6±2.0c,d 29.8±1.6c 52.3±1.7b,c 5.2±0.3c 6.0±0.3c 12.8±0.7c 19.1±1.0c,d 
Valencia OJ 
CF2.8% 




Didymin Didymin Narirutin Hesperetin Naringenin Eriodictyol Myricetin 
Navel 
Fruit 
22.6±2.5a 58.4±3.7a 53.3±0.5a 32.1±4.5a,b 37.4±2.0b 21.8±2.0a 32.5±0.9a 44.0±0.4a 55.7±1.0a 
Navel OJ 14.7±1.2
c 20.1±1.4b 53.9±4.8a 24.4±1.8b 57.6±4.7a 4.5±0.3b 5.7±0.6b,c 11.5±1.0c 22.6±1.7b 
Navel OJ 
P1% 
19.6±0.5a,b 22.7±1.3b 56.1±3.9a 34.8±1.4a 61.1±0.9a 5.8±0.3b 6.3±0.4b 14.5±0.9b 22.8±1.8b 
Navel OJ 
CF1% 
16.8±0.6b,c 19.3±1.0b 54.3±2.2a 27.2±0.8b 56.2±0.6a 5.0±0.3b 5.8±0.3b 11.9±0.3c 21.0±0.3b 
Navel OJ 
CF2.8% 












Table 7. Absolute (μmol/100g) bioaccessibility of polyphenols from aqueous digesta of Valencia orange juice beverages formulated 
with varying types and amounts of fiber, and from orange fruit and orange puree. 
 
 
Table 8. Absolute (μmol/100g) bioaccessibility of polyphenols from aqueous digesta of Naval orange juice beverages formulated with 




Didymin Didymin Narirutin Hesperetin Naringenin Eriodictyol Myricetin Total 
Valencia 
Fruit 
19.1±0.3a 1.0±0.1a 3.6±0.1a 1.9±0.1a 4.4±0.1a 5.3±0.2a 25.5±0.9a 1.9±0.1a 1.9±0.1a 64.5±1.5a 
Valencia 
OJ 
13.7±1.1b,c 0.1±0.01c 2.0±0.2b 0.6±0.03c,d 2.1±0.2b 1.6±0.1b 2.1±0.2c 0.3±0.03c,d 0.5±0.1c 23.2±1.8c 
Valencia 
OJ P1% 
13.5±0.8b,c 0.1±0.01c 1.6±0.04c 0.7±0.1c 1.8±0.1c 1.4±0.1b 2.0±0.04c 0.3±0.01d 0.5±0.02c 21.9±1.1c 
Valencia 
OJ P2.8% 
15.6±0.9b 0.3±0.01b 2.4±0.1b 0.5±0.03d 1.8±0.04c 5.6±0.3a 12.6±0.1b 1.0±0.01b 1.2±0.04b 40.9±1.3b 
Valencia 
OJ CF1% 



































































































































Figure 3. Glucose transport by Caco-2 small intestinal epithelial cells treated with 
glucose (control) or co-treated with glucose and (a) Valencia or (b) Navel orange juice 




























































































Table 9. Glucose transport by Caco-2 small intestinal epithelial cells treated with glucose 
(control) or co-treated with glucose and orange juice digesta. d7-Glucose was used as a 
























Relative (%) d7-Glucose 
Transport Compared to 
Daily Glucose Control 
Control  
(6mM Glucose) 
 0  100±3.1a 
Valencia Fruit 35.9 ± 2.5 51.2±8.9
c,d 
Valencia OJ 12.9 ± 3.0 31.6±1.7
 e
 
Valencia OJ P1% 12.2 ± 1.8 64.4±2.7
 b
 
Valencia OJ P2.8% 22.7 ± 2.1 45.3±3.1
 d
 
Valencia OJ CF1% 11.4 ± 1.6 44.3±1.8
 d
 
Valencia OJ CF2.8% 11.9 ± 0.3 57.9±2.6
 b,c
 
Navel Fruit 37.2 ± 3.4 36.6±3.1
 d
 
Navel OJ 11.2 ± 3.0 65.9±2.1
 b,c
 
Navel OJ P1% 12.8 ± 1.5 53.1±8.4
 c,d
 
Navel OJ CF1% 13.2 ± 1.6 80.0±4.7
 b
 







Starting SM phenolic profiles of eleven orange juice samples 
Several phenolic species including flavanones, flavones, flavonols, and their 
glycosides were observed in SM of the eleven orange products screened (Figures 1 and 2; 
Tables 1, 3, and 4). Flavanones hesperedin and naringenin were the most prominent 
flavonoids observed in SM of orange products. Hesperedin levels ranged between 23.3 to 
34.3 μmol/100g and 27.1 to 36.8 μmol/100g in Valencia and Navel SM, respectively. 
Naringenin levels ranged between 11.1 to 34.7 μmol/100g and 15.7 to 36.4 μmol/100g in 
Valencia and Navel SM, respectively. All remaining flavanones and flavones were 
present in orange products between 0.2 to 12.9 μmol/100g. Finally, quercetin-glucoside 
(a flavonol derivative) was present at low levels (0.2 to 0.4 μmol/100g) in all orange 
products except Valencia fruit (0.9±0.03 μmol/100g).  
Levels of each flavonoid were compared between orange products (Tables 3 and 
4). Overall, Navel SM had higher level of most flavonoids compared to Valencia SM, 
with the exception of quercetin-glucoside in Navel fruit and eriodictyol in Navel OJ 
without added fiber. When comparing flavonoid levels within variety, Valencia fruit SM 
had significantly higher (p<0.05) levels of flavonoids compared to all Valencia OJ, with 
exception of hesperedin and hesperetin, which were at similar levels compared to 
Valencia OJ containing Citri-Fi (2.8%) (34.3±0.1 and 11.8±0.1 μmol/100g, respectively). 
On the other hand, Navel fruit had significantly higher (p<0.05) levels of didymin 
species, narirutin, naringenin, eriodictyol, and myricetin compared to Navel OJ, but 




in Valencia and Navel OJ resulted in significantly increased (p>0.05) levels of most 
flavonoids compared to remaining beverage formulations, with levels being similar to 
those from whole fruit. No further notable trends with regards to addition of fiber to OJ 
formulations were observed.  
In vitro bioaccessibility of flavonoids from orange juice  
Valencia and Navel fruits and formulated OJ beverages were subjected to a three-
stage in vitro digestion model. Relative (%) bioaccessibility (%BA; Tables 5 and 6) and 
absolute bioaccessibility (Tables 7 and 8) of flavonoids from each type of orange product 
were calculated to determine impacts of orange variety or presence of added fiber 
(pomace or Citri-Fi) on bioaccessibility of flavonoids from orange fruit or OJ. %BA of 
individual phenolics ranged from 4.0 to 78.4% (Tables 5 and 6). Hesperedin, hesperetin, 
naringenin, eriodictyol, and myricetin %BA was significantly higher (p<0.05) from 
Valencia and Navel fruits compared to all OJ beverages. %BA from fruits ranged from 
19.1 to 44.0% compared to 4.0 to 22.8% from juices, with the exception of Valencia OJ 
with pomace (2.8%). Most flavonoids were significantly more (p<0.05) bioaccessible 
from Valencia OJ with pomace (2.8%) (25.1 to 78.4% BA) compared to Valencia fruit 
and remaining OJs. Due to their high levels in starting material, absolute BA of 
hesperedin and naringenin from orange samples were much higher compared to other 
flavonoids, ranging from 2.1 to 28.3 μmol/100g compared to 0.1 to 5.9 μmol/100g 





Modulation of glucose transport across Caco-2 intestinal epithelial cells by OJ digesta 
To determine the impact of bioaccessible phenolics on glucose transport, Caco-2 
cells were treated with diluted AQ digesta resulting from in vitro digestion of orange 
fruits and OJs (11.1 to 37.2 total phenolics; 11-13mM glucose plus fructose) spiked with 
d7-glucose (2mM). All digesta resulting from in vitro digestion of fruit and fruit juices, 
significantly (p<0.05) decreased d7-glucose transport over 60 min relative to matching 
phenolic-free controls by 20.0 to 68.4% (Figure 3, Table 9) . Valencia OJ without added 
fiber decreased glucose transport significantly (p<0.05) compared to Valencia fruit and 
Valencia OJ with added fibers, decreasing transport by 68.4±1.7% compared to 35.6 to 
55.7%. Navel whole fruit digesta decreased glucose transport compared with control to a 
significantly greater extent (p<0.05) compared to digesta from Navel OJ without added 
fiber and Navel juice with Citri-Fi (1%), decreasing transport by 63.4±3.1% compared to 
34.1±2.1 and 20.0±4.7%, respectively. Further, addition of Citri-Fi for 2.8% total fiber in 
Navel OJ decreased glucose transport to a significantly (p<0.05) greater extent compared 
to addition of Citri-fi for 1% total fiber by 49.1±3.3 compared to 20.0±4.7%.  
Discussion 
Health professionals have been urging consumers to avoid consuming foods that 
are high in sugars and simple carbohydrates with the concern being the increased rate at 
which glucose from such foods reaches high concentration in blood, termed 
hyperglycemia. Importantly, hyperglycemia is one of the main contributors to obesity and 




the target of much scrutiny [7,8]. Although 100% fruit juices are considered sugary 
beverages, a recent meta-analysis suggests that, unlike sugar-sweetened beverages, fruit 
beverages may not have a negative impact on glucose control in adults [9]. In support, 
results from recent clinical studies showed consumption of phenolic-rich 100% fruit 
beverages resulted in lower blood glucose levels compared to matching sugar sweetened 
beverages [10–12]. 
Previous research has demonstrated the ability of plant phenolics to mitigate 
starch digestion and intestinal glucose transport [5,13–19]. Further, recent studies 
indicate effects observed in vitro may translate to lowered glycemic response following 
phenolic-rich fruit beverage compared to a sugar sweetened beverage in vivo. Glycemic 
response was lower for volunteers that consumed apple juice (400 mL) compared to that 
of those that consumed phenolic-free beverages matched for sugar content, indicating that 
phenolic components in apple juice may decrease intestinal glucose uptake [10]. Further, 
a study was conducted to determine impacts due of fiber addition to apple juice on 
glucose response in men. The fibers (mixture of xanthan gum with konjac-mannan or 
guar gum) were added to ~0.25% w/w in apple beverages. Subjects consumed both fiber 
formulated juices and fiber-free control juice (300 mL) separately in a randomized 
crossover design. Results showed that fiber had no impact on glucose response at levels 
assessed [20].  However, levels of fiber used in these formulations were low. To explore 
the possibility for OJ phenolics in the context of OJ food matrix to impact glycemic 
response, a coupled in vitro digestion and cell culture model was utilized to determine 
impacts of bioaccessible phenolics from OJ formulated with and without added fibers on 




Levels of total flavanones, the primary phenolic species in OJ, observed here (214 
to 315 mg/L) is comparable to those previously reported (133-760 mg/L) [21–26]. 
Further, most individual flavanone levels fell within range of those previously reported, 
with the exception of hesperedin and hesperetin which were present at relatively low and 
high levels, respectively, (33 to 52 and 118 to 164 mg/L compared to 76 to 365 and 49 
mg/L hesperedin and hesperetin).  
Flavonoid bioaccessibility is required for bioactivity in the gut and, ultimately, 
bioavailability and systemic bioactivity. Didymin, and narirutin were the most 
bioaccessible flavonoids from Valencia and Naval OJ, with bioaccessibility ranging 
between 30 and 65%. However due to high starting concentrations, hesperetin and 
naringenin had considerably higher absolute bioaccessibility (up to 2.0 and 2.4 μmol/rxn 
for juices and whole fruits, respectively) compared to remaining flavonoids. Results for 
narirutin, hesperedin, and didymin %BA were consistent with previous reports [22,24]. 
However, total phenolic and hesperetin bioaccessibility were about 2x lower than 
previously reported. Hesperetin levels in starting material were much higher compared to 
remaining flavonoids, therefore low overall phenolic bioaccessibility compared to values 
reported in literature are likely due to low bioaccessibility of hesperetin. Interestingly, 
flavonoid bioaccessibility was generally higher from orange fruit than OJ.  
An overview of how phenolic interaction with fiber may impact bioaccessibility 
and bioavailability of phenolics has previously been reviewed [27,28]. Phenolic 
hydroxide groups and phenolic rings non-covalently interact with polar groups and 
hydrophobic areas on polysaccharides, respectively, primarily through hydrogen bonds, 




be protection of plant phenolics from degradative reactions during digestion and 
subsequent release of intact phenolic in the duodenum resulting in increased phenolic 
bioaccessibility. Conversely, failure of interaction to be released in small intestine results 
in delivery of phenolics to colon for further metabolism by gut microbiota or excretion. 
Here, bioaccessibility of phenolics from Navel or Valencia OJ formulated with pomace 
or Citri-Fi were compared to fiber-free controls. Pomace addition to 1% in Navel, but not 
Valencia OJ, resulted in increased %BA of most flavonoids compared to their respective 
controls. However, addition of pomace to 2.8% in Valencia OJ resulted in increased 
(p<0.05) flavonoid %BA compared to remaining Valencia OJ. On the other hand, 
addition of Citri-Fi to 2.8% in Navel and Valencia formulations decreased 
bioaccessibility of specific phenolics (didymin, narirutin, myrecitin). Pomace consists of 
a network of fibers that has ordered, cellulosic structure [29] whereas commercial Citri-Fi 
is derived from orange fibers that have been mechanically processed to have a more 
porous structure with increased surface area [30]. Our results suggest that the cellulosic 
structure of the fibers in pomace may allow for temporary hydrophobic binding with 
phenolics followed by release in the duodenum. On the other hand, interactions with 
Citri-Fi fibers may be more abundant and strong in comparison to pomace fiber due to 
increased surface area resulting in more limited release of phenolics in the duodenum. 
The free, bioaccessible portion of flavonoids here are in AQ, whereas intact flavonoids 
found in DG are bound. Flavonoid concentration in DG from Citri-Fi fromulations was 
7.14 to 9.86 μM greater compared to AQ fraction whereas that in DG from OJ formulated 
with pomace or without fiber was only 1.9 to 6.9 μM higher than AQ (Figures 1 and 2). 




to pomace during duodenal digestion, and therefore not part of the bioavailable fraction 
in the lumen.  
In addition to reports suggesting phenolics may modulate carbohydrate digestion, 
recent research has shown various plant-derived phenolic extracts mitigate glucose 
transport across Caco-2 intestinal cell monolayers by up to 50% [5,16]. However, there is 
no information on whether the bioaccessible flavonoid fraction from phenolic-rich foods 
may have an effect on intestinal glucose uptake. Therefore, we investigated the impact of 
the bioaccessible (AQ) fraction obtained from in vitro digestion of each orange fruit or 
OJ on glucose transport in a Caco-2 human intestinal cell model. AQ feeding material 
contained between 9-40µM flavonoids. AQ fraction from every orange product, except 
from Navel juice with Citri-Fi (1%) significantly (p<0.05) decreased d7-glucose transport 
over 60 min relative to matching phenolic-free controls. Although Valencia and Navel 
fruit AQ contained higher concentration of phenolics compared to OJ AQ, Valencia fruit 
AQ did not significantly decrease (p<0.05) glucose transport compared to Valencia OJ 
AQ and Navel fruit AQ decreased glucose transport to a significantly greater extent 
(p<0.05) only compared to AQ from Navel OJ and Navel OJ with Citri-Fi added for 1% 
total fiber in product. There are no clear trends related to effects due to addition of 
specific types or amounts of fiber to OJ on its ability to impact glucose transport in vitro.  
 
Conclusions 
Orange juice contains a significant amount of flavonoids. Although high in sugar, 




compared to consumption of phenolic-free beverages. Our results show oranges and OJ 
are particularly rich in hesperetin and naringenin. In agreement with previous reports, OJ 
flavonoids are moderately bioaccessible [22,24]. Addition of fiber modulated flavonoid 
bioaccessibility, with effects being dependent on fiber structure. Specifically, the ordered 
cellulosic structure of pomace fiber appeared to promote flavonoid bioaccessibility 
whereas porous Citri-Fi fibers appeared to reduce flavonoid bioaccessibility. Results 
from the coupled in vitro digestion and Caco-2 intestinal cell model suggest that 
bioaccessible OJ flavonoids decrease intestinal glucose transport, and the effect is not 
affected by fiber. However, the model does not take into consideration gut transit and 
gastric emptying both of which are modified by fiber and may also have an impact rate of 
glucose transport. Overall these results suggest substitution of sugary beverage with OJ in 
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